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General introduction and outline of this thesis
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General introduction and outline of this thesis
The circulation is a closed circuit, in which blood fl ows to the heart (venous return), 
to be pumped by the heart (via the lungs) to the aorta (cardiac output, CO). Starling 
placed the heart centrally in the circulation as demonstrated by the cardiac function 
curve (fi gure 1.1). Consequently, analysis of CO mostly focuses on preload, heart rate, 
contractility and afterload. However, it is important to realize that CO and venous return 
(VR) are intertwined, because the heart can only pump out that which it receives. In 
this respect preload can be redefi ned as VR. In steady-state conditions VR equals CO:
   VR = CO
CO can differ from VR only for short periods of time, for example when contractility 
is changed with a positive or negative inotropic agent. However, as the heart cannot 
store blood volume or pump out more than venous return, CO and VR must reach a 
new equilibrium.
Figure 1.1 Cardiac function curve
Relationship between right atrial pressure (Pra) and cardiac output (CO).
Basic physiology of the circulation
Whether it is the heart or the VR that maintains circulation is still subject to debate.1,2 
In cardiac failure, the heart obviously is the impeding component in the circulation and 
will determine the upper limit of CO. However, in persons without heart failure the 
question above still remains. Anderson makes a strong case for the VR as the driving 
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During diastole the heart is fi lled with blood. Transmural intracardiac pressures remain 
positive even during diastole.3 Yet, only negative intracardiac pressures could suck 
blood into the heart. It follows that the heart does not actively suck blood, but instead 
fi lls passively. The heart can therefore be described as a passive fi lling pump, which 
even offers some resistance to fi lling, because of the heart’s limited volume-pressure 
compliance. So which force drives blood into the heart? Logically only a peripheral 
venous pressure in excess of right atrial pressure (Pra) could direct blood into the heart. 
The pressure gradient of this peripheral venous pressure and Pra determines VR.4,5 The 
function of the heart is to lower the pressure at the ventricular inlet (Pra) and to raise the 
pressure at its outlet into the arterial system.6 The resulting pressure gradient between 
the arterial and venous system will in turn maintain fl ow, completing the circle.
Is it possible to primarily increase CO? Positive inotropic agents, which increase 
contractility, also affect vascular tone.7,8 Thus theoretically, the most direct way to 
increase CO would be to increase heart rate (HR); but will this work in practice? Cowley 
and Guyton9 showed that HR did not infl uence CO at normal levels of VR; only in 
cases of increased VR with use of an arteriovenous fi stula, when the heart became the 
limiting factor, a higher HR increased CO. Thus, in patients with unimpaired cardiac 
function the only way to increase CO is to increase VR. Subsequently, the heart has two 
built-in mechanisms that enable the heart to pump out what it receives. One of these 
mechanisms is increasing contractility, i.e. the Frank-Starling mechanism, and the 
other mechanism is increasing HR, i.e. the Bainbridge refl ex caused by stretching of 
the right atrium. Thus, selectively increasing HR or increasing contractility and thereby 
augmenting stroke volume (SV), will not increase CO, simply because the heart cannot 
pump out more than it receives from the venous system. When VR is stable, an increase 
in HR will be compensated for with a decrease in SV. Similarly a decrease in HR rate 
will result in increased SV.
Late in the 19th century, Bayliss and Starling10 already acknowledged the role of the 
venous part of the circulation, as a “forgotten or disregarded chapter in the physiology 
of circulation”. And although Guyton et al.11-13 studied the physiology of venous return 
extensively, the statement of Bayliss and Starling still holds today, primarily because of 
the inability to determine venous return in the clinical situation.
Venous system
The venous system contains approximately 75% of total blood volume. Most of this 
venous blood volume is located in small veins and venules, which act as a reservoir 
of blood (capacitance vessels). The total intravascular blood volume can be divided 
into unstressed volume and stressed volume. The blood volume that fi lls up the blood 
vessels without building up an intravascular pressure is called unstressed volume (Vu), 
while the volume that stretches the blood vessels is called stressed volume (Vs). The 
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pressure that exists in the stressed volume compartment is called mean systemic fi lling 
pressure (Pmsf), which is the main subject of this thesis.
Bathtub model
Using a bathtub with a drain opening as model for the circulation, Magder1 describes 
the total of Vu and Vs as the water in the bathtub (fi gure 1.2A). The fl uid below the 
drain opening is Vu and the fl uid above is Vs. Vs is the effective circulating volume, 
just like in the bathtub model the water above the drainage point will be drained from 
the bathtub, while the water below (Vu) will remain in the bathtub. The pressure of 
the fl uid column above the drainage point is Pmsf. By adding a reservoir with lower 
pressure (Pra), fl uid fl ows from the bathtub to this reservoir (right atrium). A pump 
(heart) then pumps the fl uid into the tap (arterial system), which fi lls the bathtub again. 
Figure 1.2 Bathtub model of the circulation
The water beneath the drainage pipe, which cannot leave the bathtub, resembles unstressed volume 
(Vu). The water above the drainage pipe, which can be drained from the bathtub, resembles stressed 
volume (Vs). The height of the water column above the drainage pipe is the hydrostatic pressure, 
which is mean systemic fi lling pressure (Pmsf). Water leaves the bathtub via a drainage pipe to a 
reservoir (right atrium) and will be pumped again into the bathtub by the heart. The pressure in the 
reservoir is right atrial pressure (Pra). 
Drainage from the bathtub (which is venous return) is determined by the pressure difference between 
Pmsf and Pra as well as by the characteristics op the drainage pipe (resistance to venous return, Rvr). 
Panel A: The pressure in the bathtub (Pmsf) exceeds the pressure in the reservoir (Pra) and water will 
fl ow to the reservoir.
Panel B: The reservoir is placed higher, Pra now equals Pmsf, and fl ow will cease. Note that the 
function of the pump (heart) is to lower Pra and to return water to the tub. Adopted from Magder.1
In this analogy the height of the water in the bathtub (Pmsf), the height of the reservoir 
(Pra) and the characteristics of the drain are the primary determinants of the rate of 
emptying of the bath (i.e. VR). The height of the water above the Pra (the presure 
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difference between Pmsf and Pra) is called the pressure gradient for VR. In this model 
infl ow by the tap (i.e. CO) is important to fi ll the bathtub, but does not infl uence the 
emptying of the bath. Thus the role of the heart is to lower Pra14, allowing a better 
drainage from the bathtub, and to restore volume for VR. Only in heart failure the heart 
becomes a limiting factor, because Pra increases and volume cannot be restored. 
Ultimately when Pra is raised to a value equal to Pmsf, fl ow will stop (fi gure 1.2B). 
On the other hand, when fl ow is ceased by stopping the heart, Pra will increase until 
it reaches the value of Pmsf. It follows that Pmsf is not directly infl uenced by cardiac 
function. Pmsf is infl uenced by Vs and by compliance, which is the change in blood 
volume due to a given change in blood pressure (C = ΔV/ΔP). In a less compliant 
venous system a small change in volume will induce a greater increase in pressure.
In conclusion, the pressure gradient between Pmsf and Pra is the driving force for 
VR and consequently CO. Pmsf can be seen as a measure of Vs, because Pmsf is the 
pressure present in Vs. Vs can be enlarged by volume loading, but also by recruitment 
of fl uid from the unstressed to the stressed compartment (through venoconstriction).
Venous return curve
VR is the amount of blood returning to the heart. Flow, and also VR, can only exist 
when there is a pressure gradient. Pra is the back pressure in the pressure gradient for 
VR. Guyton et al.4,12 showed in his classical experiments in dogs that when Pra is 
elevated, CO and VR are reduced. As described above, when Pra is increased further 
and further, VR declines until it ultimately ceases. This relation between Pra and CO 
can be depicted in a venous return curve (fi gure 1.3). The value that Pra reaches at 
zero fl ow is equal to Pmsf. Oppositely, with decreasing Pra, VR increases. When Pra 
becomes close to atmospheric pressure, transmural pressure of the great veins will 
become negative, resulting in a collapse of the great veins. This collapse will limit VR 
to a maximum value.
In the bathtub analogy, the characteristics of the drain are also important for the drainage 
of the bathtub. A narrow drain will slow down drainage, while a wide drain will increase 
drainage. In the circulation the impeding factor for drainage is the resistance for venous 
return (Rvr). Venous return can now be defi ned as the ratio of the pressure gradient for 
venous return and the resistance to venous return (Rvr):
 VR = (Pmsf – Pra)/Rvr
Rvr is also included in the VR curve, as the reciprocal of the slope of the curve (fi gures 
1.3 and 1.4). When Rvr is increased, the slope of the VR curve becomes less steep, 
while Pmsf is unchanged and VR decreases. Increasing stressed volume by either by 
adding fl uid or recruitment from the unstressed compartment will increase Pmsf, which 
will shift the VR curve to the right and increase VR.
Chapter 1
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Figure 1.3 Venous return curve
The relationship between right atrial pressure (Pra) and cardiac output (CO), called the venous 
return (VR) curve, during spontaneous breathing. When VR is zero, Pra is equal to Pmsf. When Pra 
approaches atmospheric pressure (around 0), VR is maximal. At negative values of Pra, the great 
veins will collapse, limiting VR. The slope of the curve is determined by the resistance to venous 
return (Rvr). 
Figure 1.4 Changes in venous return curve
Infl uences of resistance to venous return (Rvr) and volume increase on the venous return curve. 
An increase in Rvr will limit venous return (VR), without changing mean systemic fi lling pressure 
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Combining cardiac function curve and venous return curve
One of Guyton’s major contributions was that he combined the VR curve and the cardiac 
function curve. Because during steady state VR and CO must be equal, both curves can 
be combined4, with Pra on the x-axis and with VR and CO on the y-axis (fi gure 1.5). 
The intersection of these curves resembles the operating point of the circulation. As we 
described before, the VR curve can be infl uenced by changing the volemic state (Pmsf) 
or by changing Rvr. Similarly, the cardiac function curve can be altered by a change in 
cardiac performance (i.e. myocardial infarction, positive or negative inotropic agents). 
However, for an increase in CO an increase in VR is essential.
In steady state, the VR curve and the cardiac function curve can be depicted as in fi gure 
1.5. For simplicity we used Pra as parameter for the x-axis for the combining of VR and 
cardiac function curve. For the latter the actual parameter on the x-axis should be right 
atrial transmural pressure. After all the heart is located in the thoracic cavity, which 
has a pressure different from atmospheric pressure. It follows that the degree of stress 
on the cardiac fi bers before contraction is related to transmural pressure (Pra minus 
pleural pressure). For the VR curve the absolute value of Pra can be used, because the 
pressure surrounding veins and venules is atmospheric pressure and Pra is calibrated 
against atmospheric pressure. Still, for the combined graph with cardiac function 
and VR curve, we will use the absolute value of Pra instead of right atrial transmural 
pressure, although respiration will infl uence the curves in a different way.
Figure 1.5 Combination of cardiac function curve and venous return curve
The venous return curve and the cardiac output curve are depicted in one graph. The point where 


















Respiratory infl uences on cardiac function curve and venous return 
curve
Spontaneous breathing. Pleural pressure continuously changes during the respiratory 
cycle. In a spontaneously breathing patient inspiration causes a negative pleural 
pressure and a smaller decrease in Pra, increasing transmural pressure. The increase 
in transmural pressure leads to a rise in CO. During expiration the opposite occurs: 
pleural pressure increases, Pra increases to a lesser degree and transmural pressure 
decreases. The decrease in transmural pressure will decrease CO. Accordingly these 
respiratory induced changes in Pra cause a shift of the cardiac function curve during the 
respiratory cycle15, while the VR curve remains unchanged (fi gure 1.6).
Figure 1.6 Infl uence of respiration
During spontaneous inspiration intrathoracic pressure and right atrial pressure (Pra) decrease, while 
venous return (VR) increases. The operating point of the circulation shifts from a to b. Cardiac output 
(CO) increases, because right atrial transmural pressure increases. To account for this increase in CO, 
the cardiac function curve shifts to the left as the parameter on the x-axis should actually be right 
atrial transmural pressure.
Positive end-expiratory pressure. Pleural pressure and Pra will be increased when 
positive end-expiratory pressure (PEEP) is applied. Transmural pressure decreases 
because Pra increases less than pleural pressure increases.16,17 As a result the cardiac 
function curve will shift to the right as pleural pressure and Pra increase (fi gure 1.7). In 
left ventricular dysfunction PEEP can have a different effect and even augment CO. In 
this case the increase in CO is caused by a reduction in left ventricular afterload, because 



















General introduction and outline of this thesis
16
PEEP also infl uences the VR curve. Via downward displacement of the diaphragm, 
increasing intra-abdominal pressure and compression of the liver, and by squeezing 
of the lungs, stressed volume is increased. This leads to an increase in Pmsf19, and the 
VR curve will therefore shift to the right. Will VR change? If both Pra and Pmsf are 
increased by applying PEEP, the pressure gradient for VR will remain constant.20 At 
positive intrathoracic pressures, transmural pressure of the great veins will become 
negative at higher values of Pra. This will result in a collapse of the great veins at 
higher Pra values and thus the point refl ecting the maximal value of VR (Pcrit) will 
shift to the right (fi gure 1.7). In conclusion, PEEP interferes with CO and VR in a more 
complicated manner than just by increasing Pra.
Figure 1.7 Infl uence of positive end-expiratory pressure
The baseline curve is with zero end-expiratory pressure (ZEEP); point a is the operating point of 
the circulation. When positive end-expiratory pressure (PEEP) is applied, right atrial pressure (Pra) 
increases and venous return (VR) decreases; the operating point shifts to b. Transmural right atrial 
pressure decreases, and cardiac output (CO) decreases with a shift of the cardiac function curve to 
the right. PEEP has three additional effects: 1. recruitment of volume by squeezing liver and lungs, 
resulting in a rise in mean systemic fi lling pressure (Pmsf; shift of VR curve to the right) and 2. 
collapse of the great veins at higher values of Pra (thus the point refl ecting the maximal value of VR 
(Pcrit) will shift to the right). The combined effect is the shift of the operating point of the circulation 
to c.
Clinical conditions interpreted with cardiac function curve and venous 
return curve
Hemorrhagic shock. In a patient with hemorrhage Vs and Pmsf are decreased. The VR 
curve is shifted to the left, decreasing VR and CO. This can be compensated for by 






















Venoconstriction will recruit volume from Vu to Vs, successively restoring Vs, Pmsf 
and VR. When this compensatory mechanism fails and hypovolemic shock occurs, 
administration of positive inotropic agents clearly will not increase CO. HR increases 
as a side effect of intrinsic catecholamine release, but will not increase CO either, 
because VR is insuffi cient. It follows that VR and CO will be restored by volume 
loading, or (less effectively) by venoconstrictive medication facilitating the volume 
recruitment from the unstressed compartment.
Distributive shock. Distributive shock, e.g. septic shock, is characterized by arterial 
and venous vasodilation. Vs and Pmsf, but also Rvr will be decreased; the VR curve 
is shifted to the left and has become steeper. Volume resuscitation will restore Vs, 
Pmsf and shift the VR curve to the right. The reduced Rvr will maintain a steeper 
VR curve, and VR and CO can even exceed the premorbid values, provided there is 
no cardiac limitation, e.g. due to myocardial depression. Venoconstrictive agents will 
also shift the VR curve to the right by recruitment of volume from Vu to Vs, thereby 
increasing Pmsf. Additionally by increasing Rvr, the VR curve will become less steep. 
Thus therapeutic measures, besides antibiotics and sepsis source control, are volume 
resuscitation, vasoconstrictive medication or in case of myocardial depression, positive 
inotropic agents.
Cardiac failure. In heart failure, Pcv increases and CO can only be maintained by 
increasing Pmsf. Thus compensatory mechanisms are fl uid retention and venoconstriction 
to increase Pmsf. The drawback of this compensatory mechanism is the development of 
edema due to the increased hydrostatic pressures, when these exceed osmotic pressures. 
Volume infusion or administration of venoconstrictive agents will also increase Pmsf, 
but have the same hazard of causing edema, without improving VR and CO much. Rvr 
will be increased as well, impeding an increase in VR. What we need is medication 
that moves the cardiac function curve upward and decreases the Rvr. Dobutamine and 
phosphodiesterase inhibitors possess those qualities.
In conclusion, in daily practice the VR curve could be altered by changes in volume 
status or by redistribution of volume from Vu to Vs (venoconstriction or venodilation), 
and by changes in Rvr (e.g. by vasoactive medication). The cardiac function curve can 
be infl uenced by several interventions such as medication (positive or negative inotropic 
agents) and level of PEEP. If the VR curve and cardiac function curve of a patient are 
known, more insight in the pathology and natural compensation mechanisms could be 
achieved. Moreover the effects of interventions as volume loading or medication could 
be predicted and evaluated using both curves.
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Measurement of mean systemic fi lling pressure
In order to determine the gradient for VR, we need to know both Pra and Pmsf. 
Measurement of Pra or central venous pressure (Pcv) is part of clinical routine in 
the ICU. But how can we determine Pmsf? One possible method could be to reduce 
VR to zero, then Pcv would become equal to Pmsf. Thus, Pmsf could be measured 
during cardiac arrest, when CO and VR are equal to zero. Furthermore, Pmsf could 
theoretically be measured anywhere in the circulation during the circulatory stop-fl ow, 
because during a cardiac arrest the pressure equilibrates throughout the entire vascular 
system.
In 1894 Bayliss and Starling10 were the fi rst to conclude that intravascular pressures 
equilibrated during cardiac arrest induced by vagal stimulation in a dog model (fi gure 
1.8). Also in a dog model, Guyton12 increased Pra by varying the height of a tube in 
the right atrium, which was connected to a pump, thereby replacing the right ventricle 
(fi gure 1.9). When Pra was increased to a level that CO stopped, Pmsf could be measured. 
Guyton constructed venous return curves with this method. In humans, Starr21 was the 
fi rst to measure Pmsf by inserting a needle into the heart or a great vein in patients who 
had died shortly before. He observed that patients who died after prolonged cardiac 
congestion had signifi cantly higher values of Pmsf than the patients who died without 
congestion or cardiac disease (fi gure 1.10). The higher Pmsf values in heart failure 
patients can be explained as a compensation mechanism for the increased Pcv in order 
to maintain a pressure gradient for venous return as described earlier.
Figure 1.8 Pressure course during cardiac arrest
Bayliss and Starling’s10 experiment to measure mean systemic fi lling pressure (Pmsf) in a dog. When 
the circulation is arrested by vagal stimulation, the arterial and venous pressures equilibrate to Pmsf. 
Figure adopted from Bayliss.10
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Pmsf in animals using stop-fl ow 
In animal studies Pmsf was measured by inducing a circulatory arrest or a stop-fl ow 
using different measurement techniques. Stopping the heart was achieved by either 
inducing ventricular fi brillation22-24 or administration of acetylcholine.22,25,26 During 
the circulatory arrest Pcv increased and arterial pressure decreased. Because the 
development of equilibrium takes time, and a venoconstrictive refl ex can occur within 
5-12 seconds23,27, a pump was used  for rapid arterial-to-venous blood transfer. Pmsf 
was then estimated by measuring Pcv is equal to Pa after approximately 7-10 seconds. 
Another method to stop circulation is by applying a circulatory obstruction. With an 
infl atable balloon around the pulmonary artery27,28 or by infl ating a balloon inside the 
right atrium29 circulatory obstruction was achieved in rats. However, with the circulatory 
obstruction technique venous pressure (Pv) remained lower than arterial pressure (Pa), 
when no arteriovenous pump was used. Pmsf was then calculated with the formula: 
Pmsf = Pv + 1/30•(Pa-Pv).28 The correction factor 1/30 was based on compliance 
measurements, where venous compliance was 30-fold higher in comparison to arterial 
compliance.30 Yamamoto et al.29 compared the circulatory obstruction technique with 
and without rapid arteriovenous blood transfer and found a different correction factor 
of 1/60.
Figure 1.9 Experimental model for controlling right atrial pressure and venous return
The external perfusion system, bypassing the right ventricle, for controlling right atrial pressure and 
venous return to construct venous return curves. Figure adopted from Guyton.12
Pmsf in animals using inspiratory holds
Without the necessity to create a circulatory stop-fl ow, Pmsf can be measured with 
a method based on the hemodynamic effects of mechanical ventilation. Pcv can be 
increased by changing intrathoracic pressures with inspiratory holds created by a 
mechanical ventilator. Positive airway pressure increases Pcv and thereby compromises 
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VR and CO. In a study in pigs, Versprille31 randomly applied tidal volumes between 
25 and 300 ml, i.e. 2.5-30 ml·kg-1, during inspiratory holds of 7.2 seconds. During 
these inspiratory pauses hemodynamic steady-state conditions were met to assure that 
VR and CO were equal. Pcv and pulmonary artery fl ow were measured at the end of 
each inspiratory hold. A venous return curve was then plotted, showing an inverse 
linear relationship between VR and Pcv. Pmsf was calculated by extrapolation of 
the curve to a venous return value of zero, where Pcv becomes equal to Pmsf (fi gure 
1.11). Pmsf measurement with use of fl ow measurement in the aorta, instead of in the 
pulmonary artery, lead to comparable values.32 Finally, Pinsky33 showed that Pmsf and 
instantaneous venous return curves could be achieved by applying smaller tidal volume 
ventilation (< 10 ml·kg-1) in canines.
Figure 1.10 Measurement of mean systemic fi lling pressure (Pmsf)
Starr’s measurement of mean systemic fi lling pressure (Pmsf) in humans soon after death. The crossbars 
indicate average values. Pmsf in patients with organic heart disease and prolonged congestion is 
higher than in patients without congestion or cardiac abnormalities. Figure adopted from Starr.21
Pmsf in humans during cardiac arrest
In 2000 and 2003 the fi rst measurements of Pmsf in humans during induced cardiac 
arrest were reported.20,34 By inducing ventricular fi brillation in patients undergoing 
surgical implantation of an implantable cardioverter-defi brillator a circulatory arrest 
was created. In both studies equilibrium of arterial and venous pressure was not met. 
Jellinek20 considered Pra to be Pmsf after 7.5 seconds of stop-fl ow. After 13 seconds 
the average arteriovenous pressure difference was 13.2 ± 6.2 mmHg and even after 
20 seconds of cardiac arrest there was no equilibration of pressures.34 The lack of 
equilibrium was attributed to a waterfall mechanism, but could also be explained by short 
duration of the cardiac arrest. However, longer periods of cardiac arrest are considered 
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to be unethical34 and potentially infl uenced by vasomotor refl exes.20 Disadvantages of 
this method of assessing Pmsf are: 1. equilibrium between arterial and venous pressure 
is not reached, thus the value Pmsf can only be estimated and 2. more importantly the 
method is not applicable during routine patient care. Thus far, only the method with 
inspiratory holds lends itself for measuring Pmsf in patients at the bedside.
Figure 1.11 Measurement of mean systemic fi lling pressure with inspiratory holds
Relationship between fl ow (Qpa, measured in the pulmonary artery, on the y-axis) and central venous 
pressure (Pcv) during inspiratory hold procedures at 7 different airway pressures. The arrow indicates 
the value that Pcv reaches at zero fl ow, which is mean systemic fi lling pressure (Psf). Figure adopted 
from Versprille.31
In this thesis measurement of Pmsf and Guytonian analysis of venous return curve are 
taken from the animal laboratory to the intensive care unit.
The measurement of Pmsf with inspiratory holds in pigs and in ICU patients is 
described in part 1 (Chapter 2, 3 and 4). Chapter 2 contains a historic overview of 
Pmsf measurement and an overview of other parameters in control of venous return. 
In Chapter 3 the assessment of venous return curve and Pmsf in postoperative cardiac 
surgery patients is described. Chapter 4 explores in pigs if pulse contour analysis can 
be used in measurement of Pmsf and if the number of inspiratory holds can be reduced.
In part 2 the implications of measurement of Pmsf are explored: the possibility of 
measuring Pmsf in the arm during regional stop-fl ow and the comparison of Pmsf 
with a model analog value of mean systemic pressure (Chapter 5), prediction of fl uid 
responsiveness (Chapter 6), bedside assessment of vascular compliance, stressed 
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volume and cardiac function curves (Chapter 7) and determination of critical closing 
pressure with inspiratory holds and its implications regarding the existence of a vascular 
waterfall (Chapter 8).
In part 3 the effects of vasoactive medication on the hemodynamic status are explored: 
dobutamine effects on venous return curve and vascular resistances (Chapter 9) and 
norepinephrine effects on cardiac function and venous return curves (Chapter 10).
In part 4 the clinical relevance of determination of Pmsf and venous return curves, and 
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Abstract
The physiology of the venous part of the human circulation seems to be a forgotten 
component of the circulation in critical care medicine. One of the main reasons, probably, 
is that measures of right atrial pressure (Pra) do not seem to be directly linked to blood 
fl ow. This perception is primarily due to an inability to measure the pressure gradient 
for venous return. The upstream pressure for venous return is mean systemic fi lling 
pressure (Pmsf) and it does not lend itself easily to be measured. Recent clinical studies 
now demonstrate the basic principles underpinning the measure of Pmsf at the bedside. 
Using routinely available minimally invasive monitoring of continuous cardiac output 
and Pra one can accurately construct venous return curves by performing a series of 
end-inspiratory hold maneuvers, in ventilator-dependent patients. From these venous 
return curves, the clinician can now fi nally obtain at the bedside not only Pmsf, but also 
the derived parameters: resistance to venous return, systemic compliance and stressed 
volume. In conclusion, measurement of Pmsf is essential to describe the control of 
vascular capacitance. It is the key to distinguish between passive and active mechanisms 





Starling and Bayliss1 late in the 19th century described the control and function of the 
venous circulation. This work and the subsequent rediscovery of the venous circulation 
by Guyton et al. represent the forgotten side of the physiology of the circulation. The 
lack of appreciation of the venous side of the circulation persists today. To a large extent 
this void in our training of critical care physicians and lack of use of these principles at 
the bedside refl ect the inability of the practicing physician to appropriately assess the 
venous side of the circulation. Clearly, measures of central venous pressure (Pcv) as 
estimates of right atrial pressure (Pra) bear little relation to cardiac preload. Furthermore, 
most physicians adhere to the philosophy that the energy necessary to cause cardiac 
output is due to the mechanical force of ventricular contraction. Accordingly, most 
analysis of the determinants of cardiac output centralizes in the infl uence of preload, 
contractility, afterload, and heart rate on the heart. However, it is axiomatic that the heart 
can only pump into the arteries that which it receives. The heart has minimal reservoir 
capacity and even in heart failure states venous return matches the cardiac output very 
closely over a few heart beats. It follows, therefore, that the only way cardiac output 
can increase is if venous return increases. Thus, apart for relative short periods of 
changing blood fl ow, the heart can only put out as much blood as it receives from the 
venous system. The venous system contains as much as 75% of the total blood volume 
with approximately 3 fourths of it in the small veins and venules. It is the pressure 
difference between these venous capacitance vessels and the right atrium that defi nes 
the pressure gradient for venous return. However, this venous driving pressure refl ects 
only stressed volume and not the total venous blood volume. Importantly, changes in 
venous vasomotor tone and blood fl ow distribution can markedly alter this upstream 
venous pressure without any change in total blood volume. For more details, the reader 
is invited to read several excellent review articles.2-5
Short history and basic concepts
When Starling and Bayliss1 performed a sympathectomy and induced a cardiac arrest 
by vagal stimulation in a dog model with cannulae in the femoral vein, femoral artery, 
portal vein, inferior caval vein and aorta, they observed that all vascular pressures 
rapidly equilibrated. They called this common stop-fl ow pressure “mean systemic 
pressure” (Pms).
Half a century later, Starr6 postulated that Pms was the driving pressure for venous 
return. He was the fi rst to measure Pms in humans by inserting a needle into a great 
vein or into the heart in patients who had died, within 30 minutes after occurrence 
of death. Mean systemic pressure was higher in patients dying from prolonged heart 
failure (average 20 cmH2O) than in patients dying from other causes (average 10.6 
cmH2O). He concluded that the increase of Pms in heart failure patients was due to 
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compensatory mechanisms such as fl uid retention and vasoconstriction.
Guyton et al.7,8 showed that the relationship between stepwise changes in right atrial 
pressure (Pra) and the resulting changes in venous return describes a venous return 
curve, which itself is a function of the circulating blood volume, vasomotor tone and 
blood fl ow distribution. Importantly, right atrial pressure at the extrapolated zero fl ow 
pressure-intercept refl ects mean systemic fi lling pressure (Pmsf) and the slope of this 
relation describes the resistance for venous return (Rvr), that is venous return = (Pmsf 
– Pra)/Rvr.7,8 We use the term Pmsf to connote the pressure in the systemic vascular 
compartment. In practice the mean pressure of the entire circulation is slightly higher 
than Pmsf because of the addition of pulmonary venous blood to the systemic circulation 
due to the higher left atrial than right atrial pressure normally seen. The relationship 
between Pra and venous return was described in animal models with an artifi cial 
circulation8,9 and in animals with an intact circulation using invasive hemodynamic 
monitoring.10-13 However, until recently, it had never been properly evaluated in 
humans with an intact circulation.
Bedside determination of Pmsf
Venous return as a controller of cardiac output is a very useful concept in explaining the 
pathophysiology of shock3,11, congestive heart failure14, circulatory effect of mechanical 
ventilation15 and the physiological effects of vasoactive drugs.16-19 However, it has not 
been used in common medical practice. One of the main reasons, probably, is that its 
main variable Pmsf does not lend itself to be easily measured in patients. Indeed, until 
recently Pmsf could only be estimated during stop-fl ow conditions20,21, conditions that 
occur rarely in clinical critical care settings.
We22 recently reported on a novel method to determine Pmsf, Rvr, stressed volume (Vs) 
and systemic circulatory compliance (Cs) using clinical available minimally invasive 
monitoring at the patient’s bedside. To our knowledge, no other clinical studies have 
been undertaken to measure Pmsf in patients at the bedside. We reasoned that since Pra 
is the back pressure to venous return, then just like Guyton et al.7,8 demonstrated in 
intact dogs 50 years ago that if Pra was transiently elevated, then cardiac output would 
rapidly decrease to a new equilibrium point along a line describing the patient’s venous 
return curve. Basically, we could construct venous return curves by measuring steady-
state mean Pcv – as surrogate for Pra - and pulse contour cardiac output (COmf) during 
12-second inspiratory hold maneuvers at different ventilatory plateau pressures (Pvent). 
For practical purposes, we chose Pvent of 5, 15, 25, 35 cm H2O, because they were 
easily attained with acceptable change in lung volume and within safe limits of airway 
pressure rises during ventilation. An example of the hemodynamic changes during 
such an inspiratory hold is presented in fi gure 2.1. When Pvent increases, Pcv increases 
concomitantly, whereas COmf and arterial pressure (Pa) decrease with a delay of 3-4 
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beats, reaching a steady state between 7 and 12 seconds after start of infl ation. From 
the steady-state values of Pcv and COmf obtained during a series of four inspiratory 
pause periods a venous return curve can be constructed by fi tting a linear regression 
line through these data points (fi gure 2.2). Extrapolation to the point of zero fl ow gives 
a direct estimate of Pmsf. To validate that this derived Pmsf behaved in a fashion 
predicted by classic Guytonian physiology, we studied the effect of volume loading on 
both Pmsf and the slope of the venous return curve. We would have predicted that if 
volume loading increased stressed volume, Pmsf would increase as a function of the 
venous vascular compliance and that cardiac output would increase only if the pressure 
gradient for venous return (Pcv – Pmsf) increased without an increase in the resistance 
to venous return. Indeed, in response to fl uid loading we observed an increase in Pmsf 
and no change in the slope of the venous return curve, similar to the results shown 
by Guyton et al.8 From the change in Pmsf (point a to point b) in response to the 500 
ml fl uid loading, we calculated circulatory compliance and stressed volume (fi gure 
2.3). Stressed volume is the volume that extends the blood vessels (see below). Thus 
measuring Pmsf and its change with volume loading or removal allows more insight 
in parameters and mechanisms that control the peripheral circulation in critically ill 
patients.
Figure 2.1  Example of an inspiratory hold maneuver
Effects of an inspiratory hold maneuver on arterial pressure (Pa), central venous pressure (Pcv), 
airway pressure (Pvent) and beat-to-beat cardiac output (COmf). Preceding the hold maneuver the 
effects of a normal ventilatory cycle are plotted. From 22 with permission.
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Parameters for venous return
Parameters that determine venous return and thus cardiac output are: mean systemic 
fi lling pressure, right atrial pressure, resistance to venous return, systemic compliance, 
stressed and unstressed volume. These parameters are indicated in the fi gures 2.2 and 
2.3. Different aspects of their control will be reviewed below.
Mean systemic fi lling pressure
Pmsf is a measure of effective volume status, otherwise known as the effective 
circulating blood volume, and (theoretically) independent on cardiac function. 
Importantly, volume status and fl uid responsiveness (i.e. a signifi cant increase in 
cardiac output on fl uid loading) are not synonymous. Even hypovolemic patients can 
be non-responders to fl uid loading. Fluid responsiveness depends on the intersection of 
the venous return curve and the cardiac function curve. Fluid expansion will lead to a 
greater improvement in cardiac output in a patient with a normal cardiac function than 
in a patient with impaired cardiac function.3,23
Figure 2.2 Venous return curves
Relationship between venous return (COmf) and central venous pressure (Pcv) for an individual 
patient. Venous return curves are plotted for normovolemia (a) and after volume loading with 500 
ml, that is hypervolemia (b). Venous return is the blood fl ow that returns to the heart, Pmsf is mean 
systemic fi lling pressure, Pcv is central venous pressure and Rv the resistance for blood fl ow from 
Pmsf to Pcv measured near the entrance of the right atrium. The inverse of the slope of the lines is 
Rv. V is the total blood volume and V0 is unstressed volume, the difference is stressed volume (Vs). 
Cs is systemic compliance (see also fi gure.2.3). The points a and b indicate Pmsf for normovolemia 
and hypervolemia respectively.
Our22 reported Pmsf values in postoperative cardiac surgery patients were higher than 
those postulated to be present under normal resting conditions. This might be explained 
by the fact that we were studying a selected group of patients following cardiac surgery 
and in whom aggressive volume resuscitation and vasoactive drug therapy are routinely 
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Furthermore, in a previous hemodynamic study on similar postoperative patients by 
our group, we have documented that these patients are hypervolemic.24 Presumably, 
Pmsf would be lower in subjects not experiencing these marked circulatory stressors. 
However, in our intensive care unit, we were limited to study Pmsf in patients following 
cardiac surgery in whom inspiratory hold maneuvers could be readily performed.
Figure 2.3 Determination of systemic compliance and stressed volume
Relationship between change in blood volume and mean systemic fi lling pressure (Pmsf) for 
normovolemia (a) and after volume loading with 500 ml, that is hypervolemia (b). In the fi gure 
systemic compliance (Cs), stressed (Vs) and unstressed volume (V0) are indicated. The value of Cs 
can be found by dividing the administered volume of 500 ml by the change in Pmsf (from a to b) of 
fi gure 2.2. Removal of 1270 ml blood in this patient will lead to a Pmsf of 0 mmHg, what rests in the 
circulation is unstressed volume with no blood fl ow. 
Venous resistance
The slope of the venous return curve is proportional to the reciprocal of the resistance 
to venous return. Thus, changes in the resistance of venous return (Rvr) must alter the 
slope of the venous return curve. An increase in slope means a decrease in Rvr such 
that for the same Pra and Pmsf cardiac output will be greater and a decrease in slope 
means an increased Rvr. Venous resistance can be altered in many ways. An increase of 
Rvr can occur due to constriction of the conducting veins, however, unlike the arterial 
side which has thick muscular vessel walls venoconstriction causes only a minimal 
increase in Rvr. Rvr can also be increased by increased blood viscosity. However, 
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Venoconstriction of an organ decreases its unstressed blood volume, causing its local 
upstream pressure to transiently rise, expelling blood into the systemic circulation 
because some of the unstressed volume is shifted to stressed volume (see below). Most 
of the venoconstriction with change in unstressed volume occurs in the splanchnic 
circulation, which has a more prominent innervation.2,3 However, as splanchnic blood 
fl ow must subsequently pass across a second parenchymal bed, the liver, splanchnic 
Rvr is much higher than for other organs including the brain, kidney, muscle and 
skin any change in splanchnic Rvr has minimal effect on total Rvr.3,25 Accordingly, 
venoconstriction of the splanchnic circulation has a minimal incremental effect on 
Rvr but a signifi cant ability to increase Pmsf. The balance between venoconstriction 
of venous vessels outside and inside the splanchnic area is controlled by α- and β2-
adrenenergic activation of the different parts of the systemic circulation and is the 
primary means of controlling cardiac output and matching metabolic needs to blood 
fl ow distribution. Those interested in reading more about this important aspect of the 
control of the circulation are referred to the papers by Gelman2, Rothe5 and Pang.17
Compliance, stressed and unstressed volume
As described above, the intravascular volume can be divided in unstressed volume 
and stressed volume. The intravascular volume that fi lls these vessels up to the point 
where intravascular pressure starts to rise is called unstressed volume, whereas the 
volume that stretches the blood vessels and causes intravascular pressure to rise is 
called the stressed volume. By defi nition, the stressed volume results in a positive 
transmural vascular pressure, which is defi ned as the pressure inside the vessel relative 
to the pressure outside the vessel wall. Since the pressure gradient for venous return 
is from the extrathoracic venous vessels to the right atrium, the back pressure to 
venous return is Pra and not its transmural pressure. This is a very important concept 
and explains the dynamic changes in venous return that occur during breathing and 
whenever intrathoracic pressure is artifi cially varied. In the setting of circulatory 
shock due to inadequate venous return, as may occur with hypovolemia, sepsis and 
heart failure, the two main therapeutic interventions that can increase stressed blood 
volume and thus Pmsf so as to restore venous return to an adequate level of blood fl ow 
are the administration of intravenous fl uids and pharmacological manipulation with 
vasopressor agents to increase vascular tone. 
If one observes any blood fl ow in a patient then there must be a measurable Pmsf 
and then the unstressed volume has been fi lled up. Subsequent fl uid administration 
must increase the stressed volume. If one can measure Pmsf sequentially, then one 
can note the change in Pmsf for a change in volume, thus allowing the physician at 
the bedside to directly estimate vascular compliance and stressed volume (fi gure 2.3). 
Until recently, stressed volume has only been measured in humans on cardiac bypass 
for major vascular surgery.26 Patients were put on a cardiac bypass pump and when the 
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patients were in hypothermic cardiac arrest, the pump was turned off and blood was 
drained passively in a reservoir. The amount of blood drained was the stressed volume. 
In these hypothermic anesthetized patients Magder and De Varennes26 found stressed 
volume was on average 20.2 ml/kg, which value is close to our calculated result of 19.5 
ml/kg in intact patients.22
Administration of vasopressors and inotropes can be used to enlarge or reduce 
stressed volume. Vasopressors increase stressed volume by recruiting volume from 
the unstressed compartment. For instance, infusion of norepinephrine (an α- and β1-
adrenergic agonist) into anesthesized dogs increased arterial pressure, cardiac output, 
total peripheral resistance, hepatic vein resistance and Pmsf and reduced heart rate 
and liver volume.27 Note that the increase in venous resistance and total peripheral 
resistance on itself would diminish cardiac output. Evidently the increase in cardiac 
output by the increase in Pmsf dominated the negative impact on cardiac output by the 
increase of arterial and venous resistance. These results were later confi rmed in rabbits 
by the same authors.19 Although it is clear that norepinephrine is capable of increasing 
Pmsf, there are differences in Pmsf response among different species of animals.17 
The effects of catecholamines on increasing venous return and cardiac output may be 
signifi cant. However, knowledge of the volume status is of great importance before 
administrating these drugs into a critically ill patient whose endogenous adrenergic 
stimulation is already maximal. Norepinephrine may reduce splanchnic blood pooling, 
increase Pmsf, Rvr and Rsys of the splanchnic circulation, but the resulting decrease 
in fl ow of the splanchnic circulation may increase ischemia in the gut and liver.4,28 
However, inotropic agents, like dobutamine, can cause vasodilation, owing to their 
peripheral -adrenergic effect. Thus, the use of dobutamine as single-agent therapy for 
a hypotensive heart failure patient in whom fl uid resuscitation has not been completed 
usually causes worsening hypotension, owing to the decrease in stressed volume despite 
an associated increased cardiac contractility. If measured, one would see dobutamine 
increasing vascular compliance.
The technique of estimating vascular compliance presented in our study22 might enable 
one to perform studies on the effects of vasoactive drug infusion (e.g. norepinephrine 
infusion) on Pmsf, Vs, Rvr and Cs in humans with an intact circulation. In this way we 
may validate the theories on the control of venous return obtained from animal studies. 
More extended description of different vasoactive drugs on venous return can be found 
in the review of Pang.17
Localization of Pmsf
Pmsf refl ects a physiological concept: the circulation behaves as if the upstream 
pressure for venous return is Pmsf because if Pra is rapidly varied, blood fl ow co-varies 
in a fashion consistent with that specifi c Pmsf. One may ask, where is this Pmsf located 
and is Pmsf common to all organs? The localization of Pmsf within the circulation is a 
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conceptual model at best, since it refl ects a lumped parameter of all the vascular beds. 
However, its position in the pooled vascular beds will shift depending on changes in 
arterial and venous resistances.11,13 The ratio of the resistance of venous return and 
systemic vascular resistance describes the location within the circulation where Pmsf 
exists. A higher ratio implies a more upstream Pmsf location. Still, Pmsf usually resides 
in the small venous lacunae downstream from the capillary beds. It will be interesting 
to see how this location of Pmsf within the circulation may change with the use of 
vasoactive drug therapy and in patients with either sepsis or heart failure. Finally, if one 
were to perfuse individual organs in isolation, their respective Pmsf values would also 
be different because of their differing degrees of stressed and unstressed volumes as 
well as their extravascular tissue pressures. However, during steady-state conditions, 
fl ow through all organs is stable and not changing. As all organs drain into a common 
vena caval drainage circuit, to the extent that venous resistance upstream from those 
sites is not high, then the Pmsf of all vascular beds should be nearly the same. Otherwise, 
fl ow would vary among organs until the Pmsf became common. Thus, theoretically, 
one should be able to measure Pmsf from an arm vessel during stop-fl ow conditions 
as long as tissue pressure and venous blood volume are not transiently altered by the 
measuring technique. This intriguing construct opens the possibility to simplify the 
direct measurement of Pmsf without the need of continuous measures of cardiac output 
and Pcv. Studies exploring this concept are on-going.
Conclusion
The determination and regulation of venous return defi nes cardiac output and allows 
the clinician to understand the most important mechanisms regulating cardiovascular 
homeostasis. Recently, we developed a novel method to measure Pmsf, Rvr, systemic 
compliance and stressed volume at the bedside in ventilated patients. This exciting 
technique opens the door of future studies of the determinants of venous return and the 
control of cardiac output in different patient populations, different pathophysiologic 
conditions and under different pharmacologic conditions. In the future, cardiovascular 
therapy will be based on assumptions derived by venous return physiology and can 
be directed by measuring Pmsf, Rvr, stressed volume and systemic compliance in a 
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Abstract
With the determination of the relationship between blood fl ow and central venous 
pressure (Pcv) mean systemic fi lling pressure (Pmsf), circulatory compliance and 
stressed volume can be estimated in patients in the intensive care unit (ICU). We 
measured the relationship between blood fl ow and Pcv using 12-second inspiratory 
hold maneuvers transiently increasing Pcv to three different steady-state levels and 
monitored the resultant blood fl ow via the pulse contour method during the last 3 
seconds in twelve mechanically ventilated postoperative cardiac surgery patients in the 
intensive care unit. Inspiratory holds were performed during normovolemia in supine 
position (baseline), relative hypovolemia by placing the patients in 30 head-up position 
(hypo), and relative hypervolemia by volume loading with 0.5 l colloid (hyper). The 
Pcv to blood fl ow relation was linear for all measurements with a slope unaltered by 
relative volume status. Pmsf decreased with hypo and increased with hyper (18.8 ± 4.5 
mmHg, to 14.5 ± 3.0 mmHg, to 29.1 ± 5.2 mmHg [baseline, hypo, hyper, respectively, 
p < 0.05)]. Baseline total circulatory compliance was 0.98 ml·mmHg-1·kg-1 and stressed 
volume was 1677 ml. In conclusion, Pmsf can be determined in intensive care patients 
with an intact circulation with use of inspiratory pause procedures, making serial 




The cardiovascular system is a closed circuit with varying blood fl ow out of the heart 
into the arterial system (cardiac output [CO]) and fl ow back to the heart from the venous 
system (venous return [VR]), which may not be equal at any point in time owing to 
ventilation-induced changes in venous return, but which over time must be equal.1,2 
Thus, under steady-state apneic conditions CO and VR become equal. Guyton et al.3,4 
showed that the relationship between stepwise changes in right atrial pressure (Pra) 
and the resulting changes in VR describes a VR curve, which itself is a function of the 
circulating blood volume, vasomotor tone and blood fl ow distribution. Importantly, Pra 
at the extrapolated zero-fl ow pressure intercept refl ects mean systemic fi lling pressure 
(Pmsf) and the slope of this relation describes the resistance for venous return (Rvr).3,5 
This relationship between Pra and VR was well described in animal models with an 
artifi cial circulation4, in patients during stop-fl ow conditions6, and in animals with 
an intact circulation using invasive hemodynamic monitoring.7-10  However, it has 
never been evaluated in humans with an intact circulation. If such VR curves could 
be easily calculated at the bedside, then complex cardiovascular analysis would be 
feasible, thereby, augmenting greatly our understanding of the dynamic determinants 
of circulatory insuffi ciency states and their responses to therapies. Intravascular blood 
volume can be divided in unstressed volume (the blood volume necessary to fi ll the 
blood vessels without generating an intravascular pressure) and stressed volume (the 
blood volume which generates the intravascular pressure, which is Pmsf in no-fl ow 
conditions).
Previously, Pinsky7 constructed instantaneous VR curves based on the beat-to-beat 
changes in Pra and simultaneously measured right ventricular output during a single 
mechanical breath, neglecting possible transient effects of increasing Pra on VR.1,2 
Versprille and Jansen8 prevented these transient changes by measuring Pra and right 
ventricular output during steady-state conditions generated by ventilator-applied 
inspiratory pause periods at different infl ation volumes. Unfortunately, it is diffi cult to 
measure pulmonary blood fl ow on a beat-to-beat basis at the bedside. We hypothesized 
that if inspiratory hold maneuvers that increase Pra create a new steady state, then VR 
and CO would again be equal and direct measures of left-sided CO could be used to 
estimate steady-state VR.
Thus, we studied the effect of 12-second inspiratory hold maneuvers on the relation 
between central venous pressure (Pcv), as a surrogate for Pra, and arterial pulse contour-
derived cardiac output (COmf), as a surrogate for VR, as Pcv was varied by inspiratory 
hold maneuvers and intravascular volume status altered by a head-up tilt body position 
(relative hypovolemia) and intravascular volume loading (hypervolemia).    
Materials and methods
Patients. Twelve postoperative patients after elective coronary artery bypass surgery 
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or aortic valve replacement were included in the study after approval by the university 
medical ethics committee and patient’s informed consent was obtained. All patients 
had symptomatic coronary artery disease without previous myocardial infarction and 
were on beta-adrenergic blocking medication. Patients with congestive heart failure 
(New York Heart Association class 4), aortic aneurysm, extensive peripheral arterial 
occlusive disease, or postoperative valvular insuffi ciency, were not considered for this 
study. Patients with postoperative arrhythmia or the necessity for artifi cial pacing, or 
use of a cardiac assist device were also excluded.
Anesthesia during surgery was maintained with sufentanil and propofol and patients 
were ventilated  in synchronized intermittent mandatory ventilation mode (Evita 4 
servo ventilator Dräger, Lübeck, Germany) adjusted to achieve normocapnia (arterial 
pCO2 between 40 and 45 mmHg) with tidal volumes of 6-8 ml·kg
-1 and a respiratory 
rate of 12-14 breaths·min-1. Fraction of inspired oxygen (FiO2) was 0.4 and a positive 
end-expiratory pressure of 5 cmH2O was applied. A hemodynamic stability was 
achieved using fl uids and catecholamines. During the study interval all subjects were 
hemodynamically stable and no changes were made in their vasoactive drug therapy. 
Every patient experienced full recovery from anesthesia within 8 hours following 
surgery and was discharged from intensive care unit on the fi rst postoperative day. 
 
Measurements. Arterial blood pressure (Pa) was monitored via a 20-G, 3.8-cm long 
radial arterial catheter inserted by Seldinger technique and connected to a pressure 
transducer (PX600F, Edwards Lifesciences). Pcv was measured with a central venous 
catheter inserted through the right internal jugular vein (MultiCath 3 venous catheter, 
Vigon GmbH & Co, Aachen, Germany) and connected to a pressure transducer 
(PX600F, Edwards Lifesciences). Both Pa and Pcv transducers were referenced to the 
intersection of the anterior axillary line and the fi fth intercostal space. Airway pressure 
(Pvent) was measured at the entrance of the endotracheal tube. Pvent was balanced at 
zero level against ambient air. Standard electrocardiogram leads were used to monitor 
heart rate. Beat-to-beat CO was obtained by Modelfl ow (COmf) pulse contour analysis 
as previously described by us.11-13 We calibrated the pulse contour CO measurements 
with 3 thermodilution CO measurements equally spread over the ventilatory cycle.12
Experimental protocol. Before starting the protocol, the mechanical ventilation mode 
was switched to airway pressure release ventilation with the same rate, FiO2, and positive 
end-expiratory pressure level. Inspiration pressure was adapted to have the same gas 
exchange as in SIMV mode. This change in ventilation mode allowed external control 
of the ventilatory process. We developed a computer program to drive the ventilator. 
During the observation period ventilator settings, sedation and vasoactive medications 
remained unchanged. No spontaneous breathing movements were observed during the 
study. Pa, Pcv and Pvent were recorded on computer disk for offl ine data analysis at a 
sample frequency of 100 Hz and 0.2 mmHg resolution. 
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We constructed VR curves by measuring steady-state Pa, Pcv and COmf over the fi nal 
3 seconds for a set of four 12-second inspiratory hold maneuvers at Pvent plateau 
pressures of 5, 15, 25, 35 cm H2O. The inspiratory hold maneuvers were separated by 
1-minute intervals to reestablish the initial hemodynamic steady state. An example of 
the hemodynamic changes during an inspiratory hold is presented in fi gure 3.1. When 
Pvent increases, Pcv increases concomitantly, whereas COmf and Pa decrease with a 
delay of three-four beats, reaching a steady state between 7 and 12 seconds after start 
of infl ation. From the steady-state values of Pcv and COmf during the four inspiratory 
pause periods, a VR curve was constructed by fi tting a linear regression line through 
these data points (fi gure 3.2).
The four inspiratory hold maneuvers were performed under three sequential volumetric 
conditions: initial baseline conditions (baseline) with the subject lying supine, relative 
hypovolemia by rotating the bed to a 30 degree head-up (anti-Trendelenburg) position 
(hypo) and after administration of 500 ml hydroxyethyl starch (130/0.4) in supine 
position (hyper). Measurements were done 2 minutes after head-up tilt and 2-5 minutes 
after the fl uid bolus, which was given in 15-20 minutes.
Figure 3.1  Example of an inspiratory hold maneuver
Effects of an inspiratory hold maneuver on arterial pressure (Pa), central venous pressure (Pcv), 
airway pressure (Pvent) and beat-to-beat cardiac output (COmf). Preceding the hold maneuver the 
effects of a normal ventilatory cycle are plotted.
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Data analysis and statistics. We fi tted the set of four data points of Pcv and COmf by 
linear regression for each volume state to defi ne the VR curve. We defi ned Pmsf as the 
extrapolation of this linear regression to zero fl ow (fi gure 3.2), assuming that Pvent 
does not affect Pmsf.  We have previously validated this extrapolation in piglets.8-10
Total systemic vascular resistance (Rsys) was calculated as the ratio of the pressure 
difference between mean Pa and mean Pcv and COmf (Rsys = (Pa - Pcv)/COmf). The 
resistance downstream of Pmsf was taken to refl ect the Rvr and was calculated as 
the ratio of the pressure difference between Pcv and Pmsf and COmf (Rvr = (Pmsf-
Pcv)/COmf). Systemic arterial resistance (Ra) was taken to be the difference between 
systemic and venous resistance. The ratio of Rvr and Rsys describes the location within 
the circulation where Pmsf exists. A higher ratio implies a more upstream Pmsf location. 
Systemic compliance (Csys) was calculated by dividing the amount of fl uid (Vload) 
administrated to induce the hyper state by the Pmsf difference between baseline and 
hyper (Csys = Vload /(PmsfHyper –PmsfBaseline). We assume Csys to be constant for the 
three volemic conditions studied. Stressed vascular volume (Vs) was calculated as the 
product of Csys and Pmsf. We calculated Vs for all three relative volume conditions.
Data are presented as mean ± SD. Linear regressions were fi tted using a least-squares 
method. The changes between the three conditions were tested by a paired Student’s t 
test, with differences corresponding to a p < 0.05 considered signifi cant. We compared 
baseline to both hypo and hyper. 
Figure 3.2 Venous return curves
Relationship between venous return (COmf) and central venous pressure (Pcv) for an individual 
patient. Venous return curves are plotted for three conditions, baseline (a), hypovolemia (b) and 
hypervolemia (c).
Results
Sixteen patients were recruited into the study, but four were excluded from analysis 
because they could not receive an additional volume challenge. Table 3.1 shows the 
patient characteristics and table 3.2 shows the pooled data of the 12 subjects who 
completed all three steps of the protocol. 




























Table 3.1 Patient Characteristics
No Gender Age Weight Length HR Pcv CO mean Pa Temp Surgery Inotropics PropofolSufenta




1 M 60 80 172 85 8.2 4.6 72 36.8 CABG 300 15
2 M 57 78 169 119 9.9 5.7 73 36.9 CABG D 2 300 15
3 M 79 78 174 86 7.5 6.3 88 36.9 AVR D 5 200 10
4 M 50 90 190 93 7.4 3.2 138 36.3 AVR NPN 0.25 300 15
5 M 80 90 172 99 8.0 6.1 80 36.7 CABG N 0.01 200 10
6 F 64 83 167 76 7.1 5.8 88 37.4 CABG N 0.04, D 3 200 10
7 M 50 112 183 83 4.0 5.7 85 37.0 CABG N 0.06 500 15
8 M 57 91 177 63 4.9 6.4 78 35.1 CABG 300 10
9 M 71 73 179 93 8.0 8.8 91 37.1 CABG N 0.09, D 4 120 5
10 M 66 88 178 69 3.0 7.4 71 35.8 CABG N 0.02 200 10
11 M 75 95 173 77 9.0 4.4 130 36.5 CABG 300 10
12 F 60 74 158 89 3.7 5.3 86 36.6 CABG N 0.04, E 2 150 5
mean 64 86 174 86 6.7 5.8 90 36.6 256 11
SD 10 11 8 15 2.3 1.4 22   0.6 101 4
HR, heart rate; Pcv, central venous pressure;  CO, cardiac output; mean Pa, mean arterial pressure; Temp, body 
temperature; CABG, coronary artery bypass grafting; AVR, aortic valve replacement; D, dobutamine; NPN, 
nitroprusside sodium; N, norepinephrine; E, enoximone.
Venous return curve analysis. Pcv and COmf decreased during hypo and increased 
during hyper. Similarly, Pmsf decreased during hypo and increased during hyper, 
whereas the slope of the VR (conductance) was not signifi cantly different for the three 
conditions of baseline, hypo and hyper. The pressure gradient for VR did not change 
with hypo but increased with hyper such that Rvr was unchanged by hypo but increased 
with hyper. Importantly, Rsys, did not change. Thus, the estimated location of Pmsf 
was unchanged by hypo but migrated upstream with hyper. 
Table 3.2 Hemodynamic data of patients during baseline, hypo- and hypervolemic condition
   Baseline Hypo     Hyper
   Mean SD Mean SD p1     Mean SD p2
Pa (mmHg) 89.9 21.6 75.7 17.3 0.001 96.5 14.9 0.170
Pcv (mmHg) 6.72 2.26 4.02 2.12 0.001 9.67 2.63 0.007
COmf (l•min-1) 5.82 1.44 4.76 1.30 0.001 6.83 1.36 0.002
HR (min-1) 86.0 14.7 85.7 15.1 0.456 84.3 10.7 0.401
Slope (l•min-1•mmHg-1) -0.465 0.151 -0.429 0.160 0.388 -0.389 0.135 0.134
Pmsf (mmHg) 18.76 4.53 14.54 2.99 0.005 29.07 5.23 0.001
Pvr (mmHg) 12.04 3.70 10.52 2.27 0.106 19.40 6.88 0.003
Rvr (mmHg•min•l-1) 2.18 0.86 2.41 1.14 0.184 2.91 1.10 0.037
Rsys (mmHg•min•l-1) 15.89 9.00 16.95 10.27 0.379 13.52 5.60 0.122
Rvr/Rsys (%) 14.94 5.00 14.84 2.37 0.931 22.62 8.07 0.006
Values are means ± SD; n = 12 patients. Pa, arterial pressure; Pcv, central venous pressure; COmf, cardiac 
output; HR, heart  rate; Slope, slope of venous return curve; Pmsf, mean systemic fi lling pressure; Pvr, pressure
difference between Pmsf and Pcv; Rvr, resistance for venous return; Rsys, resistance of the systemic 
circulation. Statistical comparison, p1, paired t-test between baseline and hypovolemic condition (hypo) and p2, 
paired t-test between baseline and hypervolemic condition (hyper).  
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Systemic compliance and stressed volume. The change in stressed volume vs. Pmsf is 
shown in fi gure 3.3. Assuming a constant compliance, the loss of stressed volume due 
to hypo is approximately 200 ml. On average, Csys was 80 ± 62 ml·mmHg-1 (0.98 ± 
0.82 ml·mmHg-1·kg-1 body weig ht) and stressed volume during baseline was 1677 ± 
1643 ml (19.5 ± 12.1 ml·kg-1 body weight). 
Figure 3.3 Pressure - volume curve
Relationship between change in blood volume and mean systemic fi lling pressure (Pmsf) for three 
conditions, baseline (a), hypovolemia (b) and hypervolemia (c). See text for discussion.
Discussion
Our study demonstrates that by using a simple inspiratory hold maneuver while 
simultaneously measuring Pcv and Pa, one can generate VR curves and derive their 
associated vascular parameters at the bedside. Our data suggest that volume-altering 
maneuvers (hypo and hyper) do not alter vascular conductance (slope of the VR 
curve). These clinical data are concordant with the long-described experimental data 
introduced by Guyton et al. over 50 years ago.4,14  Importantly, our novel approach to 
assessing VR allows these analyses to be done at the bedside in patients after coronary 
artery bypass surgery or aortic valve replacement. Patients with congestive heart failure 
(New York Heart Association class 4), aortic aneurysm, extensive peripheral arterial 
occlusive disease, postoperative valvular insuffi ciency, postoperative arrhythmia, 
or the necessity for artifi cial pacing or use of a cardiac assist device were excluded 
from this study. It will be interesting to see how these vascular parameters change in 
different disease states, such as septic shock and heart failure, and how treatments alter 
them further because these analyses allow for the repetitive estimation of circulatory 
vascular compliance and effective circulatory blood volume. 
Methodological issues. During an inspiratory pause period a new steady state was 
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(fi gure 3.1). In this example, the time needed to reach the plateau was approximately 
7 seconds. This duration is too short to be associated with changes in autonomic tone 
which would otherwise occur owing to the decrease in Pa-induced baroreceptor-
mediated increase in sympathetic tone. Samar and Coleman15 showed in rats that a total 
circulatory stop, by pulmonary occlusion, caused a simultaneous decrease of arterial 
pressure and a rise in central pressure to an equal plateau pressure within 4-5 seconds. 
This was followed by a second rise in Pcv after 10-12 seconds of circulatory arrest in 
rats15,16 and after 12-15 seconds in dogs.17 The second rise was seen in unanesthetized 
rats and during methoxyfl urane anesthesia, however, seldom seen with pentobarbital 
and inhibited by hexamethonium or spinal cord transaction.18 Thus, any secondary 
increase in heart rate or Pcv was due to sympathetic refl ex activation. We did not 
observe an increase in Pcv or heart rate during the last phase of our inspiratory pause, 
not even during pause pressures of 35 cm H2O. Furthermore, all Pa values rapidly 
reached steady-state conditions within 7 seconds, making our analysis relatively free 
of the confounding effects of varying autonomic tone. However, our subjects were also 
receiving neurosuppressive agents (propofol and sufentanil) during the study interval, 
thus sympathetic responsiveness may have been blunted. Propofol depresses the 
barorefl ex responses to hypotension and inhibits sympathetic nerve activity in healthy 
volunteers19,20, whereas sufentanil might depress baroreceptor refl exes.21  Thus, these 
studies will need to be repeated in nonanesthetized subjects to validate their usefulness 
in that population. Still, in the setting of general anesthesia, these fi ndings appear valid. 
During infl ation venous capacitance is loaded due to an increase in Pcv, which leads 
to a transient reduction in VR, in right ventricular output and consequently in left 
ventricular output.1,2 To avoid this effect on the relationship between VR and Pcv we 
measured Pcv and COmf during short periods of steady state following these initial non-
steady-state conditions (fi gure 3.1). Our Pmsf estimation method by extrapolating the 
values of four pairs of Pcv and COmf obtained from four levels of inspiratory plateau 
pressures has several advantages. First, it allows the construction of Guyton-type VR 
curves with an intact circulation, an opportunity not presently available. Second, Pmsf 
can be determined without creating stop-fl ow conditions, such as stopping the heart 
by electrical fi brillation or injection of acetylcholine or by blocking the circulation. 
And third, Pmsf is not infl uenced by changes in lung or thorax compliance. Lung or 
thorax compliance affects the transfer of the applied Pvent to intra-thoracic pressures. 
Thus, during an inspiratory hold the resulting Pcv depends on these compliances. But, 
indeed, the measured Pcv and CO will always be on the same line in the VR plot. For 
instance, in a patient with stiffer lungs, during an inspiratory hold the transfer from 
Pvent to intra-thoracic pressure will be less, resulting in a smaller increase in Pcv and 
a smaller decrease in CO.
We assumed a linear relation between Pcv and COmf to extrapolate to the condition of 
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COmf is zero (fi gure 3.2). This assumption is based on the observation of linearity of the 
VR curves presented by Guyton and colleagues4,14 and  expressed by the mathematical 
relation VR = CO = (Pmsf – Pcv)/Rvr. Furthermore, this linearity has been confi rmed 
in the intact circulation in several animal studies.7-10,22,23 Our VR curves were best 
fi tted with straight lines allowing extrapolating the venous return curve to fl ow zero. 
This linearity was neither affected by hypo nor hyper.
Our estimated Pmsf values  are higher than those described in highly instrumented 
animals, which are in dogs 7-12.5 mmHg4,7,14,17,24,25, rats 7-9 mmHg15,16, pigs 10-
12 mmHg8-10, and as high as 20-30 mmHg in conscious calves implanted with an 
artifi cial heart.26 We report baseline Pmsf values of 18.8 mm Hg in our cardiovascular 
surgical patients. A primary difference between the prior animal studies and our patient 
observations is the difference in baseline Pcv. In the animal studies, this value is close 
to zero whereas Pcv in our patient population is on average 6.7 mm Hg. If one assumes 
a similar Rvr, this Pcv pressure difference would extrapolate to a Pmsf of 12 mm Hg 
for our subjects if their Pcv was zero (see table 3.2). Thus, our Pmsf values are coupled 
with the increased Pcv.  
Our present data seem to be in confl ict with those of our previous study, wherein we 
demonstrated that inspiratory hold maneuvers did not decrease blood fl ow, as estimated 
by thermodilution pulmonary artery fl ow27 despite an increase in Pcv. There were no 
differences between the two studies in terms of Pa (75 ± 15 versus 88 ± 18 mmHg), Pcv 
(9 ± 4 versus 8 ± 2 mmHg) and CO (5.7 ± 1.52 versus 5.6 ± 1.6 l·min-1, previous to present 
mean pooled data, respectively). However, two major differences in the protocols exist. 
First, the inspiratory hold maneuver used by van den Berg et al.27 had a temporarily 
higher infl ation pressure at the beginning of the maneuver which was decreased to the 
steady-state plateau value, and second, the bolus thermodilution method was applied 
during the inspiratory pause in the fi rst study whereas we used the Modelfl ow pulse 
contour CO method to measure instantaneous fl ow in the present one. Reexamination of 
the data of van den Berg et al.27 suggests that the thermodilution injections might have 
been performed before the plateau in blood fl ow had been reached. If this were the case, 
then the thermodilution CO values would overestimate steady-state values, resulting in 
an underestimation of the slope of the VR curve. Furthermore, in their study27 plateau 
pressures from 0 up to 19 cm H2O were used whereas we used plateau pressures from 5 
up to 35 cm H2O, which are comparable to those used by Versprille and Jansen
8 in their 
animal experiments. The limited range of applied plateau pressures in the van den Berg 
study27 might have hampered the construction of proper VR curves. Jellinek et al.28 
estimated in ten patients during episodes of apnea and ventricular fi brillation, induced 
for defi brillator testing, a mean Pmsf value of 10.2 mmHg and Schipke et al.6 estimated 
a mean Pmsf value of 12 mm Hg in a similar group of 85 patients. However, both 
studies were done on highly anesthetized nonvolume resuscitated subjects. Our method 
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of estimation of Pmsf differs considerably from stopping fl ow by defi brillation of the 
heart and our method allows an estimation of Pmsf with intact circulation, applicable in 
the intensive care unit. Still, until paired comparisons of Pmsf are made using the two 
techniques (i.e., stop-fl ow and our me thod) in the same subjects direct comparisons and 
interpretation of the data can not be made.
 
Using these maneuvers to assess cardiovascular status. Moving patients from supine 
into a head-up tilt position shifts blood from the central compartment to the legs, 
creating a relative hypovolemic state as manifest by a decreasing Pmsf, Pcv and CO. 
Potentially, other confl icting processes could also be occurring simultaneously. As the 
blood volume shifted to the legs increase femoral venous pressure, venous vascular 
diameter will increase decreasing vascular resistance from the legs. The impact of the 
intra-abdominal volume shift off the diaphragm is less clear but may increase hepatic 
resistance if chest wall movement compresses the subdiaphragmatic liver. The results 
of these effects lead to no change in Rvr and a decrease in COmf, Pa, Pcv and Pmsf 
(table 3.2).  
Volume loading creates relative hypervolemia which results in an increase of Pmsf, 
Pcv, CO and Pa. The higher CO can only be generated by a higher fi lling of the right 
atrium refl ected in an increase of Pcv. Because the pressure gradient for VR is increased 
more than Rvr, CO increases (table 3.2). 
Pmsf is the pressure at the midpoint of the vascular pressure drop from the aorta 
to the right atrium.  In practice, it is usually located in the venules and is less than 
arteriolar pressure and more than Pcv but close to capillary-venule tissue pressure.8,18 
The localization of Pmsf within the circulation is a conceptual model at best, since it 
refl ects a lumped parameter of all the vascular beds. However, its position in the pooled 
vascular beds will shift depending on changes in arterial and venous resistances as 
was pointed out by Versprille and Jansen.8 Our data suggests that the vascular site for 
Pmsf exists in the range of the capillary-venule pressures, i.e. Rvr/Rsys = 15% (table 
3.2). And, indeed, this site shifted upstream (Rvr/Rsys = 23%) with hyper, whereas 
hypo had no effect on the site of Pmsf (Rvr/Rsys = 15%). These data suggest that 
in the immediate postoperative period increased sympathetic tone keeps Pmsf in the 
venular side but with volume loading and a presumed reduction of vasomotor tone, this 
point shifts retrograde toward the arterial system. It will be interesting to see how this 
location changes with the use of vasoactive drug therapy and in patients with either 
sepsis or heart failure. We also saw that Rvr increased during hypervolemic conditions 
whereas conductance (conductance = 1/Rvr) was constant. We are not sure why this 
would be the case, because anatomically and physiologically speaking, the same factors 
affect both resistance and conductance. Potentially, our technique systematically 
overestimated Pmsf, and thus pressure gradient for VR under hypervolemic conditions 
due to squeezing of blood volume out of the lung, or the associated increase in Pcv 
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decreased the fl ow through the more dependent venous conduits. Our study design 
does not allow us to speculate further on these Rvr changes.
Whole body vascular compliance is calculated as the ratio of the change of volume to 
the change in estimated Pmsf (∆V/∆P). Using our inspiratory hold technique we found 
a vascular compliance, Csys, of 0.98 ml·mmHg-1·kg-1 body weight. The administration 
of 500 ml of colloid can expand plasma volume with more than 500 ml, because of fl uid 
recruitment of the extravascular space and fl uid loss (urine and blood loss), contribute 
to the volume expansion. Previous studies in instrumented anesthetized animals have 
reported a linear relation between Pmsf and blood volume over a Pmsf of 5-20 mmHg.18 
Thus, vascular compliance over this Pmsf range may be considered constant. From this 
constant total systemic vascular compliance and the change in Pmsf from baseline to 
hypo we calculated an effective volume loss to be about 200 ml. This loss is due to a 
shift of blood from stressed to unstressed blood volume. 
The stressed volume can be estimated from the compliance and Pmsf. In normovolemic 
patients in supine position we estimated an averaged stressed volume of 1677 ml or 
19.5 ml·kg-1. To our surprise, this calculated stressed volume is close to the stressed 
volume of 20.2 ml·kg-1 reported by Magder and De Varennes29 in patients undergoing 
hypothermic circulatory arrest for surgery on major vessels. They measured stressed 
volume as the volume that drained from the patient into the reservoir of the pump when 
the pump was turned off. 
Previously reported values for Csys ranged from 1.4 to 2.6 ml·mmHg-1·kg-1 in dogs17,30-
33 and from 1.5 to 2.4 ml·mmHg-1·kg-1 in rats.15,16,34 The lower compliance (0.98 
ml·mmHg-1·kg-1) observed in our patients may refl ect species differences or differences 
in methodology used. The main difference in methodology is related to the time 
between volume loading and the determination of Pmsf. In animal studies, the Pmsf 
measurement is performed 30 seconds after volume loading, whereas we fi nished our 
measurements after > 20 minutes following volume loading. According to Rothe18, it 
is virtually impossible to measure the vascular capacitance characteristics, and thus 
passive V/P curves and stressed volume of the total body in refl ex-intact animals and 
humans. This limitation is because one cannot change blood volume and measure Pmsf 
in < 7-10 seconds, which is the maximal delay before refl ex venoconstriction normally 
becomes evident, unless these refl exes are blocked. In our patients, the use of propofol 
and sufentanil might have blocked these refl exes19-21 and might be the explanation for 
the corresponding stressed volume results of our study and the study of Magder and De 
Varennes.29  
Conclusions
Pmsf can be determined in intensive care patients with an intact circulation with use of 
inspiratory pause procedures, making estimations of circulatory compliance and serial 
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Abstract
The volemic status of a patient can be determined by measuring mean systemic fi lling 
pressure (Pmsf). Pmsf is obtained from the venous return curve, i.e. the relationship 
between central venous pressure (Pcv) and blood fl ow. We evaluated the feasibility and 
precision of Pmsf measurement. In ten piglets we constructed venous return curves 
using seven 12-second inspiratory holds transiently increasing Pcv to seven different 
steady-state levels and monitored the resultant blood fl ow, by pulse contour (COpc) 
and by fl ow probes around the pulmonary artery (COr) and aorta (COl). Pmsf was 
obtained by extrapolation of the venous return curve to zero fl ow. Measurements were 
repeated to evaluate the precision of Pmsf.
During the inspiratory holds, 133 paired data points were obtained for COr, COl, COpc 
and Pcv. Bland-Altman analysis showed no difference between COr and COl, but a small 
signifi cant difference was present between COl and COpc. All Pcv versus fl ow (COl 
or COpc) relationships were linear. Mean Pmsf was 10.78 with COl and 10.37 mmHg 
with COpc. Bland-Altman analysis for Pmsf with COl and with COpc, showed a bias 
of 0.40 ± 0.48 mmHg. The averaged coeffi cient of variation for repeated measurement 
of Pmsf with COl was 6.2% and with COpc 6.1%. In conclusion, du ring an inspiratory 
hold pulmonary fl ow and aortic fl ow equilibrate. Cardiac output estimates by arterial 
pulse contour and by a fl ow probe around the aorta are interchangeable. Therefore, the 




Usually, a pulmonary artery catheter (PAC) is placed for the assessment of cardiac output 
(CO) and of intravascular volume status, by measuring central venous pressure (Pcv) and 
pulmonary capillary wedge pressure (Pcwp). However, the values of Pcv and Pcwp are 
often considered to be misleading in estimating volume status and the effect of volume 
loading.1,2 In patients on mechanical ventilation, infl ation increases pleural pressure 
and central venous pressure, which in turn may respectively decrease systemic venous 
return, right ventricular (RV) fi lling, and transiently impair RV ejection.3 Therefore, 
RV stroke volume decreases during the infl ation and recovers during expiration (fi gure 
4.1). The larger the cyclic changes in RV output induced by mechanical ventilation and 
hence in left ventricular (LV) preload are, the larger the cyclic changes in LV stroke 
volume (SVV) and arterial pulse pressure (PPV). These cyclic changes in LV output 
induced by mechanical ventilation are thought to be larger when the heart operates on 
the steep rather than on the fl at portion of the Frank-Starling curve.4,5 Therefore, SVV 
and PPV have been proposed as an indicator of fl uid responsiveness, i.e. predictors 
of an increase in cardiac output with fl uid loading.5-8 However, SVV and PPV have 
never shown to be an effective measure of fi lling status (also called stressed volume) 
of a patient. As a consequence, SVV and PPV do not give basis for protection against 
a too high fi lling status, which can result in pulmonary edema, myocardial ischemia 
and diffi culties in weaning of mechanical ventilation; increasing hospital stay and even 
mortality.9 Therefore, the search for a measure of volume status and a predictor of fl uid 
loading on cardiac output continues.
Given the clinical relevance of a measure of effective fi lling status, we investigated 
how this fi ts with Guyton’s theory on venous return.10,11 A theory that follows the 
fundamental physical law, of Newton, that a force is needed to accelerate a mass, or 
that fl ow can only be the result of a pressure gradient. According to Guyton’s concept 
the difference between mean systemic fi lling pressure (Pmsf) and right atrial pressure 
(Pra) or Pcv is the driving force for venous return. Where Pmsf is the equilibrium 
pressure in the systemic circulation under condition of no fl ow and Pcv is the back 
pressure to venous return. Recently, we validated a bedside technique to estimate mean 
systemic fi lling pressure.12 In this and previous animal research papers3,13-15 we made 
several assumptions for the determination of mean systemic fi lling pressure. Firstly, we 
assumed that venous return to the heart equals left ventricular output during the end of 
an inspiratory hold (fi gure 4.1). Secondly, we expected arterial pulse contour cardiac 
output to be equal to left ventricular output measured by a fl ow probe. And thirdly 
in our clinical study we reasoned that three or four inspiratory holds were enough to 
describe reliable a venous return curve.
The aim of this study was to test the validity of these assumptions and to determine the 
precision of the estimated value of mean systemic fi lling pressure. 
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Materials and methods
All experiments were performed in accordance with the “Guide for Care and Use of 
Laboratory Animals” published by the US National Institute of Health and the protocol 
was approved by the local Animal Care Committee.
Figure 4.1 Example of an inspiratory hold procedure
Effects of an inspiratory hold on aortic pressure (Pao), central venous pressure (Pcv), airway pressure 
(Pt) and beat-to-beat cardiac output (CO) with a probe around the pulmonary artery (COr), around 
the aorta (COl) and by pulse contour analysis (COpc). Preceding the hold the effects of a normal 
ventilation cycle are plotted. Note the difference in beat-to-beat changes of COr and COl or COpc. 
Surgery
Ten piglets (8-10 wk, mean weight 11.0 ± 0.9 kg) were studied. Anesthesia was induced 
with 30 mg·kg-1 sodium pentobarbital intra-peritoneally, followed by a continuous 
infusion of 9.0 mg·kg-1·h-1. After tracheostomy, the animals were ventilated at a rate 
of 10 breaths per min and with a tidal volume adjusted to maintain arterial pCO2 of 
approximately 5.33 kPa (40 mmHg), while a positive end-expiratory pressure of 2 


































































cmH2O was applied. pCO2, airway pressure (Pt) and airfl ow were measured in the 
tracheal cannula. The animals were placed in supine position on a thermo-controlled 
operating table (38°C). A catheter was inserted through the right common carotid 
artery into the aortic arch to measure arterial pressure (Pao) and to sample arterial 
blood. Two other catheters were inserted through the right external jugular vein. A 
pulmonary artery catheter was inserted to measure pulmonary artery pressure, to 
measure thermodilution cardiac output (COtd) and to sample mixed venous blood. A 
quadruple-lumen catheter was inserted into the superior vena cava to measure Pcv and 
to infuse sodium pentobarbital and pancuronium bromide (Organon N.V., Boxtel, the 
Netherlands). The catheters for vascular pressure measurements were kept patent by 
an infusion of saline with 2.5 IE Heparin ml-1 at 3 ml·h-1. The bladder was cannulated 
trans-abdominally to check urine loss in order to maintain fl uid balance. After an 
intercostal thoracotomy in the second left intercostal space, two electromagnetic fl ow 
probes (type transfl ow 601, model 400, Skalar, Delft, the Netherlands) were placed 
within the pericardium with one probe around the pulmonary artery and another around 
the ascendant part of the aortic arch to measure pulmonary artery fl ow (COr) and aortic 
fl ow (COl). Two suction catheters, one dorsal and one ventral, were inserted into the 
left pleural space. The thorax was closed airtight and both air and fl uids were evacuated 
for 1-2 minutes with -10 cmH2O suction while applying a PEEP of 10 cmH2O. After 
surgery and while on continuous pentobarbital infusion, the animals were paralyzed 
with an intravenous infusion of pancuronium bromide (0.3 mg·kg-1·h-1), after a loading 
dose of 0.1 mg·kg-1 in 3 min.
Measurements
The electrocardiogram (ECG), Pao, pulmonary artery pressure (Ppa), Pcv, fl ow probe 
signals and tracheal airway pressure (Pt) were simultaneously recorded. Zero level of 
blood pressures was chosen at the level of the tricuspid valves, indicated by the pulmonary 
artery catheter during lateral-lateral radiography. The airway pressure transducer was 
balanced at zero level against ambient air. During the observation periods, ECG, blood 
fl ow and pressure signals were sampled in real time for 30-second periods at 250 Hz. 
The mean of four thermodilution cardiac output measurements equally distributed of the 
ventilatory cycle was used to obtain the value of COtd (apparatus and method described 
in).16-18 Areas under the pulmonary artery blood fl ow curve and the aortic fl ow curves 
were analyzed online and calibrated by COtd to estimate beat-to-beat cardiac output 
(COr and COl). Pulse contour cardiac output (COpc) from aortic pressure (for piglets 
adapted Modelfl ow method, FMS, Amsterdam, the Netherlands) was calibrated by the 
same COtd value. After the surgical procedure the animals were ventilated at a rate of 
10 min-1 with an infl ation time of 2.4 seconds and an expiration time of 3.6 seconds. 
Tidal volume was readjusted to an end-expiratory pCO2 of approximately 5.33 kPa (40 
mmHg), usually corresponding with a slightly higher arterial pCO2. The ventilatory 
settings were kept constant during the observation periods.
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We determined Pmsf using inspiratory holds as previously described.3,14,15,19 Briefl y: 
During infl ation of the lungs venous capacitance is loaded due to an increase in Pcv, 
which leads to a transient reduction in venous return, in right ventricular output and 
consequently in left ventricular output (fi gure 4.1). To avoid transient effects on the 
relationship between venous return and Pcv, we measured Pcv and right and left 
ventricular output (COr, COl and COpc) during short periods of end-inspiratory steady 
state following these initial non-steady-state conditions. CO and Pcv are determined 
over the fi nal 5 seconds for a set of seven 12-seconds inspiratory hold procedures at 
seven randomly applied tidal volumes between 0 and 300 ml. The inspiratory hold 
maneuvers are separated by 5-minute intervals to re-establish the initial hemodynamic 
steady state. From the steady-state values of Pcv and cardiac output (COl and COpc) 
during the seven inspiratory pause periods two venous return curves were constructed 
by fi tting linear regression lines according to the method of least square means through 
these data points (fi gure 4.2). Pmsf,l and Pmsf,pc  are defi ned as the extrapolation of 
these linear regressions to zero fl ow with COl and COpc respectively.3,14,15,19
Figure 4.2 Venous return curves
Panel A, the relationship between cardiac output (CO) obtained during the end of the inspiratory hold 
from the fl ow probe around the aorta (COl,hold) and central venous pressure (Pcv,hold). Panel B, 
similar relationship obtained by arterial pulse pressure analysis (COpc,hold). Mean systemic fi lling 
pressure (Pmsf) is obtained by extrapolation of the linear fi t to CO is 0. The bold data points are taken 
from fi gure 4.1. 
Protocol
To eliminate the effects of surgery, opening of the pericardium, and applying mechanical 
ventilation on the hemodynamic measurements, the piglets were allowed to stabilize for 
60 to 120 minutes after surgery. Data collection started once heart rate (HR), mean Pao 
and Pcv were stable for at least 15 minutes. After stabilization, series-1 measurements 
were performed by applying the seven inspiratory holds. After 50 minutes these 





















































Data analysis and statistics
The results of the data pairs of COr, COl and COpc obtained during each inspiratory 
hold were compared by linear regression and the difference between them by Bland-
Altman analysis. To describe the venous return curve we fi tted the set of seven data 
points of Pcv and COl and of Pcv and COpc by linear regression for series-1 and 
series-2. We defi ned Pmsf as the extrapolation of this linear regression to zero fl ow 
(fi gure 4.2), assuming that airway pressure does not affect Pmsf. Repeatability was 
calculated from the two baseline conditions using Bland-Altman analysis. Hereto, 
for each animal the mean and difference of the values of series-1 and series-2 were 
determined. The upper and lower limits of agreement were calculated as bias ± 2SD. 
The coeffi cient of variation (COV) was calculated as 100% x (SD/mean). Differences 
in variables during series-1 and series-2 were analyzed using paired t-tests. The effect 
of reduction of the number of inspiratory holds on Pmsf values was studied as follows: 
4-holds by selection of holds 1, 3, 5, 7 (see fi gure 4.2); 3-holds by holds 1, 4, 7 and 
2-holds by 1 and 7. All values are given as mean ± SD. A p-value < 0.05 was considered 
statistically signifi cant.
Results
Ten 8–10 week old piglets (all females) bodyweight of 11.0 ± 0.9 kg were studied. 
The fi rst series of measurements in animal 1 were excluded for analysis because 
of a technical problem in recording a proper left ventricular outfl ow signal. Mean 
hemodynamic characteristics of the animals during series 1 and 2 were: Pao 75.8 ± 6.7 
mmHg, Ppa 15.5 ± 3.5 mmHg, Pcv 3.7 ± 0.5 mmHg, heart rate 146 ± 42 min-1, COtd 
17.72 ± 3.12 ml·s-1.
The hemodynamic changes during a normal ventilatory cycle and during a ventilatory 
hold are illustrated in an individual example by plotting Pao, Pcv, Pt and beat-to-beat 
changes of COr, COl and COpc against time, see fi gure 4.1. The fi gure shows that 
during infl ation a rise in Pcv and a concomitant decrease in CO occurs. Also, a shift 
between the changes in right ventricular cardiac output and left ventricular is observable. 
However, 8 seconds after start of the inspiratory hold a plateau in COr, COl and COpc 
occurs. During the normal ventilatory cycle the modulation in right ventricular output 
is larger than that of left ventricular output. Pooled data during normal ventilation are 
shown in table 4.1. A Kolmogorov-Smirnov test indicated normal distribution of all 
data.
CO during inspiratory hold procedures
During the inspiratory holds, illustrated in fi gure 4.1, Pcv increased to a constant level 
for 12 seconds. This increase in Pcv led to a decrease in Pao, COr, COl, and COpc. 
Over the last 5 seconds of the hold their CO beat-to-beat values were constant. Over 
this period in total 133 paired averaged data points were obtained for COr, COl, and 
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COpc. Regression analysis showed that COr, COl and COpc were highly related to 
each other (COl = 1.002·COr, R2 = 0.955; COpc = 0.965·COr, R2 = 0.940; and COpc 
= 0.961·COl, R2 = 0.965, fi gure 4.3A). The result of Bland-Altman analysis for the 
difference between methods is given in table 4.1 and fi gure 4.3B. No difference was 
found between COr and COl, but a small signifi cant difference was present between 
COr and COpc as well as between COl and COpc. The COV for repeated measurements 
(series-1 and series-2) of COr, COl and COpc were 12%, 10% and 12% respectively.
Table 4.1 Bland-Altman analysis of cardiac output results
Mean        Difference      Limits of agreement
       Bias       SD COV    Lower Upper
ml•s-1        ml•s-1       ml•s-1         %       ml•s-1       ml•s-1 p
COr - COl 11.23 -0.03 0.66 5.9 1.29 -1.35         0.621
COr - COpc 11.06 0.32 0.78 7.1 1.88 -1.24      < 0.001
COl - COpc 11.08 0.34 0.62 5.6 1.58 -0.90      < 0.001
Bland-Altman analysis of cardiac output results by measurements with a fl ow probe around the pulmonary
artery (COr), around the aorta (COl) and arterial pulse contour analysis (COpc). p-value for the 
difference between bias value and zero is given (n = 133).
Venous return curves and Pmsf
An individual example of the Pcv versus blood fl ow (COl and COpc) relationships, i.e. 
the venous return curves, is given in fi gure 4.2. Observable is the linear relationship 
through the data points obtained from the seven inspiratory holds. For all 10 animals 
this venous return curve was linear, as can be observed in fi gure 4.4 for Pcv versus 
COpc. For all observations the averaged slope of the venous return curve Pcv versus 
COl is -2.228 ± 0.368 and for Pcv versus COpc is -2.355 ± 0.337 (difference p = 0.03), 
the averaged squared correlation coeffi cients (R2) are 0.912 (ran ge 0.887-0.966) and 
0.970 (range 0.929-0.993) respectively. The population averaged values of Pmsf with 
COl and Pmsf with COpc are 10.77 ± 1.00 mmHg and 10.38 ± 1.09 mmHg (difference 
p = 0.003) respectively. Bland-Altman analysis for the difference between methods 
(table 4.2) showed that the small difference between Pmsf,l and Pmsf,pc of 0.40 ± 0.48 
mmHg (COV = 4.5%) is, however, statistically signifi cant (p = 0.009).
Repeatability
Bland-Altman analysis for repeated measurements for Pmsf,l  showed a bias of -0.18 
mmHg and a precision of 0.67 mmHg (COV = 6.2%) and for Pmsf,pc these values 
were -0.27 mmHg and 0.63 mmHg (COV = 6.1%). There was no difference between 
the fi rst and second series of Pmsf,l  and Pmsf,pc  (p = 0.58 and 0.22 respectively).
Data reduction
The results of reduction of the number of data points per venous return curve from 7 
to 4, 3 and 2 inspiratory holds is shown in table 4.2. A remarkable good agreement 
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between Pmsf with COl and Pmsf with COpc was found for Pmsf with 7, 4, 3 and 2 
inspiratory holds per venous return curves. The difference between the techniques was 
statistically signifi cant but was maximally 4.5%. No difference between the fi rst and 
second series per animal was found and the COV for repeated measurements of Pmsf 
ranged from 2.2 to maximally 6.5% (table 4.2).
Figure 4.3 Cardiac output by aortic probe and pulse contour cardiac output
Cardiac output measured during the end of the inspiratory hold by the aortic probe (COl) and pulse 
contour cardiac output (COpc). In panel A, regression between COl and COpc is given. Noticeable 
is the small underestimation of COpc in the low output range. In panel B, Bland-Altman analysis of 
COl and COpc is shown. 
Figure 4.4 Venous return curves of the 10 individual animals. 
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Table 4.2 Bland-Altman analysis for the difference between mean systemic fi lling pressures
n,h Mean  Difference   Limits of agreement
 Bias       SD COV   Lower Upper
      mmHg    mmHg mmHg         %      mmHg mmHg p
Difference
Pmsf,COl and 7 10.57 0.40 0.48 4.5 -0.56 1.35 0.009
Pmsf,COpc 4 10.50 0.47 0.27 2.6 -0.07 1.01 0.006
3 10.97 0.37 0.47 4.3 -0.58 1.32 0.003
2 10.39 0.49 0.23 2.2 -0.02 0.95 0.001
Repeatability
Pmsf,COl 7 10.77 -0.18 0.67 6.2 -1.47 1.11 0.339
4 10.74 -0.37 0.57 5.3 -1.50 0.77 0.073
3 10.66 -0.39 0.64 6.0 -1.62 0.85 0.079
2 10.63 -0.35 0.61 5.7 -1.56 0.86 0.098
Pmsf,COpc 7 10.37 -0.27 0.63 6.1 -1.54 1.01 0.218
4 10.27 -0.39 0.62 6.0 -1.58 0.84 0.084
3 10.42 -0.27 0.68 6.5 -1.63 1.09 0.239
2 10.14 -0.23 0.48 4.7 -1.19 0.72 0.159
Bland-Altman analysis for the difference between mean systemic fi lling pressures (Pmsf) measured with a
fl ow probe around the aorta (Pmsf,COl) and with arterial pulse pressure analyses (Pmsf,COpc) as well as 
Bland-Altman analysis for repeated measurements. Both analyses were done for 7, 4, 3 and 2 inspiratory hold
maneuvers (n,h). p-value for the difference between bias value and zero is given.
Discussion
Our analysis shows clearly: 1. COr equals COl equals COpc at the end of the inspiratory 
holds; 2. the feasibility of pulse contour analysis to estimate the venous return curve 
and the unambiguous determination of mean systemic fi lling pressure; and 3. Pmsf can 
be estimated with 2-7 inspiratory holds.
The measurement of Pmsf under clinical conditions was limited to the availability of 
planned, unavoidable circulatory arrest for instance during testing of ICD.20,21 But, 
recently we12 showed the feasibility of bedside determination of effective volume-
status, Pmsf, by the application of 4 inspiratory holds and measurement of Pcv and pulse 
contour cardiac output during these holds. In this and former animal studies3,12,14,15 we 
made several assumptions for the determination of mean systemic fi lling pressure: 1, 
we assumed venous return to the heart to be equal to the left ventricular output during 
the end of the inspiratory holds; 2, we expected pulse contour cardiac output to be 
equal to left ventricular output; and 3, we reasoned that three or four inspiratory holds 
were enough to reliably describe the venous return curve.
Venous return equals left ventricular output
In comparing CO techniques, the limits of agreement of COr with COl (2SD/mean) 
were 9%. Together, with a bias for the difference between techniques which was not 
signifi cantly different from zero and a COV for repeated measurements of 12% and 
10% for COr and COl, the two methods are interchangeable. Thus, measurement of left 
ventricular output during inspiratory holds allows the estimation of right ventricular 
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output and most presumably also from right atrial input, as the right heart has a limited 
storing capacity for blood.
Left ventricular output equals arterial pulse contour cardiac output
The technical set-up with a fl ow probe around the pulmonary artery or aorta is not 
generally applicable in humans. Therefore we have chosen to evaluate a beat-to-beat 
determination of cardiac output by arterial pulse contour analysis. Most commercial 
pulse contour methods (PiCCO, LiDCO, FloTrac-Vigileo and Modelfl ow) use a 
pressure to volume conversion based on in vitro measurements of the human aorta. 
From a comparative study it became clear that there are differences in aortic compliance 
between humans and pigs.22 In humans the compliance of the aorta decreases non-
linearly with increasing pressures between approximately 30 and 200 mmHg.23 This 
relation is age dependent. For pigs the compliance fi rst increases in the lower pressure 
range and next decreases in the higher pressure range. This increase and decrease in 
pigs is less pronounced than the decrease in compliance in humans. No information 
is available about age dependency in pigs. In our present study we approximated the 
pressure-dependent compliance in the pig with a constant compliance. This might lead 
to a slightly underestimated pulse contour cardiac output in the lower arterial pressure 
range. Indeed in this range the actual compliance is slightly larger than the used constant 
compliance leading to an underestimated stroke volume and CO (fi gure 4.3A). Still, 
Bland-Altman analysis showed a good agreement between COl and COpc with limits 
of agreement of -0.90 to1.58 ml·s-1 and a COV of 5.6%. This was accompanied by a 
small, although signifi cant, mean difference (bias = 0.34 ml·s-1) and a low coeffi cient 
of variation for repeated measurements. We conclude that our pulse contour CO 
measurement can replace the measurement of LV output with a probe around the aorta.
Mean systemic fi lling pressure by LV output and arterial pulse contour CO
The venous return curve constructed with the results of measurement of Pcv and COl 
or COpc during the inspiratory holds was linear in all 10 animals. The correlation 
coeffi cients with COl or COpc in the fi t were high (mean R2 = 0.971 and 0.984 
respectively).  The extrapolation of the linear fi t to zero fl ow resulted in a mean Pmsf,l 
of 10.77 ± 1.00 mmHg and of Pmsf,pc of 10.38 ± 1.09 mmHg. Also the repeatability 
or precision of the results of the two series of measurements per animal is good, mean 
difference between the fi rst and second series of measurements is -0.18 ± 0.67 mmHg 
for Pmsf,l and -0.27 ± 0.63 for Pmsf,pc. The small COV (6.2% and 6.1% for Pmsf,l and 
Pmsf,pc respectively) clearly indicates the unambiguous validity of our method with 
inspiratory holds to determine Pmsf.
Bland-Altman analysis for the difference between Pmsf,l and Pmsf,pc showed a small 
but signifi cant mean difference of 0.40 ± 0.48 mmHg. Detection of this small mean 
difference can be explained largely by the high correlation coeffi cient of the linear 
fi t. With small limits of agreement and with a small mean difference we concluded 
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that the two methods are interchangeable. Thus, pulse contour analysis can be used to 
determine the venous return curve and Pmsf.
Number of inspiratory holds to describe the venous return curve
Application of 7 inspiratory holds and recovery to baseline value takes approximately 
35 – 40 minutes. Reduction of 7 to 4, 3 or even 2 inspiratory holds will shorten the time 
needed to determine the venous return curve and Pmsf, which makes the method more 
clinically feasible. The results given in table 4.2 indicate that already 2 inspiratory 
holds (i.e. the hold with infl ation of 0 and 300 ml) allow an accurate estimate of Pmsf. 
The use of four inspiratory holds in our previous clinical study12 seems thus more than 
suffi cient.
Comparison with Pmsf values found in literature
We found difference in Pmsf values of approximately 8 mmHg between the experimental 
settings with our animals (10.4 mmHg) and the clinical setting with postoperative cardiac 
patients (18.8 mmHg)12 using the same measurement technique. This can be explained 
partly by: the difference in fi lling status; all postoperative cardiac patients had a positive 
fl uid balance whereas in our animal study only fl uid was given to compensate for blood 
loss during surgery; and a difference in positive end-expiratory pressure (patients 5 
cmH2O and in our piglets zero cmH2O). These differences during baseline condition 
are refl ected in different Pcv values (patients 6.7 mmHg and our piglets 3.7 mmHg). 
Furthermore, the Pmsf may be patient population and species dependent. For animals 
Pmsf values between 724 and 30 mmHg25 are reported.
We based our analysis on the assumption that the venous return curve is linearly 
dependent on applied central venous pressure. Except for a minor infl ection at low or 
negative values of Pcv such linearity was demonstrated by Guyton et al.10 in open chest 
experiments. Pinsky26 in dogs and Versprille and Jansen3 in pigs confi rmed this linearity 
in closed chest circumstances after thoracotomy. Furthermore, Pinsky26 demonstrated 
that Pmsf obtained by linear extrapolation of the venous return curves did not differ 
from the value measured during circulatory arrest. The Pmsf-values calculated from Pcv 
and COl or COpc are in agreement with the Pmsf-values determined by the inspiratory 
hold procedure3,13-15 and stop-fl ow measurements.27
Conclusions
During an inspiratory hold pulmonary fl ow and aortic fl ow equilibrate. Cardiac output 
estimates by the pulse contour method and by a fl ow probe around the aorta are 
interchangeable. Therefore, venous return can be estimated by pulse contour methods. 
Mean systemic fi lling pressure can be estimated with equal precision with both blood 
fl ow measurement methods. Four, three or even two inspiratory holds satisfy to construct 
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Abstract
Effective circulating blood volume can be estimated by measuring mean systemic 
fi lling pressure. We assessed the level of agreement between different bedside 
estimates of mean systemic fi lling pressure (Pmsf), arm equilibrium pressure (Parm) 
and model analogue (Pmsa) in eleven mechanically ventilated postoperative cardiac 
surgery patients. Sequential measures were made in supine position, rotating the bed 
to 30 head-up tilt and after fl uid loading (500 ml colloid). During each condition four 
inspiratory hold maneuvers were done to determine Pmsf, arm stop-fl ow was created 
by infl ating a cuff around the upper arm for 30 seconds to measure Parm, and Pmsa 
was estimated from a Guytonian model of the systemic circulation. Mean Pmsf, Parm 
and Pmsa across all three states were 20.9 ± 5.6, 19.8 ± 5.7 and 15.9 ± 4.9 mmHg, 
respectively.
Bland-Altman analysis for the difference between Parm and Pmsf showed a non-
signifi cant bias of -1.0 ± 3.08 mmHg (p = 0.062), a coeffi cient of variation (COV) 
of 15% and limits of agreement (LOA) of -7.3 and 5.2 mmHg. For the difference 
between Pmsf and Pmsa we found a bias of -6.0 ± 3.1 mmHg (p < 0.001), COV 17% 
and LOA -12.4 and 0.3 mmHg. Changes in Pmsf and Parm and in Pmsf and Pmsa were 
directionally concordant in response to head-up tilt and volume loading. In conclusion, 
Parm and Pmsf are interchangeable. Changes in effective circulatory volume are tracked 




Accurate assessment of cardiovascular state in the critically ill is diffi cult because 
easily measured parameters, such as blood pressure and cardiac output (CO), can co-
exist with different levels of ventricular pump function and effective circulating blood 
volume. Thus, identifying the appropriate therapy and targeting specifi c measurable 
endpoints of therapy are problematic. Although assessing dynamic changes in arterial 
pulse pressure or left ventricular stroke volume during ventilation and passive leg-
raising maneuvers improves identifi cation of fl uid responsiveness, they do not 
quantify effective circulating blood volume or the cause or lack thereof. Although fl uid 
resuscitation therapy is important in the management of unstable patients, excessive 
fl uid resuscitation can be harmful in acute lung injury1, head injury2 and postoperative 
patients.3 Thus, a measure of effective volume status is useful to avoid volume overload 
since even volume-overloaded patients may remain volume responsive.
Mean systemic fi lling pressure (Pmsf) is a functional measure of effective intravascular 
volume status. It is the pressure anywhere in the circulation during circulatory arrest.4 
Importantly, central venous pressure (Pcv) to Pmsf pressure difference defi nes the 
driving pressure for venous return, and together with the resistance to venous return 
defi nes CO. We have shown that Pmsf can be measured in ventilator-dependent patients 
using inspiratory hold maneuvers defi ning Pcv-CO data pairs that when extrapolated to 
zero CO reports Pmsf.5,6 This calculated Pmsf parameter accurately follows changes 
in intravascular volume.5,7
Unfortunately, this inspiratory hold technique requires a sedated and ventilated patient, 
not universally seen in critically ill patients. We thus studied two simpler bedside 
methods for determining Pmsf as previously suggested by Anderson8 and Parkin.9 
Anderson hypothesized that the circulation of the arm behaves similar to total systemic 
circulation during steady-state conditions. Accordingly, we measured transient stop-
fl ow forearm arterial and venous equilibrium pressure, referred to as arm equilibrium 
pressure (Parm). Parkin9 proposed estimating the effective circulatory volume based 
on an electrical analog simplifi cation of Guytonian circulatory physiology estimating 
mean circulatory pressure (Pmsa) from directly measured Pcv, mean arterial pressure 
and CO. The aim of our study was to compare the level of agreement between 
simultaneously measured Pmsf, Parm and Pmsa in three intravascular volume states in 
critically ill patients.
Materials and methods
The study was approved by the hospital ethics committee of Leiden University Medical 
Center (P01.111, 29 January 2002) and carried out in Leiden. Written informed consent 
was obtained from all patients prior to surgery. The institutional review board of 
University of Pittsburgh approved review and analysis of data. Eleven patients were 
enrolled and studied after cardiac surgery.
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Patients 
We limited our study to cardiac surgery patients requiring pulmonary artery and radial 
artery catheters for perioperative monitoring. Our study partially used hemodynamic 
data from the same patients reported in another study but examined different protocol-
based measures.7 All patients had coronary artery or valvular disease with preserved 
ventricular function (EFlv > 0.4). Patients with aortic aneurysm, severe peripheral 
vascular disease, postoperative arrhythmia, postoperative valvular insuffi ciency or 
needing artifi cial pacing or the use of a cardiac assist device were excluded. All subjects 
were studied during their initial postoperative period in the ICU, while sedated (propofol 
3.0 mg·kg-1 ·h-1 and sufentanil 0.06-0.19 μg·kg-1·h-1) and mechanically ventilated with 
airway pressure release ventilation adjusted to achieve normocapnia, with 7-11 ml·kg-1 
tidal volumes, 5 cmH2O positive end-expiratory pressure, FiO2 0.4 and f = 11-13 min
-1 
(Evita 4, Dräger AG, Lübeck, Germany). During the study interval all subjects were 
hemodynamically stable and no changes were made in their vasoactive drug therapy.
Measurements
All subjects also had a central venous catheter. Arterial pressure (Pa) and Pcv were 
recorded onto a computer for offl ine analysis. Pa and Pcv pressure transducers were 
referenced to the intersection of the anterior axillar line and the 5th intercostal space and 
re-referenced after a 30 head-up rotation. Airway pressure (Paw) was measured at the 
proximal end of the endotracheal tube. Beat-to-beat cardiac output (CO) was obtained 
by Modelfl ow pulse contour analysis as previously described by us.10-12 We calibrated 
the pulse contour CO measurements with 3 therm odilution CO measurements equally 
spread over the ventilatory cycle.11
We have previously described the inspiratory hold method for estimating Pmsf.5 
Briefl y, four 12-second inspiratory holds were applied at Paw of 5, 15, 25 and 35 
cmH2O respectively. The resulting Pcv and CO were measured during the plateau phase 
(between 7-12 seconds of each inspiratory hold maneuver), and the zero CO intercept 
of the Pcv and CO pairs estimated Pmsf. 
Parm estimates of Pmsf8 assumes Pa and Pv equilibrium following rapid vascular 
occlusion. We performed a pilot study in nine patients after either cardiac surgery or 
cardiopulmonary resuscitation to determine the stop-fl ow time. We measured arterial 
and venous pressures in the same hand and created upper extremity blood stop-fl ow 
using a rapid cuff infl ator (Hokanson E20, Bellevue, Washington) to pressures 50 
mmHg above systolic pressure and held occlusion for 35-60 seconds (fi gure 5.1). 
Measurements were performed three times to assess repeatability (table 5.1). Arterial 
and venous pressures equilibrated after 25-30 seconds of stop-fl ow, with a mean 
difference of -0.73 ± 1.07 mmHg at 30 seconds. Thus, we chose the 30-second value of 
the arterial pressure for Parm for the present study.
The Pmsa estimate9 uses a mathematical model of the systemic circulation comprising 
compliant arterial and venous compartments and resistances to blood fl ow. The model 
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parameters are adjusted to match those of the patient’s current measured variables, 
such that  P msa = a•Pcv + b•Pa + c•CO, where a and b are dimensionless constants (a 
+ b = 1, typically a = 0.96, b = 0.04) and c has the dimensions of resistance and is a 
function of patient’s height, weight and age. 
c=0.038•(94.17+0.193•age)/(4.5•[0.99(age-15)] •0.007184• [height0.725] •[weight0.425]) 
Protocol
Measurements were carried out within 2 hours of arrival in the ICU following initial 
hemodynamic stabilization. To induce changes in volume status, measurements were 
performed in supine position (baseline), in a 30 head-up tilt (HUT) and again in supine 
position after 500 ml hydroxyethylstarch (HES 130/0.4) rapid fl uid administration 
(VOL). Measurements of Pa, Pv, Pcv, CO were done during baseline in supine 
position, 2 minutes after change to HUT and 2-5 minutes after fl uid loading with Pmsf, 
Parm and Pmsa calculated for each step. Repeatability of Parm was determined by 
two measurements during baseline and after VOL. The study protocol lasted about 
60 minutes. All patients completed all steps of the protocol and there were no adverse 
events.
Figure 5.1  Example of an inspiratory hold maneuver
Representative registration of radial artery pressure and venous pressure before (–15 to 0 seconds), 
during (0 to 36 seconds) and after the occlusion of the upper arm of a patient. Arm vascular occlusion 
equilibrium pressure (Parm) is taken as the arterial pressure 30 seconds after stop-fl ow. Note the 
infl uence of mechanical ventilation on arterial and venous pressure before and after occlusion.
Statistical analysis 
After confi rming normal distribution of data with the Kolmogorov–Smirnov test, 
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using paired t-tests. Calculations of bias, precision and limits of agreement (LOA) 
between Pmsf and both Parm and Pmsa were performed using Bland-Altman analysis 
with bias refl ecting the mean difference between Pmsf and either Parm or Pmsa and 
precision as the standard deviation (SD) of these differences. After adjustment for the 
number of observations (n = 33) LOA are defi ned as bias ± 2.04 • SD. For repeatability 
of Parm (n = 40) LOA are bias ± 2.02 • SD. The coeffi cient of variation (COV) is 
calculated as 100% • SD/mean. Repeatability of Parm was calculated by Bland-Altman 
analysis using duplicate measurements at baseline and after VOL, which were pooled 
together. A p-value < 0.05 was considered statistically signifi cant. Unless otherwise 
stated, data are presented as mean ± SD.
Table 5.1 Pilot study arm equilibrium pressure
Time     Pa    Pv    Pa-Pv
    Mean       SD Repeat    Mean      SD Repeat    Mean      SD Repeat
sec      mmHg       mmHg %  mmHg      mmHg %  mmHg      mmHg %
15 23.32 2.41 5.45 21.96 2.05 9.20 1.35 2.69 4.89
20 22.11 1.88 6.11 22.12 2.02 9.58  -0.01 1.62 5.52
25 21.42 1.56 6.91 22.06 1.91 9.79 -0.63 1.02 5.18
30 21.08 1.38 6.55 21.81 2.05 9.58 -0.73 1.07 4.55
Effect of time on arterial pressure (Pa), venous pressure (Pv) and the difference between Pa and Pv during
upper arm stop-fl ow. The results of a pilot study in 9 patients are indicated. Repeat, the averaged repeatability 
of three sequential measurements and SD, standard deviation.  
Results
Patient characteristics are presented in table 5.2 and mean hemodynamic data for the 
protocol in table 5.3. Mean Pa decreased during HUT and was unchanged with VOL. 
Pcv, CO, Pmsf, Parm and Pmsa decreased during HUT and increased with VOL.
Pmsf, Parm and Pmsa decreased in all patients during HUT (3.4 ± 2.6, 3.0 ± 2.0 and 
3.7 ± 2.3 mmHg, p < 0.001, p = 0.001 respectively). VOL was associated with an 
increase in Pmsf, Parm and Pmsa (8.7 ± 5.3, 8.7 ± 3.8 and 4.5 ± 2.1 mmHg, p < 0.001 
all, respectively). Parm was not different from the Pmsf during baseline, HUT or VOL 
(p = 0.236, p = 0.423 and p = 0.173 respectively). However, Pmsf and Pmsa differed 
signifi cantly for the three conditions (p < 0.001 all). Pmsf regressed signifi cantly with 
Parm (fi gure 5.2A) (slope = 0.944, correlation coeffi cient (R) = 0.847) and Pmsa (fi gure 
5.2B) (slope = 0.704, R = 0.822). 
Baseline Pmsf and Parm did not correlate with Pcv, Pa and pulse pressure. Baseline 
Pmsa correlated with Pcv (Pearson correlation coeffi cient R = 0.846, p = 0.001) and 
with pulse pressure (R = 0.697, p = 0.017). Pmsa did not correlate with mean, systolic 
and diastolic arterial pressure (p > 0.28 for all).
For the changes in Pmsf, Parm and Pmsa induced by HUT only Pmsa correlated 
signifi cantly with changes in Pcv (R = 0.931, p < 0.001). For the changes induced by 
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VOL both Pmsf and Pmsa correlated with changes in Pcv (R = 0.781, p = 0.005 and R 
= 0.911, p < 0.001). No signifi cant correlation was found with changes in Pa or pulse 
pressure for changes in Pmsf, Parm and Pmsa. 
 
Table 5.2 Patient Characteristics
Mean Range
Age (years) 64  50-80
Gender 9 male, 2 female
Weight (kg) 86    73-112




Respiratory rate (min-1) 12  11-13
Tidal volume/predicted (ml•kg-1) 9    7-11
PEEP (cm H2O) 5





Sodium nitroprusside 1 0.25
CABG, coronary artery bypass grafting; AVR, aortic valve replacement 
Table 5.3 Hemodynamic data of patients during baseline, head-up tilt and fl uid loading
     Baseline      HUT     + 500 ml
     Mean SD      Mean SD p1     Mean SD p2
Pa (mmHg) 88.8 17.9 77.3 17.0    < 0.001 97.9 15.3    0.003
Psys (mmHg) 128.5 21.9 107.2 16.9    0.001 143.3 17.7    0.004
Pdias (mmHg) 69.0 17.7 62.4 17.9    0.001 75.2 15.6    0.040
PP (mmHg) 59.5 14.7 44.8 9.9    0.016 68.1 12.1    0.076
Pcv (mmHg) 7.1 2.0 4.4 1.8    0.001 10.4 1.3    0.001
CO (l•min-1) 5.8 1.6 4.8 1.2    0.006 7.0 1.7    0.004
HR (min-1) 88 14 87 15    0.574 86 10    0.475
Pmsf (mmHg) 19.7 3.9 16.2 3.0    0.001 28.3 3.6 < 0.001
Parm (mmHg) 18.4 3.7 15.4 3.1    0.001 27.1 4.0 < 0.001
Pmsa (mmHg) 14.7 2.7 10.9 2.0    < 0.001 19.2 1.1 < 0.001
Values are means ± SD; n = 11 patients. Pa, mean arterial pressure; Psys, systolic arterial pressure; Pdias, diastolic 
arterial pressure; PP, pulse pressure; Pcv, central venous pressure; CO, cardiac output; HR, heart rate; Pmsf, mean
systemic fi lling, pressure; Parm arm equilibrium pressure; Pmsa, model analogue mean circulatory pressure. 
Statistical comparison, p1, paired t-test between baseline and head-up tilt condition (HUT) and p2, paired 
t-test between baseline and after fl uid loading condition (+ 500 ml).  
Agreement of methods
For all measurements Pmsf and Parm displayed a non-signifi cant bias of -1.0 ± 3.08 
mmHg (p = 0.062), COV of 15% and with LOA of -7.3 and 5.2 mmHg (fi gure 5.2B). 
The biases for Pmsf and Parm were: baseline -1.3 ± 3.4, HUT -0.8 ± 3.2, VOL -1.2 ± 
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2.8 mmHg. For all measurements Pmsf and Pmsa displayed a bias of -6.0 ± 3.1 mmHg 
(p < 0.001), COV of 17% and LOA of -12.4 and 0.3  mmHg (fi gure 5.3B). The biases 
for Pmsf and Pmsa were: baseline -5.0 ± 2.8, HUT -5.3 ± 3.2, VOL -8.1 ± 2.7 mmHg. 
Mean Pmsf, Parm and Pmsa across all three states were 20.9 ± 5.6, 19.8 ± 5.7 and 14.9 
± 4.0 mmHg, respectively.
Figure 5.2 Regression (A) and Bland-Altman analysis (B) of arm equilibrium pressure (Parm) 
and mean systemic fi lling pressure (Pmsf).  
In panel A, the solid line is the regression line and the dashed line is the line of identity. In Panel B, 
the solid line indicates the bias and the dashed lines are the limits of agreement.
Figure 5.3 Regression (A) and Bland-Altman analysis (B) of model analogue pressure (Pmsa) 
and mean systemic fi lling pressure (Pmsf).
In panel A, the solid line is the regression line and the dashed line is the line of identity. In Panel B, 
the solid line indicates the bias and the dashed lines are the limits of agreement.
Changes of Parm (ΔParm) and Pmsa (ΔPmsa) versus changes in Pmsf (ΔPmsf) are 
shown in fi gure 5.4. Both ΔParm and ΔPmsa regressed signifi cantly (p < 0.001) with 
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tabulation agreement of positive and negative changes in each of the methods for HUT 
and VOL displayed directionally balanced concordance for all data pairs for both 
Parm and Pmsa versus ΔPmsf.
Figure 5.4 Changes in mean systemic fi lling pressures.
Changes in mean systemic fi lling pressure by arm equilibrium pressure (Parm) (A) and by model 
analogue (Pmsa) (B) plotted against changes in mean systemic fi lling pressure by inspiratory hold 
procedures (Pmsf). The regression line is indicated by a solid line.
Repeatability of Parm
Bland-Altman analysis for Parm duplicate measurements during both baseline and 
VOL revealed a bias of 0.03 ± 1.02 mmHg, LOA from -2.04 to 2.09 mmHg and COV 
of 5%. No difference was found between the fi rst and second of the duplicate Parm 
measurements (p = 0.915).
Discussion
Our study demonstrates that estimates of Pmsf measured 30 seconds after arm stop-fl ow 
(Parm) are interchangeable with Pmsf calculated using inspiratory hold maneuvers in 
mechanically ventilated postoperative cardiac surgery patients. Furthermore, changes 
in volume status by HUT and VOL are similarly tracked by Pmsf, Parm and Pmsa. These 
data support the hypothesis formulated, but not previously validated, by Anderson8, that 
during steady-state fl ow conditions the arm is representative of the entire circulation, 
such that a rapid vascular occlusion will result in its stop-fl ow Pa approximating Pmsf. 
Thus, both Pmsf and Parm can be used at the bedside to measure effective circulating 
blood volume. Furthermore, Pmsa can reliably tract changes in effective circulating 
blood volume status.
The use of both Parm and Pmsa has practical advantages over our previously validated 
inspiratory hold maneuver Pmsf approach. Neither requires positive-pressure breathing 
or multiple simultaneous measures of Pcv and CO during inspiratory hold maneuvers, 
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progresses. Parm requires only the peripheral arterial catheter. Pmsa requires both 
central venous and peripheral arterial catheters. Thus, these two novel approaches 
markedly increase the applicability of assessment of effective circulating blood volume 
to a broader patient population.
Methodological consideration
Radial artery pressure. Shortly after cardiopulmonary bypass, radial artery pressure 
can be signifi cantly less than aortic pressure13-15, but this difference disappears after 
about 60 minutes, coinciding with hemodynamic stabilization.13 Our study started after 
approximately 2 hours after cardiopulmonary bypass in stable patients. Therefore, we 
believe that mean radial artery pressure reliably refl ected central aortic pressure. We 
recently documented in a porcine model of acute endotoxemia16 that similar central 
to regional arterial pulse pressure changes occur. However, the value of Pmsf is not 
dependent on the calibration of the pulse contour method as long as a linear change in 
CO is followed by a linear change in CO derived from pulse contour. Indeed, Pcv at 
CO equal to zero is not even infl uenced by a calibration factor.
Arm stop-fl ow procedure.   In the pilot stop-fl ow study described above, we observed 
that a plateau pressure developed in both arterial and venous pressures after 20-30 
seconds as predicted by Anderson.8 However, a further decrement in both Pa and Pv 
developed after 35-40 seconds, indicating probable hypoxia-induced vasodilation. We 
also observed the best repeatability and lowest standard deviations between the arterial 
and venous pressure at 25-30 seconds of stop-fl ow, which was the time we used in this 
study. Furthermore, stop-fl ow durations longer than 5 minutes are needed to produce 
reactive hyperemia in the human forearm.17,18 Thus, if stop-fl ow maneuvers are limited 
to < 1 minute, regional blood fl ow will also normalize after an additional 1 minute.19 
The rapid cuff infl ator infl ates in less than 0.3 seconds.20 In this time there is only 
a brief cessation of venous return prior to arterial stop-fl ow equal to approximately 
one heart beat. We expect this overestimation to be negligible because the amount of 
infl ow is small compared to the total distal arm blood volume. Finally, since longer 
vascular occlusion maneuvers are routinely used to assess dynamic changes in tissue 
O2 saturation without complications
21, we feel that this much shorter vascular occlusion 
maneuver is safe. 
Model analogue Pmsa. No clinical evaluation of Pmsa against other methods to measure 
Pmsf has been done so far. The validity of the Pmsa algorithm was successfully tested 
using a closed loop control of fl uid replacement during continuous hemodiafi ltration.22 
Our data support these fi ndings because ΔPmsf and ΔPmsa faithfully track each other.
Pmsf. We showed that Modelfl ow pulse contour CO was interchangeable with 
pulmonary artery and aortic fl ow probe derived CO in swine23, and that Modelfl ow-
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derived Pmsf was interchangeable with fl ow probe-derived Pmsf with a COV for 
duplicate measurements of 6.1%. Still, we report mean baseline Pmsf values of 19.7 
mmHg in our cardiac surgical patients, which are higher than Pmsf values reported 
between 7-12 mmHg in animal studies.24-27 Using the same inspiratory hold technique 
and pulse contour analysis we found Pmsf values of 10.38 ± 1.09 mmHg in pigs.23 A 
primary difference between the prior animal studies and our patient observations is the 
difference in baseline Pcv. In the animals studies this value is close to zero whereas Pcv 
in our patient population is on average 7.1 mmHg. The pressure gradient for venous 
return (Pmsf minus Pcv) in our study (12-13 mmHg) is therefore similar to the pressure 
gradient for venous return in the animal studies. Thus, our Pmsf values are coupled 
with the increased Pcv. However, high values of Pmsf still predispose to peripheral 
edema formation.
Jellinek et al.28 and Schipke et al.29 estimated Pmsf in patients during episodes of 
apnea and ventricular fi brillation, and found a mean Pmsf value of 10.2 mmHg and 
12 mmHg, respectively. However, both studies were done on highly anesthetized non-
volume resuscitated subjects. Our method of estimation of Pmsf differs considerably 
from stopping fl ow by ventricular fi brillation, and our method allows an estimation of 
Pmsf with intact circulation, applicable in the intensive care unit.5,30
Agreement between Parm, Pmsa and Pmsf. We found agreement between Pmsf and 
Parm (fi gure 5.2) and ΔPmsf and ΔParm were concordant in all interventions (fi gure 
5.4). Therefore, both methods should equally measure and follow changes in effective 
circulating blood volume. There was poor agreement between Pmsa and Pmsf. The 
large bias makes the methods non-interchangeable. However, the full concordance 
between Pmsf and Pmsa indicates that the Pmsa method is very applicable to track 
changes in effective circulating blood volume, as indeed was documented by Parkin et 
al. in dialysis patients.22 
 Finally, effective circulating blood volume is a functional measure, not an absolute 
one. In our study the vasoactive medication was not changed. Changing vasomotor 
tone will alter unstressed volume, stressed volume and compliance. Any treatment that 
alters unstressed volume will also alter effective circulating blood volume independent 
of changes in blood volume, as was demonstrated by Guyton et al.4
 Can either Parm or Pmsa replace the Pmsf method in the bedside assessment of 
effective circulating blood volume? Based on the established argument of Critchley 
and Critchley31, a new method may replace an older established method if the new 
method itself has errors not greater than the older method. The Parm method showed 
a non-signifi cant bias when compared to Pmsf. A single measurement of Pmsf has a 
COV of about 6%.23 We found a 5% repeatability for Parm. Thus, our data support the 
argument that Parm may replace inspiratory hold-maneuver generated Pmsf.
A signifi cant bias (p < 0.001) was observed between Pmsf and Pmsa, precluding the 
substitution of raw Pmsa values for Pmsf. However, based on the linearity of Pmsf and 
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Pmsa (fi gure 5.3A) one can adjust the Pmsa values using a calibration factor of 1.42 
(i.e. the reciprocal of the slope of the regression 0.704). After this calibration is applied 
to Pmsa values, indicated in fi gure 5.3A by an arrow from the regression line to the line 
of identity, the bias reduces to zero. The expected precision of the calculation of Pmsa 
is approximately 10% (this COV is largely caused by the COV in Pcv measurement, a 
value of 10 mmHg can be 9.51 or 10.49 mmHg). Although this 10% is higher than the 
6% for Pmsf, after recalibration the Pmsa model analogue may replace Pmsf. It must be 
emphasized that the correction factor only describes our postoperative cardiac surgery 
population and will require similar validation in other patient groups. 
Study limitations. The number of patients included in the study is relatively low. 
However, we still found a signifi cant difference between Pmsa and Pmsf. With a larger 
study population the difference between Pmsf and Parm could have become signifi cant. 
However, the absolute difference of -1.0 mmHg is not clinically relevant. We included 
patients with preserved left ventricular function, after relatively simple cardiac 
surgery, and excluded patients with previous myocardial infarction and/or congestive 
heart failure (New York Heart Association class 4). These patients are known to have 
markedly increased vascular tone with an associated decreased proportional unstressed 
vascular volume. Thus, caution needs to be used when extrapolating the accuracy of 
these comparisons to other patients groups. During the study, we made no changes 
in medication. Therefore, we cannot report on the values and comparison of Pmsf, 
Parm and Pmsa during changes in vasoactive medication, which infl uences vascular 
elastance, resistance and conductance properties. A fundamental limitation of the Parm 
technique is the need to measure arterial pressure from a radial arterial site. In patients 
with sepsis or on high levels of vasopressors, radial artery compliance may not refl ect 
central arterial compliance, although mean Pa remains accurate.16 Therefore, in these 
patients it is not clear if Parm or Pmsa will tract Pmsf. Still, under those conditions, the 
diagnosis of decreased effective circulating blood volume is rarely an issue.
Conclusions 
The equilibrium pressure in the arm during stop-fl ow (Parm) and inspiratory hold 
maneuver-derived Pmsf values are interchangeable in mechanically ventilated 
postoperative cardiac surgery patients. Thus, the mean systemic fi lling pressure can be 
simply measured at the bedside by measuring arterial pressure during upper arm stop-
fl ow, without the need of inspiratory hold maneuvers or central venous or pulmonary 
artery catheters. Furthermore, changes in effective circulatory volume are accurately 
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Abstract
In pharmacological research, arm occlusion pressure is used to study hemodynamic 
effects of drugs. However, arm occlusion pressure might be an indicator of static 
fi lling pressure of the arm. We hypothesised that arm occlusion pressure can be used 
to predict fl uid loading responsiveness. Twenty-four patients who underwent cardiac 
surgery were studied during their fi rst 2 hours in the ICU. The lungs were ventilated 
mechanically and left ventricular function was supported as necessary. Arm occlusion 
pressure was defi ned as the radial artery pressure after occluding arterial fl ow for 
35 seconds by a blood pressure infl ated to 50 mmHg above systolic blood pressure. 
The cuff was positioned around the arm in which a radial artery catheter had been 
inserted. Measurements were performed before (baseline) and after fl uid loading (500 
ml hydroxyethyl starch 6%). Patients whose cardiac output increased by at least 10% 
were defi ned as responders. In responders (n = 17), arm occlusion pressure, mean 
arterial pressure and central venous pressure increased and stroke volume variation and 
pulse pressure variation decreased. In non-responders (n = 7), arm occlusion pressure 
and central venous pressure increased, and pulse pressure variation decreased. Mean 
arterial pressure, stroke volume variation and heart rate did not change signifi cantly. The 
area under the curve to predict fl uid loading responsiveness for arm occlusion pressure 
was 0.786 (95% confi dence interval 0.567-1.000), at a cut-off of 21.9 mmHg, with 
sensitivity of 71% and specifi city of 88% in predicting fl uid loading responsiveness. 
Prediction of responders with baseline arm occlusion pressure was as good as baseline 
stroke volume variation and pulse pressure variation. In conclusion, arm occlusion 
pressure was a good predictor of fl uid loading responsiveness in our group of cardiac 





Fluid therapy is an important tool in hemodynamic management of patients with 
suboptimal tissue perfusion. However, excessive fl uid resuscitation can result in general 
and pulmonary oedema, increasing hospital stay and even mortality.1 In mechanically 
ventilated patients with a regular heart rhythm, stroke volume variation (SVV) and pulse 
pressure variation (PPV) perform well as predictors of a clinically signifi cant increase 
in cardiac output (CO) after fl uid administration (i.e. fl uid loading responsiveness).2,3 
In vasoplegic patients, both indicators failed.4,5 Furthermore, SVV and PPV have never 
been shown to act as a measure of volume status. Therefore, the search for a measure 
of volume status and a predictor of fl uid loading responsiveness which can be used 
independent of respiratory settings and heart rhythm continues.6 
A physiological measure of effective volume status is mean systemic fi lling pressure: 
the equilibrium pressure anywhere in the circulation under circulatory arrest. The 
pressure gradient between static fi lling pressure and central venous pressure (Pcv) is 
the driving force for venous return and thus for CO. Consequently, increasing mean 
systemic fi lling pressure and thereby the pressure gradient for venous return by fl uid 
expansion should improve CO, assuming a constant resistance to venous return and 
adequate myocardial function. 
In pharmacology research, upper arm occlusion pressure (Parm) has been used to 
determine the effects of drugs on venous capacitance and arterial resistance.7 We 
hypothesised that Parm might function as an indicator of mean fi lling pressure and 
volume status of the arm. Mean fi lling pressure of the arm has never been studied as 
a predictor of fl uid responsiveness. We determined Parm by measuring radial artery 
pressure 30 seconds after occlusion of arterial fl ow induced by infl ating a cuff around 
the upper arm. The aim of this study was to explore the value of Parm as a predictor 
of fl uid loading responsiveness. This approach is attractive, as it would provide the 
clinician with a simple, readily available and robust measurement that can be made at 
the bedside. 
Methods
Twenty-four patients undergoing elective cardiac surgery were included after approval 
of the institutional ethics committee (P06.149, chairman Prof. Dr. F.C. Breedveld, 
approval date 5 December 2006) and personal informed consent was obtained. Al l 
patients had symptomatic coronary artery or valve disease with preserved ventricular 
function. Patients with aortic aneurysm, extensive peripheral arterial occlusive disease, 
postoperative severe arrhythmia, postoperative valve insuffi ciency or the necessity for 
artifi cial pacing or use of a cardiac assist device were excluded. 
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Prior to surgery, a pulmonary artery catheter (Intellicath; Edwards Lifesciences; Irvine, 
CA, USA) was inserted to measure thermodilution cardiac output (COtd) and Pcv, and 
a 20 G radial artery catheter was used to measure radial artery pressure. Anaesthesia 
was maintained with propofol (2.5 mg·kg-1·h-1) and sufentanil (0.06-0.20 μg·kg-1·h-1). 
The lungs were mechanically ventilated (Evita 4; Dräger, Lübeck, Germany) in a 
volume-control mode with standard settings (12 breaths·min-1, tidal volume 8-10 ml·kg-1 
·min-1, FiO2 0.4, positive end-expiratory pressure 5 cmH2O). During the o bservation 
period, the patients were kept in the supine position. The use of sedative and vascular 
medication remained unchanged. No fl uids were administered during the observation 
period outside the study protocol.
Arterial occlusion in the arm was created with a rapid cuff infl ator (Hokanson E20, 
Bellevue, Washington, USA) connected to compressed air and an upper arm cuff. The 
cuff was positioned around the same arm as that used to measure radial artery pressure. 
The cuff pressure was increased stepwise to 50 mmHg above the patients’ systolic 
arterial pressure. The duration of arm occlusion was 35 seconds. Arm occlusion pressure 
(Parm) was calculated as the average value of the radial artery pressure over 1 second 
at 30 seconds after the start of arm occlusion.
The radial artery pressure was analysed with the “Modelfl ow” program (FMS, 
Amsterdam, the Netherlands) to provide beat-to-beat values of cardiac output (COmf) 
using the pulse contour CO method, calibrated using the averaged value of three COtd 
measurements spread equally over the ventilatory cycle.8 From the beat-to-beat values 
of “Modelfl ow”, SVV, PPV and heart rate (HR) were determined. SVV and PPV were 
calculated for 5 ventilatory cycles and their values were averaged. Pcv, mean arterial 
pressure (Pa), COmf and HR were averaged over 30 second intervals.
The study protocol started within 2 hours after arrival of the patients in the ICU and 
took approximately 15 minutes. Values of Parm, Pcv, Pa, COmf, SVV and PPV were 
collected before (baseline) and 2-5 minutes after rapid fl uid loading. Volume loading 
was achieved by using 500 ml 6% hydroxyet hyl starch solution (Voluven; Fresenius 
Kabi, Bad Homburg, Germany). Shortly after the end of the study protocol, sedation 
was stopped and weaning procedures were started. We observed no adverse events 
during the study protocol and all patients were discharged from the ICU on the fi rst 
postoperative day.
Statistical analysis
A formal power analysis was not performed because relevant data were not available 
from the literature. However, study sample size is similar to those in other fl uid loading 
responsiveness studies. We used a Kolmogorov-Smirnov test and a paired t-test. Patients 
were classifi ed as responders to fl uid loading when the increase in COmf was at least 
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10%. The 10% cut-off corresponds to more than twice the reported precision of the 
“Modelfl ow” method (i.e. twice the SD for repeated measurements).9,10 Consequently, 
responders experienced a clinically signifi cant change in CO. Prediction of fl uid 
responsiveness for COmf, Parm, Pa, Pcv, SVV and PPV was tested by calculating the 
area under the receiver operating characteristic (ROC) curve (AUC) together with the 
95% confi dence intervals (95% CI). A p-value for the difference between the AUC and 
the reference value of 0.5 (i.e. prediction of responders and non-responders by chance) 
was calculated. All values are given as mean ± SD. A p-value of less than 0.05 was 
considered to be statistically signifi cant. Statistical analysis was performed using SPSS 
16.0 (SPSS Inc., Chicago, Illinois, USA) and MedCalc 9 (MedCalc Inc., Mariakerke, 
Belgium) software.
Results
Twenty-four patients (19 males) aged 64 ± 10 years with a body surface area of 2.0 
± 0.2 m2 completed the study protocol. Seventeen underwent coronary artery bypass 
grafting, and seven also underwent repair of one or two valves. Norepinephrine (0.01-
0.2 μg·kg-1·min-1) was used in 16 patients, dobutamine (1.0-7.5 μg·kg-1·min-1) in nine 
and sodium nitroprusside (0.5 μg·kg-1·min-1) in one. The doses of these drugs were not 
changed during the observation period. Hemodynamic data were distributed normally. 
Pooled results of hemodynamic variables at baseline and after administration of 500 ml 
of fl uid are shown in table 6.1. After fl uid loading with 500 ml, COmf, Parm, Pa and 
Pcv increased. HR did not change. PPV and SVV decreased. 
The population was divided into responders (n = 17) and non-responders (n = 7) 
(table 6.1). In the responder group COmf, Pa, Pcv and Parm increased and SVV and 
PPV decreased after fl uid loading. Parm increased from 16 to 22 mmHg. In the non-
responder group, fl uid loading caused Parm to increase from 24 to 30 mmHg. Pcv also 
increased, PPV decreased, and COmf, Pa, SVV and HR did not change signifi cantly.
Table 6.1 Changes in hemodynamic parameters at baseline and after fl uid loading with 500 ml 
of colloid 
    All patients (n = 24)     Responders (n = 17)     Non-responders (n = 7)
    Baseline 500 ml p     Baseline 500 ml p     Baseline 500 ml p
COmf (l•min-1)   5.2 ± 1.3   6.0 ± 1.4 < 0.001   5.1 ± 1.3   6.2 ± 1.4 < 0.001   5.5 ± 1.3   5.7 ± 1.3    0.148
Parm (mmHg) 18.6 ± 7.7 24.3 ± 8.7 < 0.001 16.2 ± 6.3 22.0 ± 7.6 < 0.001 24.3 ± 8.2 29.9 ± 9.1 < 0.001
Mean Pa (mmHg)   82.3 ± 15.6   90.7 ± 16.1 < 0.001 78.9 ± 9.9   88.9 ± 11.2 < 0.001   90.4 ± 23.6   94.8 ± 25.2    0.056
Pcv (mmHg)   9.0 ± 2.6 11.5 ± 2.9 < 0.001   8.6 ± 2.6 10.9 ± 2.5 < 0.001   9.9 ± 2.5 13.0 ± 3.4    0.004
PPV (%) 13.8 ± 9.0   8.0 ± 7.5 < 0.001 14.8 ± 7.8   8.1 ± 6.6    0.001   11.1 ± 11.5     7.7 ± 10.0    0.011
SVV (%)   15.5 ± 10.5   9.3 ± 9.3    0.001   16.5 ± 10.9   8.5 ± 6.5 < 0.001 13.0 ± 9.9   11.2 ± 14.6    0.627
HR (min-1)   83 ± 16   83 ± 14    0.908   83 ± 18   83 ± 16    1.000   81 ± 10   82 ± 11    0.860
CO, cardiac output; Parm, arm occlusion pressure; Pcv, central venous pressure; mean Pa, mean arterial
pressure; HR, heart rate.
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The statistical results of the ROC curves in predicting fl uid responsiveness are shown 
in table 6.2 and fi gure 6.1. AUCs for baseline COmf, Pa and Pcv were not signifi cantly 
different from 0.5, or chance. In addition, the sensitivity and/or specifi city were low. 
The results for Parm, PPV and SVV were signifi cantly different from chance (p-values 
0.012, 0.001 and 0.010 respectively) with high sensitivity and specifi city for cut-off 
values of 21.8 mmHg or less, at least 7.2 % and at least 8.8 % respectively, indicating 
that these are reliable predictors of the effect on CO of fl uid loading with 500 ml. 
There were no signifi cant differences between the AUCs of Parm and PPV (difference 
= 0.0536, 95%CI -0.198 to 0.305, p = 0.676) or Parm and SVV (difference = 0.0446, 
95%CI -0.227 to 0.317, p = 0.748).  
Discussion
 This is the fi rst study in which Parm has been examined as a predictor of the effect 
of fl uid loading on CO. Baseline Parm was signifi cantly lower in the responder 
group than in the non-responder group. We consider that Parm is a good predictor of 
fl uid responsiveness in our group of mechanically ventilated patients with preserved 
ventricular function. Simple measurements of radial artery pressure during upper arm 
occlusion could help to detect patients whose CO will increase after fl uid loading.
Table 6.2 Receiver operating characteristics from baseline values as predictors of increase 
of cardiac output by more than 10% after fl uid loading
AUC      95% CI p Sensitivity Specifi city Cut-off
     Lower Upper
COmf (l•min-1) 0.588 0.371 0.783 0.507 35 100     ≤   4.0
Mean Pa (mmHg) 0.588 0.371 0.783 0.507 100 29     ≤ 91.0
Pcv (mmHg) 0.687 0.427 0.829 0.259 71 57     ≤   9.0
Parm (mmHg) 0.786 0.572 0.924 0.012 88 71     ≤ 21.8
PPV (%) 0.844 0.649 0.962 0.001 77 71     ≥   7.2
SVV (%) 0.746 0.544 0.908 0.010 82 86     ≥   8.8
AUC, area under receiver operating curve; 95% CI, 95% confi dence interval; p-value, comparison of AUC
with AUC = 0.5; COmf, cardiac output; mean Pa, mean arterial pressure; Pcv, central venous pressure; 
Parm, stop-fl ow pressure of the arm; PPV, pulse pressure variation; SVV, stroke volume variation.
In our study, the results from ROC analysis indicate that prediction of fl uid loading on 
CO was identifi ed equally using baseline Parm, PPV and SVV, but that prediction was 
not possible using baseline COmf, Pa or Pcv. Both SVV and PPV have been reported to 
perform better as predictors of fl uid responsiveness than static pressures (Pa, Pcv and 
pulmonary artery occlusion pressure).3,11-14 However, SVV or PPV are infl uenced by 
ventilator settings as tidal volume11,15, respiratory rate16 and also by cardiac function. 
In patients with reduced cardiac function, SVV is expected to be smaller because stroke 
volume is obviously limited and consequently ventilator-induced changes in stroke 
volume will be reduced.3,12 Reuter et al.15 showed that SVV could still perform as a 
predictor of fl uid loading responsiveness in patients with reduced cardiac function. 
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In addition, determination of SVV and PPV is possible only if the patient is fully 
dependent on mechanical ventilation and has a regular cardiac rhythm. SVV and 
PPV failed to predict the effects of fl uid loading on CO accurately in spontaneously 
breathing patients4,5 and in mechanically ventilated patients with tidal volumes less 
than 8 ml·kg-1 body weight.11 In our study, the lungs were ventilated mechanically with 
tidal volumes ranging from 7 to 12 ml·kg-1 predicted body weight. Thus, for some of 
our patients SVV and PPV may have been less reliable. 
Figure 6.1 Prediction of cardiac output response
Receiver operating characteristic curves comparing the ability of baseline arm occlusion pressure 
(Parm), pulse pressure variation (PPV) and stroke volume variation (SVV) to discriminate between 
responders and non-responders. Patients were characterized as responders when cardiac output 
increased by at least 10% after fl uid loading with 500 ml colloid.
In contrast, the Parm technique does not require a specifi c tidal volume or respiratory 
rate. To measure Parm with the arm occlusion method, only a peripheral arterial catheter 
is required. These requirements allow measurement in almost any environment in the 
operating theatre and ICU. Its application is not limited to sedated and mechanically 
ventilated patients with a regular heart rhythm. In our study, Parm was a good predictor 
of fl uid loading responsiveness, equal to SVV or PPV in predicting value. However, 
our study patients were a relatively homogeneous group.
Defi nition of fl uid loading responsiveness
There is no consensus on the amount of fl uid or use of measurements to assess 
fl uid loading responsiveness. Fluid amounts between 250 and 1000 ml have been 
reported.3-5,17,18 Outcome measures used include CO4,5,18, stroke volume17 and stroke 
volume index.3 Positive responses have been defi ned as a change in outcome measure 
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level after fl uid loading with 500 ml. The 10% increase in CO was chosen because this 
increase can be measured accurately with the modifi ed “Modelfl ow” pulse contour 
method.9,10,19,20 This value corresponds with the boundaries used in other studies in 
which a 10% cut-off was used for 500 ml fl uid loading responsiveness.4,21-23 
 Considerations and limitations
The number of patients (n = 24) included in our study is relatively small and the 
distribution of responders and non-responders is unequal. However, despite this small 
number of patients, we were able to fi nd highly signifi cant results. Prediction of fl uid 
loading responsiveness by baseline Parm had high sensitivity (71%) and specifi city 
(88%). We theorise that these results can be explained by the similarity between Parm 
and mean systemic fi lling pressure. Mean systemic fi lling pressure is the equilibrium 
pressure anywhere in the circulation under circulatory arrest, whereas Parm might be 
seen as the equilibrium pressure of the arm. We hypothesise that mean systemic fi lling 
pressure may be largely equal for different vascular compartments of the body because 
their venous outfl ow pressures and arterial input pressures are relatively similar. Mean 
systemic fi lling pressure is a physiological measure of effective volume status.24,25 
The pressure gradient between mean systemic fi lling pressure and Pcv is the driving 
force for venous return and thus for CO. Increasing mean systemic fi lling pressure and 
thereby the pressure gradient for venous return by fl uid expansion should improve CO, 
assuming a constant resistance to venous return. If there is hypervolemia or limitation 
of cardiac function (i.e. the heart operates on the fl at part of the Frank-Starling 
curve) fl uid loading will increase Pcv along with mean systemic fi lling pressure, and 
venous return will not increase. It is important to stress that we excluded patients 
with previous myocardial infarction and patients with congestive heart failure (New 
York Heart Association class 4). Unfortunately, we could not classify our patients 
because no ejection fraction data were available. Therefore, we must be careful not 
to extrapolate our results to patients with heart failure. In our patients, a low Parm (< 
22 mmHg) predicted fl uid loading responsiveness. In the case of cardiac failure or 
tamponade, Pcv will rise along with Parm during volume administration. This will 
result in an unchanged pressure gradient for venous return and thus, will fail to induce 
an improvement in CO. Therefore, we anticipate that our results will be applicable to 
patients with compromised cardiac function. Rapid increments of Pcv can be seen as a 
warning of right ventricular limitation.
Conclusions
Arm occlusion pressure can be measured at the bedside. Unlike SVV and PPV, 
the measurement of Parm is relatively independent of heart rhythm, mechanical 
or spontaneous breathing, or sedation. Parm is a good predictor of fl uid loading 
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Abstract
Mean systemic fi lling pressure (Pmsf) can be measured at the bedside with minimally-
invasive monitoring in ventilator-dependent patients using inspiratory hold maneuvers 
(Pmsfhold) as the zero fl ow intercept of cardiac output (CO) to central venous pressure 
(Pcv) relation. We compared Pmsfhold to arm vascular equilibrium pressure during 
vascular occlusion (Pmsfarm) and their ability to assess systemic vascular compliance 
(Csys) and stressed volume by intravascular fl uid administration. In 15 mechanically 
ventilated postoperative cardiac surgery patients inspiratory holds at vary ing airway 
pressures and arm stop-fl ow maneuvers were performed during normovolemia and 
after each of 10 sequential 50 ml bolus colloid infusions. We measured Pcv, Pmsfarm, 
stroke volume  and CO during fl uid administration steps to construct Pcv to CO (cardiac 
function) curves and Δvolume/ΔPmsf (compliance) curves. Pmsfhold was measured 
before and after fl uid administration. Stressed volume was determined by extrapolating 
the Pmsf-volume curve to zero pressure intercept.  
Pmsfhold and Pmsfarm were closely correlated. Csys was linear (64.3 ± 32.7 ml·mmHg
-1, 
0.97 ± 0.49 ml·mmHg-1·kg-1 predicted body weight). Stressed volume was estimated 
to be 1265 ± 541 ml (28.5 ± 15 % predicted total blood volume). Cardiac function 
curves of patients with an increase of > 12% to 500 ml volume extension (volume 
responsive) were steep, while the cardiac function curves of the remaining patients 
were fl at. In conclusion, systemic vascular compliance, stressed volume and cardiac 





The accurate assessment of the volume status of a hemodynamically unstable patient 
at the bedside is challenging but, if available, would be important in assessing the 
determinants of cardiovascular insuffi ciency and response to therapy. Intravascular 
volume can be divided into unstressed volume (Vu, the volume that is needed to fi ll 
the blood vessels, without creating a distending pressure) and stressed volume (Vs, 
the volume that stresses the vascular walls, resulting in a distending pressure). This 
distending pressure is referred to as mean systemic fi lling pressure (Pmsf). Vs is an 
important cardiovascular variable, because along with the systemic vascular compliance 
(Csys), Vs determines Pmsf.1 Pmsf is the pressure to which all intravascular pressures 
equilibrate during cardiac arrest, and is the pressure which is determined by both Csys 
and Vs. Pmsf itself is a major determinant of venous return, because it defi nes the 
upstream pressure and, relative to central venous pressure (Pcv), is the driving pressure 
for venous return and thus cardiac output (CO). Vs can be considered as refl ecting 
the effective intravascular blood volume, a primary determinant of circulatory status. 
Thus, estimates of Vs and its change in response to disease or therapy can help the 
clinician in the decision of whether to choose volume resuscitation, diuresis, inotropic 
agents, or vasoactive medication in critically ill patients. In combination with a cardiac 
function curve, measuring Pmsf and Vs should provide a powerful tool to characterize 
the hemodynamic status of patients. 
Under most conditions the primary method by which CO increases is an increase in Pmsf 
causing venous return to increase. Increasing contractility in this context is primarily 
important for keeping Pcv, the back pressure for venous return, as low as possible 
and also keeping left atrial pressure low to minimize pulmonary edema formation. 
Operationally, the circulation can rapidly increase Pmsf by increasing Vs, decreasing 
Csys, or both. Accordingly, if routine bedside Pmsf measures were possible, then both 
Vs and Csys could be determined during fl uid administration or removal. When Pmsf 
is measured before and after fl uid administration, a pressure-volume relationship can 
be constructed, in which Csys is the slope of the relation (volume/Pmsf) (fi gure 
7.1). When Csys is constant, the curve is linear. Extrapolation of this relationship to a 
point where pressure equals zero, i.e. subtracting the amount volume that causes Pmsf, 
results in an estimation of Vs. 
Magder and DeVarennes2 estimated Vs in humans as the volume of blood drained into 
a reservoir in fi ve subjects during hypothermic circulatory arrest for vascular surgery. 
Although an elegant validation of the concept of Vs, this technique is not suitable for 
usual clinical care. We documented that Pmsf can be measured in ventilator-dependent 
patients at the bedside using a series of inspiratory hold maneuvers (Pmsfhold).
3 
Pmsfhold accurately followed changes in volume status induced by anti-Trendelenburg 
positioning and fl uid administration. However, the estimation of Pmsfhold requires at 
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least 3 minutes to perform the 4 inspiratory hold maneuvers. Thus, it does not lend itself 
to repeat measures at short intervals or when Pmsf is rapidly changing. We therefore 
sought a faster bedside method for determining Pmsf and found a useful proposal by 
Anderson.4 He hypothesized that the circulation of the arm behaves similar to the total 
systemic circulation and suggested that Pmsf could be measured in the arm during by 
instantaneously interrupting arterial infl ow to the arm and venous outfl ow from the 
arm. Although different vascular beds when viewed in isolation have different vascular 
compliances and resistances, which can vary independent of each other, during steady-
state conditions, all vascular beds drain to a common downstream pressure and must 
refl ect a common upstream pressure driving that fl ow. For practical reasons, we thus 
opted for measures of vascular pressures in the forearm. Accordingly, we measured 
forearm arterial and venous equilibrium pressure induced by transient stop-fl ow, referred 
to as arm equilibrium pressure (Pmsfarm) and compared its values to Pmsfhold values 
obtained with the inspiratory hold technique.3 Recently, we5 showed that stop-fl ow 
pressure in the arm predicted fl uid responsiveness as well as stroke volume variation 
(SVV) and pulse pressure variation (PPV). However, this stop-fl ow pressure has not 
been published as a measure of Pmsf.
Figure 7.1 Schematic diagram of the determination of systemic compliance and stressed volume
Relationship between change in blood volume and mean systemic fi lling pressure (Pmsf) for 
normovolemia (a) and after intravascular volume administration with 500 ml (b). In the fi gure, 
systemic compliance (Csys) , stressed volume (Vs) and unstressed volume (Vu) are indicated. The 
value of Csys can be found by dividing the administered volume of 500 ml by the change in Pmsf 
(from point a to point b). In this example, removal of 1270 ml blood will lead to a Pmsf of 0 mmHg, 
with all the remaining blood within the system resting in the unstressed volume and with zero blood 
fl ow.
The aim of the study was to assess the ability of Pmsfarm to track Pmsfhold and to 
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administration. We further hypothesized that patients who could not increase CO with 
fl uid administration would have an expanded Vs and operate on the fl at part of the heart 
function curve whereas patients who increase CO would have a lower Vs and operate 
on the steep part of the heart function curve. Accordingly, we constructed cardiac 
function curves (Pcv and CO) and estimated Csys and Vs in postoperative cardiac 
surgery patients during graded volume resuscitation. Because fl uid administration 
was needed to determine Pmsf, Csys and Vs, the study was not designed to study the 
predictive value of fl uid responsiveness of the variables.
Methods and materials
Patients. The study was approved by the hospital ethics committee of Leiden University 
Medical Center and was carried out in Leiden. The institutional review board of 
University of Pittsburgh approved review and analysis of the data. We included 15 
patients planned for elective coronary artery bypass surgery or valvular surgery. Written 
informed consent was obtained from all subjects on the day before surgery. Patients 
with congestive heart failure (New York Heart Association class 4), aortic aneurysm, 
or extensive peripheral arterial occlusive disease were not considered for the study. The 
protocol was started during the fi rst postoperative hour after admission to the intensive 
care unit (ICU). All patient’s lungs were mechanically ventilated with volume-controlled 
ventilation adjusted to achieve normocapnia, with tidal volumes of 7 to 12 ml·kg-1 and 5 
cm H2O positive end-expiratory pressure (Evita 4, Dräger AG, Lübeck, Germany). All 
patients were in sinus rhythm. Sedation was maintained with propofol (2.5 mg·kg-1·h-1) 
and sufentanil (0.06-0.20 μg·kg-1·h-1). During the study interval no changes were made 
in vasoactive drug therapy and no interventions other than the described below volume 
challenges were given to these otherwise hemodynamically stable patients. 
Physiological monitoring. Arterial blood pressure was measured with a radial artery 
catheter and Pcv was measured with a MultiCath 3 venous catheter (Vigon GmbH & 
Co, Aachen, Germany) inserted in the right internal jugular vein. Both catheters were 
connected to a pressure transducer (PX600F, Edwards Lifesciences). Zero levels of 
blood pressures were referenced to the intersection of the anterior axillar line and the 
fi fth intercostal space. Airway pressure (Paw) was measured at the proximal end of 
the endotracheal tube with an air-fi lled catheter connected to a transducer, balanced at 
zero level against ambient air. Pressures were recorded online using a data acquisition 
program on a personal computer. Pulse contour analysis (Modelfl ow pulse contour 
method) was used to determine CO and stroke volume as we have previously described 
and validated.6-9
Determination of Pmsfhold. The determination of Pmsfhold has been previous described 
in detail.3 Briefl y, four inspiratory holds of 12 seconds are applied, under control of a 
computer, at pressure levels of 5, 15, 25 and 35 cm H2O, respectively, and the resulting 
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mean Pcv and mean CO were measured during the plateau phase (between 7 and 12 
seconds into the inspiratory hold maneuver). A venous return curve is constructed by 
plotting the values of the four pairs of Pcv and CO against each other. Pmsfhold is defi ned 
as the Pcv at zero CO.
Determination of Pmsfarm by the arm stop-fl ow procedure. With a rapid cuff infl ator 
(Hokanson E20, Bellevue, Washington) connected to compressed air and a cuff around 
the upper arm blood stop-fl ow is created with a cuff pressure 50 mmHg above systolic 
blood pressure and continued for 35 seconds. Arterial pressure (Pa) and venous pressure 
(Pv) were monitored via catheters in the radial artery and in a vein in the same hand. 
Pmsfarm was defi ned as the average radial artery pressure for one second at 30 seconds 
after induction of stop-fl ow (fi gure 7.2). As validation, we compared Pmsfhold with 
Pmsfarm before and after 500 ml fl uid administration. 
Figure 7.2 Arm occlusion procedure
Representative registration of radial artery pressure and venous pressure before (–15 to 0 seconds), 
during (0 to 36 seconds) and after the occlusion of the upper arm of a patient. Pmsfarm is the mean 
arterial pressure 30 seconds after stop-fl ow. Note the infl uence of mechanical ventilation on arterial 
and venous pressure before and after occlusion.
Compliance, stressed volume and cardiac function curves. Fluid administration was 
performed in 10 steps, each lasting 2 minutes. During each step 50 ml Hydroxyethyl 
Starch (HES 130/0.4) was administered over 1 minute. Pmsfarm, Pcv and CO were 
measured one minute after the infusion. Pcv and CO after each fl uid administration 
step were taken to refl ect a right-sided cardiac function curve. The slope of the Pmsfarm-
volume infused curve  (Δvolume/ΔPmsfarm) was taken to refl ect Csys. Because Csys was 
linear over the range of volume and Pmsf measured, we extrapolated the (Δvolume/




predicted body weight to be able to calculate Vs as the proportion of predicted total 
blood volume. Predicted total blood volume was calculated as 69 ml·kg-1 predicted body 
weight for men and 65 ml· kg-1 predicted body weight for women.10 The predicted body 
weight of male patients was calculated as equal to 50 + 0.91 · (centimeters of height – 
152.4); that of female patients was calculated as equal to 45.5 + 0.91 · (centimeters of 
height – 152.4).
Statistical analysis. The Liliefors method confi rmed that data were normally distributed; 
data are presented as mean ± SD. For the comparison of Pmsfarm and Pmsfhold values 
(combined before and after fl uid administration) Pearson correlation was used. Linear 
regressions were fi tted using a least-squares method. Paired t-tests were used to test 
the changes in parameters before and after 500 ml fl uid administration. Concordance 
for changes in Pmsfarm and Pmsfhold was calculated by cross-tabulation and expressed 
in percentage. Independent sample two-tailed t-test was used to test for differences 
between patients with < 12% or > 12% change in CO after fl uid administration.  A 
p-value < 0.05 was considered signifi cant.
Results 
Fi fteen patients were included in the study. Patient clinical characteristics are shown in 
table 7.1. In all patients, arm Pa and Pv equilibrated after 20 to 30 seconds stop-fl ow. In 
fi gure 7.2 the Pa and Pv in the arm during stop-fl ow for one patient are shown.
Comparison of Pmsfhold and Pmsfarm. In 3 patients Pmsfhold was not assessable because 
of technical problems in the software control of the ventilator. In 12 remaining, patients 
measurements of Pmsfhold and Pmsfarm were obtained in supine position before and after 
500 ml intravascular fl uid administration. Pmsfarm and Pmsfhold values before and after 
fl uid administration for every patient are depicted in fi gure 7.3. Pearson correlation 
coeffi cient was 0.905 (p < 0.001). Concordance for changes in Pmsfarm and Pmsfhold 
with fl uid administration was 100%.
Cardiac function curve. In all 15 patients averaged Pmsfarm at baseline was 21.0 ± 6.8 
mmHg and increased signifi cantly to 27.7 ± 7.4 mmHg after the 10 fl uid administration 
steps of 50 ml (p = 0.001). During the fl uid administration steps, Pcv increased (table 
7.2). We separated the patients in two groups. One group of 9 patients had a CO increase 
> 12% and were in the steep part of the heart function curve (fi gure 7.4) whereas the 
other group of 6 patients operated in the fl at part of the curve. Three data points in one 
patient were not included because of technical problems. Patients with a CO increase < 
12% on 500 ml fl uid administration had signifi cantly higher Pmsfarm values at baseline 
than patients with a > 12% increase (26.4 versus 17.3 mmHg, p = 0.006). There were 
no signifi cant differences in baseline values of Pcv, Pa, SVV, PPV, or CO between the 
2 groups.
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Table 7.1 Patient and baseline hemodynamic characteristics
Characteristics Mean SD
Age (years) 64 11





Pa (mmHg) 80.7 18.2
Pcv (mmHg) 7.9 3.0
HR (min-1) 86.5 15.7
CO (l•min-1) 5.4 1.2
Temperature start of study (˚C) 36.8 0.7
Temperature end of study (˚C) 36.9 0.8
pH 7.36 0.07
pCO2 (kPa) 5.2 0.7
pO2 (kPa) 17.7 4.7







Sodium nitroprusside 1 0.5
CABG, coronary artery bypass grafting; Valve, valve repair or replacement; Pa, mean arterial
blood pressure; Pcv, central venous pressure; HR, heart rate; CO, cardiac output; SD, standard
deviation.
Compliance and stressed volume. Fluid administration resulted in an increase in 
Pmsfhold and Pmsfarm of 8.4 ± 4.2 mmHg (p = 0.0001) and 7.7 ± 6.6 mmHg (p = 0.005), 
respectively (table 7.2). The mean slope of the curve was 0.97 ± 0.47, not signifi cantly 
different from 1 (p = 0.84). The Pmsfarm-volume relationships (compliance curves) 
were linear for all patients (fi gure 7.5), with an average slope (i.e. mean Csys) of 64.3 
± 32.7 ml·mmHg-1 (0.97 ± 0.49 ml·mmHg-1·kg-1 predicted body weight) (table 7.3). 
Extrapolation of the Pmsfarm-volume curve to a Pmsfarm of zero resulted in an estimated 
Vs of 1265 ± 541 ml which equated to 28.5 ± 15% of predicted total blood volume. 
There were no signifi cant differences in Vs and Csys between the patients with and 
without > 12% increase in CO to fl uid administration. 
Discussion
This study demonstrates that using 50 ml rapid fl uid administration steps and estimating 
Pmsf by the arm stop-fl ow Pa-Pv equilibrium method allows for bedside estimates of 
Pmsf, Csys and Vs, as well as the construction of more traditional cardiac function 
curves (CO to Pcv). Furthermore, we found that the relationship between Pmsfarm and 
volume, i.e. intravascular compliance curve, is linear. This linearity allows for the 
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bedside assessment of total Csys and estimates of Vs. We were able to distinguish 
patients who operated on the steeper portion of the cardiac function curve and were 
thus volume responsive from patients that operated on the fl at part of the curve (fi gure 
7.4). Because fl uid administration was needed to determine compliance and Vs, we did 
not study fl uid responsiveness from these variables. 
Figure 7.3 Mean systemic fi lling pressure determined with inspiratory holds and during arm 
occlusion 
Plot of Pmsfhold and Pmsfarm for every patient at baseline and after 500 ml fl uid administration. Every 
patient has his/her own symbol (squares, triangles, etc.) and the values at baseline and after fl uid 
loading are connected by a line. Mean slope of the curve was 0.97 ± 0.47. Pmsfhold is mean systemic 
fi lling pressure measured with the inspiratory hold technique (see text); Pmsfarm is mean systemic 
fi lling pressure measured with the stop-fl ow procedure in the arm (see fi gure 7.2). 
Table 7.2 Changes in hemodynamic variables after 500 ml fl uid administration
     Baseline      + 500ml
     Mean SD      Mean SD p
Pmsfarm (mmHg) 21.0 6.8 27.7 7.4  < 0.0001
Pcv (mmHg) 7.9 3.0 10.6 3.5  < 0.0001
Pa (mmHg) 80.7 18.2 89.1 18.3  < 0.0001
PPV (%) 10.1 6.6 5.5 3.6         0.003
SVV (%) 14.6 11.0 7.6 5.5         0.002
CO (l•min-1) 5.4 1.2 6.0 1.4  < 0.0001
HR (min-1) 86.5 15.7 87.0 14.1         0.56        
Pvr (mmHg) 13.0 6.0 17.1 6.6  < 0.0001
Pmsfarm, mean systemic fi lling pressure measured during stop-fl ow in the arm; Pcv, central 
venous pressure; Pa, mean arterial radial pressure; PPV, pulse pressure variation; SVV, stroke 
volume variation; CO, cardiac output; HR, heart rate; Pvr, pressure gradient for venous
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Figure 7.4 Individual cardiac function curves
Individual cardiac function curves for patients with (A) and without (B) a >12% increase in cardiac 
output (CO) after 500 ml fl uid administration. Fluid administration was performed in 10 steps of 50 
ml and central venous pressure (Pcv) and CO were measured at baseline and after each volume step. 
Every patient has his/her own symbol (squares, triangles, dashes, etc). Note that the patients with 
>12% increase in CO on 500 ml fl uid administration were on the steep part and the remaining patients 
were on the fl at part of the curve. 
Cardiac function curves. Recent interest in functional hemodynamic monitoring 
variables, such as PPV and SVV during positive-pressure ventilation, presumes that 
those subjects who will respond to fl uids by increasing their CO are operating on the 
steep portion of their ventricular function curve. Although intuitively obvious, this 
presumption has never been validated. For this study we used the cardiac function curve 
as substitute for a Frank-Starling curve, with Pcv as input and CO as output variable. 
Our data confi rm this assumption. Although, Versprille and Jansen11 studying pigs and 
Pinsky12 studying dogs plotted similar cardiac function curves for the right ventricle 












































































using variations in right ventricular power and Pcv during the ventilatory cycle in 
different volume states, to our knowledge, the construction of a cardiac function curve 
and the calculation of Vs by using small additions of fl uid in ICU patients has not yet 
been published.
Figure 7.5 Individual volume-pressure curves
Individual volume-pressure curves patients with (A) and without (B) >12% increase in cardiac output 
(CO) on 500 ml fl uid administration. Fluid administration was performed in 10 fl uid administration 
steps of 50 ml and mean systemic fi lling pressure was measured with the arm occlusion method 
(Pmsfarm, see fi gure 7.2) after each fl uid administration step. Systemic vascular compliance (Csys) is 
defi ned as Δvolume/ΔPmsfarm, which is the reciprocal of the slope of the curve. Note that Pmsfarm is 
signifi cantly lower in group A compared to group B (p = 0.006) and that the slope of the curve (Csys) 
is similar in both groups.
Arm equilibrium pressure as measure of Pmsf. Because the execution of the Pmsfhold 
technique requires 3 minutes, it was not suitable to following Pmsf changes during 
the 10 rapid fl uid administration steps of 50 ml performed at intervals of 2 minutes. 
Theoretically, Pmsf can be measured anywhere in the circulation under the condition 
of stop-fl ow if regional vascular compliance does not change during the stop-fl ow 
maneuver. In a pilot study with stop-fl ow by upper arm occlusion during 60 seconds, 
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we observed that a plateau pressure developed in both Pa and Pv after 20 to 30 seconds 
of stop-fl ow. Therefore, we defi ned mean arterial pressure between 29 and 30 seconds 
as Pmsfarm. The rapid cuff infl ator (Hokanson E20, Bellevue, Washington) infl ates in 
less than 0.3 seconds.13 In this time,  venous return stops before arterial stop-fl ow, 
limiting the infl ow of blood in the arm to maximal 1 heartbeat. We expect that the 
resulting overestimation of Pmsfarm is negligible because the amount of infl ow over one 
heartbeat is small compared to the total amount of blood in the arm. It is important to 
note that we did not observe any complications from the arm occlusion procedure in 
our patients. In this study, changes in volume status assessed by Pmsfhold were faithfully 
tracked by Pmsfarm (fi gure 7.3). Therefore, we considered Pmsfarm as a valid substitute 
for Pmsfhold in estimating Pmsf. Pmsfarm has the potential to be used in clinical practice 
in the operating room and ICU, because only an arterial catheter is required and Pmsfarm 
can be measured in all patients, including spontaneously breathing patients and patients 
with arrhythmias.
Table 7.3 Hemodynamic data for individual patients
No       Pmsfarm    Compliance          Vs         CO         Pcv         Pa   Change in CO
     (mmHg)    (ml•mmHg-1)         (ml)        (l•min-1)        (mmHg)        (mmHg)  (%)
1 20.0   70.8 1264 4.0 13.8   65.6 22.5
2 23.7   77.4 1856 4.4 12.5   63.7   1.4
3 31.7   29.7 876 6.4 12.0 114.5 -4.7
4 22.0   71.9 1623 4.2   8.2   71.5   8.2
5 21.8   59.2 1346 3.7   9.7   78.2 25.5
6 11.1 163.7 1815 6.7   4.6   75.9 12.6
7 33.9   54.0 1853 4.6   8.1   68.3   4.0
8 16.0   59.9 1044 5.2   7.3   72.0 12.8
9 22.4   54.3 1187 7.6   5.3   79.3 14.7
10 14.8   88.6 1343 5.2   8.8   87.0 14.1
11 16.4   33.3 403 6.4   7.4 124.7   9.4
12 17.4   44.1 750 3.8   4.4   55.7 17.4
13 13.3   36.6 490 6.4   5.4   85.7 20.6
14 19.4   43.2 863 6.6   4.4   82.9 16.0
15 30.6   77.4 2259 5.1   7.0   85.9   2.3
mean 21.0   64.3 1265 5.4   7.9   80.7 11.8
SD 6.8   32.7 541 1.2   3.0   18.2  8.4
Pmsfarm, mean systemic fi lling pressure at baseline; compliance, the slope of the volume-pressure curve; 
Vs, stressed volume estimated by extrapolation of the volume pressure curve; CO, cardiac output; Pa, mean
arterial blood pressure; change in CO, percentage of change in CO after 500 ml fl uid administration.
Total systemic vascular compliance. Csys has been mainly measured in dogs in three 
ways: 1. measuring Pmsf during total stop-fl ow before and after fl uid administration; 
2. using a right heart bypass and changing right atrial pressure; and 3. measuring 
instantaneous right ventricular stroke volume to Pcv during positive-pressure 
inspiration (instantaneous venous return curve). With the total stop-fl ow method 
values of vascular compliance between 1.8 and 2.0 ml·mmHg-1·kg-1 body weight were 
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found.14-16 Using the bypass method and instantaneous venous return curve method, 
values between 1.3 and 2.5 ml·mmHg-1·kg-1 body weight were obtained.12,17-21 The 
mean Csys of 0.97 ± 0.49 ml·mmHg-1·kg-1 predicted body weight we found in ICU 
patients is lower than these values, which can be species related. However, it can also be 
explained by a lower volume status of the animals as is refl ected in lower Pmsf values 
reported in animals.12,16,17,19,22 Pmsf can be increased up to 25 mmHg with both fl uid 
administration and the administration of norepinephrine.23 The infl uence of medication 
in our study and in the animal studies is another possible explanation for differences 
in estimated Csys. In dogs, Csys decreased when beta-2 stimulation16, epinephrine20 
or norepinephrine24 was given. The majority of our patients (10 of 15) were treated 
with vasopressor drugs and only one patient was treated with a vasodilator to restore 
mean arterial pressure to a normal range. Fluid loss by capillary leakage, diuresis and 
blood loss during the study period, leading to a smaller volume increase, could also 
lead to an underestimation of compliance. Measurements were performed in a period 
of 25 minutes to limit this leakage factor. We monitored chest tube drainage during the 
volume challenge interval and in none of the subjects did this drainage exceed 50 ml, 
nor was diuresis pronounced during the study period. Furthermore, care was taken that 
insensible fl uid loss was compensated for with a 60 ml·hr-1 infusion of crystalloid.
 London et al. estimated human systemic vascular compliance by measuring the change 
in Pcv in response to fl uid administration.25,26 This vascular compliance, called total 
effective vascular compliance, was 2.08-2.55 ml·mmHg-1·kg-1 body weight in young 
healthy subjects and substantially lower (1.49-1.55 ml·mmHg-1·kg-1 body weight) in 
hypertensive patients.25,26 In both studies Pcv was used because Pmsf could not be 
obtained. However, it is doubtful if Pmsf can be exchanged for Pcv, because Pcv is 
also affected by the surrounding pressure and by changes in both ventricular function 
and venous return and thus CO due to intravascular volume expansion. The Pcv-based 
total effective compliance is therefore theoretically not comparable to our Pmsf-based 
determination of Csys.  
Stressed volume. Stressed volume (Vs) is only one component of the systemic vascular 
compartment. If starting from zero blood volume one were to start to fi ll the vasculature, 
the initial volume entering the intravascular space would not create a measurable 
distending pressure or Pmsf, because the vasculature can accommodate initial volume 
by conformational changes in the vessels as they start to engorge. At some minimal 
circulating blood volume subsequent volume infusion causes Pmsf to become positive 
relative to surrounding pressure. The volume in the vasculature below this level is 
called the unstressed volume (Vu) and is infl uenced by Csys. If Csys increased, then 
Vu would also increase and vice versa. Because only Vs and Csys determine Pmsf, if 
Vu were to change and total blood volume would remain unchanged, then Vs would 
vary reciprocally. 
 The pressure gradient between Pmsf and central venous pressure (Pcv) is the driving 
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force for venous return and thus for steady-state CO as well. Vs is a primary determinant 
of Pmsf and is therefore a major determinant of venous return and CO. We determined 
Vs by extrapolation of the Pmsfarm-volume curve to the zero pressure intercept 
presuming that the reduction in volume needed to achieve a zero Pmsf is equal to Vs. 
We chose this extrapolation method to determine Vs because only two parameters are 
needed: changes in volume and Pmsf. For this extrapolation method to be accurate, 
however, the Pmsf-volume change relationship (compliance) must be linear. Linear 
Pmsf-volume relationships have been described in several animal studies13,17,23,25-27, 
thus indicating a stable compliance. A constant compliance of the total vasculature was 
also found by Drees and Rothe23, while Pmsf was varied in the range from 5 to 25 mm 
Hg. Lee et al.28 also described a linear relationship between Pmsf and volume for Pmsf 
above 5 mmHg, however below 5 mmHg the curve deviated slightly from linear. 
 The average Vs in our patients was 19.6 ml·kg-1 predicted body weight. This value is 
very close to the value of 20.2 ml·kg-1 found in 5 patients on cardiopulmonary bypass 
during hypothermic circulatory arrest for major vascular surgery.2 Mean Vs was 29 % 
of predicted total blood volume, again, similar to the 30% Magder and DeVarennes2 
found and in the estimated range of 20-30% given by Jacobsohn et al.29 The wide 
variation in values of Vs can be explained by several factors. First, we included fl uid 
responsive and nonresponsive patients and thus variation in Vs can be expected. Second, 
although we had 11 points on the pressure-volume curve, because of the 10 volume 
administration steps and 1 baseline measurement for each patient, a slight change in 
slope has a large effect on the value of Vs due to the extrapolation outside of the 
range of the measurements. Third, we linearly extrapolated the Pmsfarm-volume curve. 
Because we could not measure in the lower pressure range, we cannot comment on the 
characteristics of the curve in that range. In case of nonlinearity in this lower pressure 
range, we expect Vs would be underestimated. 
Limitations. Although we report on a relatively small number of patients (n = 15) our 
results were highly signifi cant. Thus, we do not expect that increasing the number of 
patients will alter these conclusions. We studied a highly instrumented uniform patient 
population following cardiac surgery in whom baseline vasomotor tone, vascular 
permeability and cardiac performance were similar and unaffected by extraneous 
disease. Vasomotor tone can be infl uenced by temperature and metabolic acidosis. 
After surgery, the temperature can increase decreasing vasomotor tone and metabolic 
acidosis can induce vasodilation or hyporesponsiveness to vasoconstrictors. However, 
our patients were normothermic and their core temperatures were unchanged during the 
study and metabolic acidosis was absent or mild. In our study, vasoactive medication 
was not changed. Changing vasomotor tone will alter Vu, Vs and Csys. Therefore, 
conclusions about the use of this technique during changes in external pharmacologic 
support should be made with caution and need to be independently validated. It is 
not clear whether similar fi ndings and accuracy would be seen in septic patients with 
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combined loss of vasomotor tone and capillary leak. Still, Pinsky et al.17 examined 
Csys and Pmsf before and after the induction of acute endotoxic shock in a canine 
model; they found similar Csys values before and during endotoxemia although Vu 
increased markedly during endotoxemia, and during endotoxemia, all animals were 
hypotensive. 
It would be interesting to see the cardiac function curves and Pmsf-volume plots in 
different patient groups (such as sepsis, cardiac failure, trauma and ARDS) and with 
different vasoactive medication. Because total blood volume was not measured in our 
study, though it was in other studies12,17, Vu could not be determined and needed to be 
estimated from previously validated nomograms. When combined with measurements 
of total blood volume the proportion of Vs/Vu could be readily studied for a variety of 
diseases and medications. 
Conclusions
Total Csys, Vs and cardiac function curves can be determined at the bedside using 
stop-fl ow forearm pressure equalization and might be used to characterize patients’ 
hemodynamic status. We pre dict that in the future, cardiovascular therapy will be 
based on assumptions derived by venous return physiology because it will be possible 
to directly measure Pmsf, Vs, and Csys at the bedside, allowing construction of venous 
return curves and cardiac function curves during stepwise fl uid administration.
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Abstract 
Mean systemic fi lling pressure (Pmsf) can be determined at the bedside by measuring 
central venous pressure (Pcv) and cardiac output (CO) during inspiratory hold 
maneuvers. Critical closing pressure (Pcc) can be determined using the same method 
measuring arterial pressure (Pa) and CO. If Pcc > Pmsf then a vascular waterfall exists. 
The purpose of this study was to assess the existence of a waterfall and its implications 
for the calculation of vascular resistances by determining mean systemic fi lling pressure 
(Pmsf) and critical closing pressure (Pcc) at the bedside. In 10 mechanically ventilated 
postcardiac surgery patients, inspiratory hold maneuvers were performed, transiently 
increasing Pcv and decreasing Pa and CO to four different steady-state levels. For each 
patient, values of Pcv and CO were plotted in a venous return curve to determine Pmsf. 
Similarly, Pcc was determined with a ventricular output curve plotted for Pa and CO. 
Measurements were performed in each patient before and after volume expansion with 
0.5 l colloid and vascular resistances were calculated. For every patient the relationship 
between the four measurements of Pcv and CO and of Pa and CO was linear. Baseline 
Pmsf was 18.7 ± 4.0 mmHg and differed signifi cantly from Pcc 45.5 ± 11.1 mmHg; (p < 0 
.0001). The difference of Pcc and Pmsf was 26.8 ± 10.7 mmHg, indicating the presence 
of a systemic vascular waterfall. Volume expansion increased Pmsf (26.3 ± 3.2 mmHg), 
Pcc (51.5 ± 9.0 mmHg) and CO (5.5 ± 1.8 to 6.8 ± 1.8 l·min-1). Arterial (upstream of 
Pcc) and venous (downstream of Pmsf) vascular resistance were 8.27 ± 4.45 and 2.75 
± 1.23 mmHg·min·l-1; the sum of both (11.01 mmHg·min·l-1) was signifi cantly different 
from total systemic vascular resistance (16.56 ± 8.57 mmHg·min·l-1, p = 0.005). Arterial 
resistance was related to total resistance.
In conclusion, vascular pressure gradients in cardiac surgery patients suggest the 
presence of a vascular waterfall phenomenon, which is not effected by CO. Thus 
measures of total systemic vascular resistance may become irrelevant in assessing 




In  the classical vi ew, cardiac output (CO) is determined by cardiac function (contractility, 
heart rate), preload, and afterload, despite Guyton’s studies on venous return.1 For 
short periods, venous return and cardiac output can differ, but averaged over time, 
venous return must be equal to CO. When the heart is stopped and a large arteriovenous 
fi stula opened, arterial and venous pressures rapidly equilibrate to one pressure, which 
is called mean systemic fi lling pressure (Pmsf).2 Pmsf refl ects the mean weighted 
upstream pressure for venous return to the heart. The difference between Pmsf and right 
atrial pressure or central venous pressure (Pcv) during steady-state fl ow represents the 
pressure gradient for venous return, and if CO is known, one can calculate the resistance 
to venous return as the ratio of driving pressure to fl ow. Recently, we demonstrated that 
it was possible to determine Pmsf at the bedside in mechanically ventilated postcardiac 
surgery patients with an intact circulation.3 Applying inspiratory holds of increasing 
airway pressure levels, Pcv rises and CO declines to a steady-state level (fi gure 8.1). 
From the values of Pcv and CO at different airway pressures, a venous return curve 
can be constructed (fi gure 8.2). When CO is extrapolated to zero, Pcv will equal Pmsf. 
Pmsf is in turn determined by stressed blood volume and systemic vascular compliance. 
Thus, measuring Pmsf allows more insight into variables and mechanisms that control 
the peripheral circulation in critically ill patients, such as systemic venous resistance 
(Rvr), stressed and unstressed volume and vascular compliance.4,5 
During ventricular fi brillation for testing an implantable cardioverter/defi brillator in 
humans, both Pcv and arterial blood pressure (Pa) were measured and a gap between 
Pa and Pcv persisted.6-8 This gap between Pa and Pcv was also found in dogs on cardiac 
bypass after stopping bypass during 20 seconds.9 This stop-fl ow Pa value is termed 
the arterial critical closing pressure (Pcc). Thus, arterial Pcc is the pressure under 
which the fl ow between the arterial and venous side of circulation is stopped despite 
the persistence of a pressure gradient. Beyond this critical closing locus vascular 
pressures decrease rapidly to Pmsf. If there is a Pcc to Pmsf pressure gradient, we refer 
to it as a vascular waterfall. Once blood fl ows over the Pcc edge of the waterfall, the 
height of the waterfall has no effect on fl ow. With our technique of inspiratory hold 
maneuvers to calculate Pmsf as the zero fl ow intercept of venous pressure, we can also 
determine Pcc as the zero intercept of Pa. These measurements can be performed at the 
bedside and in patients with a beating heart and blood fl ow.3 
The existence of a vascular waterfall has implications for the calculation of systemic 
vascular resistance and in our understanding of the determinants of blood fl ow 
distribution (10). Traditionally, total systemic vascular resistance is defi ned as Rsys 
= [Pa-Pcv]/CO. However, this construct taken from electrical circuit theory of current 
fl owing through a wire presumes a constant pressure decrease from input site to output 
site, such that increasing output pressure (Pcv) decreases this pressure gradient and thus 
decreases CO. In the presence of a waterfall (or Starling resistor), there are two separate 
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pressure gradients, one arterial pressure gradient from the central arterial circuit (Pa) 
to Pcc and another venous pressure gradient from Pmsf to Pcv. Thus, two separate but 
in series vascular resistances can be identifi ed, one upstream of Pcc defi ning arterial 
resistance (Ra) and one downstream of Pmsf defi ning Rvr. 
The aim of our study was to determine whether there is a Pcc to Pmsf pressure gradient 
during steady-state fl ow conditions at the bedside and if so, how changes in CO, due to 
intravascular volume loading might affect it. We hypothesized that intravascular fl uid 
loading will increase Pmsf and CO but not change Pcc.
Figure 8.1 Example of an inspiratory hold maneuver
Effects of an inspiratory hold maneuver on arterial pressure (Prad), central venous pressure (Pcv), 
airway pressure (Pvent) and beat-to-beat cardiac output (COmf). Preceding the hold maneuver the 
effects of a normal ventilatory cycle are plotted. Note the rapid restoration to baseline (within 4 
seconds). 
Methods and materials 
Patients. Ten posto perative patients after aortic valve replacement, mitral valve surgery, 
or coronary artery bypass surgery instrumented with a pulmonary artery catheter 
were included in the study. The study was approved by the University Medical Ethics 
Committee of Leiden University and the University of Pittsburgh, whereas the study 
was performed in Leiden University Medical Center. Written informed consent was 
obtained from the patients. Patients with congestive heart failure (New York Heart 
Association class 4), postoperative valvular insuffi ciency, aortic aneurysm or extensive 
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peripheral arterial vascular disease, postoperative arrhythmia, or intra-aortic balloon 
counter-pulsation were excluded.
Postoperative anesthesia was maintained with propofol and sufentanil. Patient’s lungs 
were mechanically ventilated (Evita 4 servo ventilator; Dräger, Lübeck, Germany) in 
synchronized intermittent mandatory ventilation mode with tidal volumes of 6 to 8 
ml·kg-1 and a respiratory rate of 12 to 14 breaths·min-1 to achieve normocapnia (arterial 
PCO2 between 40 and 45 mmHg). A positive end-expiratory pressure of 5 cmH2O and 
a fraction of inspired oxygen of 0.4 were applied. During the study period, all patients 
were hemodynamically stable and no changes in vasoactive medication were made. 
Figure 8.2 Venous return curve and cardiac function curve
Relationship between cardiac output (CO) and central venous pressure (Pcv) in a venous return curve 
and between CO and arterial blood pressure (Pa) in a ventricular output curve for an individual 
patient. Extrapolation to the zero fl ow intercept leads to mean systemic fi lling pressure (Pmsf) for the 
venous return curve and to critical closing pressure (Pcc) for the ventricular output curve. 
Measurements. Arterial blood pressure was monitored via a 20-gauge, 3.8 cm long fl uid-
fi lled radial artery catheter. Pcv was measured with a central venous catheter inserted 
in the right internal jugular vein (MultiCath 3 venous catheter; Vigon GmbH & Co., 
Aachen, Germany). Both were connected to pressure transducers (PX600F; Edwards 
Lifesciences, Irvine, CA) and referenced to the intersection of the anterior axillary line 
and the fi fth intercostal space. Airway pressure was measured at the entrance of the 
endotracheal tube and balanced at zero level against ambient air. CO was obtained beat-
to-beat by Modelfl ow pulse contour analysis as previously described and validated.11-13 
Experimental protocol. Within 1 hour after arrival at the intensive care unit, the protocol 
started and mechanical ventilation was switched from synchronized intermittent 
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of the ventilator to perform inspiratory hold maneuvers. Respiratory rate, fraction 
of inspired oxygen, positive end-expiratory pressure, and tidal volumes were kept 
unchanged. No spontaneous breathing efforts were observed during the study. Pa and Pcv 
were recorded at a sample frequency of 100 Hz and 0.2 mmHg resolution on computer 
disk for offl ine data analysis. We calibrated the pulse contour CO measurements with 
3 thermodilution CO measurements equally spread over the ventilatory cycle. During 
the observation period, no changes were made in ventilatory settings, sedation and 
vasoactive medication. 
Steady-state Pa, Pcv and CO were measured over the last 3 seconds of 12-second 
inspiratory hold maneuvers at plateau pressures of 5, 15, 25 and 35 cmH2O, as we 
previously described.3 With increasing airway pressure, Pcv increases and CO and 
Pa decrease to a steady state between 7 and 12 seconds after start of the inspiratory 
hold (fi gure 8.1). The resulting values of Pcv were plotted against CO in a venous 
return curve for the four inspiratory hold procedures and a linear regression line was 
fi tted through these data points (fi gure 8.2). Similarly, in a ventricular output curve, 
Pa was plotted against CO for the same inspiratory hold maneuvers (fi gure 8.2). 
Measurements were done during baseline conditions and after administration of 500 
ml hydroxyethylstarch (130/0.4) over 15 minutes to assess changes in CO, Pcc, and 
Pmsf after volume expansion for each patient. 
Data analysis and statistics. Pmsf was defi ned as the zero fl ow intercept of the venous 
return curve as previously described.3 Pcc was the extrapolation of Pa to zero fl ow in 
the ventricular output curve (fi gure 8.2). For each patient linear, regressions for the 
four pairs of Pcv and CO, and of Pa and CO were fi tted using a least-squares method. 
Lilliefors method was used to test for normality. The pairwise differences for Pcc at 
baseline and after intravascular fl uid administration and the pairwise differences for 
Rsys and the sum of Rvr and Ra, were inconsistent with normal distribution. The other 
pairwise data were not inconsistent with normal distribution (p > 0.05). The differences 
between Pmsf and Pcc were tested by a paired Student t-test. A signifi cant difference 
between Pmsf and Pcc was considered consistent with a vascular waterfall. Systemic 
arterial vascular resistance was defi ned as Ra = [Pa-Pcc]/CO, and systemic venous 
vascular resistance as Rvr = [Pmsf-Pcv]/CO. Total systemic vascular resistance was 
calculated as Rsys = [Pa-Pcv]/CO. The difference between Rsys and the sum of Ra 
and Rvr, refl ecting the hydrostatic energy loss across the vascular waterfall, was tested 
with a Wilcoxon signed rank test. Linear regression between Ra and Rsys include 95% 
confi dence interval (CI) for bias and slope, together with the Pearson correlation. The 
changes in CO, Pmsf, Pcc, the gap between Pcc and Pmsf, Ra, Rvr and the slopes 
of both the venous return and the ventricular output curves induced by intravascular 
volume expansion were tested by paired Student t-tests or Wilcoxon signed rank test 
as indicated by the Lilliefors test for normality. Data are presented as mean ± SD. 




 Ten patients were included in the study. Patient characteristics are shown in table 8.1. 
The data of the venous return and ventricular output curves for all individuals before 
and after 500 ml intravascular fl uid administration are shown in table 8.2. The goodness 
of fi t of these curves through the data obtained from the inspiratory hold maneuvers, 
given by R2, is remarkably high. The slopes of the venous return and ventricular output 
curves as well as the values for Pmsf and Pcc ranged over 2:1 ratios indicating signifi cant 
different hemodynamic conditions for individual patients.
Table 8.1 Patient Characteristics
No Gender Age Weight Length Surgery Inotropics Propofol Sufenta
(years) (kg) (cm) (μg•kg-1•min-1) (mg•h-1) (μg•h-1)
1 M 60 80 172 CABG 300 15
2 M 57 78 169 CABG Dobu 2 300 15
3 M 79 78 174 AVR Dobu 5 200 10
4 M 50 90 190 AVR NPN 0.25 300 15
5 M 80 90 172 CABG Nor 0.01 200 10
6 F 64 83 167 CABG Nor 0.04, Dobu 3 200 10
7 M 50 112 183 CABG Nor 0.06 500 15
8 M 71 73 179 CABG Nor 0.09, Dobu 4 120 5
9 M 75 95 173 CABG Nor 0.02 200 10
10 M 56 69 175 MVP+TVP 300 10
mean 64 85 175 259 12
SD 11 12 7 107 3
CABG, coronary artery bypass grafting; AVR, aortic valve replacement; MVP+TVP, mitral and tricuspid valve 
repair; Dobu, dobutamine; NPN, nitroprusside sodium; Nor, norepinephrine; SD, standard deviation.
Table 8.2 Venous return and ventricular output curves for all individuals before and after 500 
ml intravascular fl uid administration
Baseline After 500 ml fl uid loading









1 -0.548 0.996 15.5 0.145 0.949  38.7 -0.371 0.983 28.7 0.284 0.987  60.6
2 -0.440 0.995 21.2 0.195 0.894  37.3 -0.612 0.999 24.4 0.245 0.995  42.5
3 -0.663 0.989 16.0 0.132 0.997  38.4 -0.469 0.987 27.4 0.168 0.995  45.5
4 -0.198 0.997 19.6 0.054 0.990  66.1 -0.193 0.999 29.0 0.064 0.941  61.8
5 -0.454 0.994 19.2 0.170 0.996  36.4 -0.429 0.988 19.6 0.164 0.987  43.3
6 -0.587 0.937 15.3 0.166 0.997  58.2 -0.482 0.972 24.3 0.138 0.973  62.5
7 -0.565 0.995 14.1 0.130 0.996  38.5 -0.434 0.769 27.8 0.186 0.736  46.4
8 -0.459 0.971 28.0 0.262 0.978  53.8 -0.491 0.985 30.5 0.542 0.977  59.0
9 -0.257 0.997 19.2 0.091 0.956  52.4 -0.373 0.956 24.2 0.169 0.965  53.9
10 -0.211 0.911 18.6 0.055 0.992  35.3 -0.224 0.997 27.0 0.089 0.881  39.5
mean -0.438 0.978 18.7 0.140 0.974  45.5 -0.408 0.964 26.3 0.205 0.944  51.5
SD 0.164 0.030   4.0 0.064 0.033  11.1 0.125 0.070   3.2 0.135 0.081    9.0
Pmsf, mean systemic fi lling pressure; Pcc, critical closing pressure; SD, standard deviation.
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Baseline measurements. In all patients, a linear relationship between CO and Pcv and 
between CO and Pa was found, with an averaged slope of -0.438 ± 0.164 (l·min-1· 
mmHg-1) and of 0.140 ± 0.064 (l·min-1·mmHg-1), respectively. In table 8.3, the 
hemodynamic values before and after intravascular volume administration are shown. 
Baseline mean Pmsf was 18.7 ± 4.0 mmHg and mean Pcc was 45.5 ± 11.1 mmHg. In 
every patient, a pressure gap between Pcc and Pmsf was observed (range 16.1–46.48 
mmHg). The values of Pmsf and Pcc were signifi cantly different (p < 0.0001) with a 
mean difference at baseline of 26.8 ± 10.7 mmHg, indicating the presence of a vascular 
waterfall. Ignoring the presence of a waterfall, total systemic vascular resistance (Rsys) 
would have been calculated as 16.56 ± 8.57 mmHg·min·l-1. However, considering a 
waterfall, Ra was 8.27 ± 4.45 mmHg·min·l-1, Rvr was 2.75 ± 1.23 mmHg·min·l-1, and 
the sum of Ra and Rvr was 11.01 ± 5.52 mmHg·min·l-1, which is signifi cantly different 
from Rsys (p = 0.005) and refl ects at least a 30% hydrodynamic energy loss across the 
vascular waterfall.
Table 8.3 Hemodynamic data of patients during baseline condition and after 
intravascular volume expansion
  Baseline     Hyper
  Mean SD     Mean SD p
Pa (mmHg) 85.5 15.4 91.4 13.5  0.059
Pcv (mmHg) 4.8 1.8 7.1 2.6  0.011
COmf (l•min-1) 5.5 1.8 6.8 1.8  0.010
HR (min-1) 91 13 88 10  0.149
SV (ml) 61.5 20.2 78.5 18.7  0.012
PP (mmHg) 61.0 15.0 75.4 15.9  0.001 
Pcc (mmHg) 45.5 11.1 51.5 9.0   0.013a
Pmsf (mmHg) 18.7 4.0 26.3 3.2       < 0.001
Slope VO (l•min-1•mmHg-1) 0.140 0.064 0.205 0.135  0.046
Slope VR (l•min-1•mmHg-1) -0.438 0.164 -0.408 0.125  0.450
Pcc-Pmsf (mmHg) 26.8 10.7 25.2 8.2  0.454
Pmsf-Pcv (mmHg) 13.8 4.0 19.2 3.1 < 0.0001
Rsys (mmHg•min•l-1) 16.56 8.57 13.49 5.77  0.028
Ra (mmHg•min•l-1) 8.27 4.45 6.54 3.67  0.008 
Rvr (mmHg•min•l-1) 2.75 1.23 3.00 1.01  0.350
Values are means ± SD; n = 10 patients. Pa, mean arterial pressure; Pcv, central venous pressure; 
CO, cardiac output; HR, heart rate; SV, stroke volume; PP, pulse pressure (systolic pressure  – 
diastolic pressure); Pcc, critical closing pressure Pmsf, mean systemic fi lling pressure; VO, 
ventricular output curve; VR, venous return curve; Rsys, total systemic vascular resistance; 
Ra, arterial vascular resistance Rv, venous vascular resistance. Statistical comparison, p, paired
t-test between baseline and volume expansion; a Wilcoxon signed rank test.
Volume loading. Pmsf, Pcv, Pcc and CO increased with intravascular volume 
administration as did the pressure gradient for venous return (Pmsf-Pcv) (table 8.3). 
The pressure gradient Pcc-Pmsf did not change signifi cantly with intravascular volume 
administration. The slope of the ventricular output curve declined (p = 0.046) refl ecting 
the decrease in Ra, whereas the slope of the venous return curve and its calculated Rvr 
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did not change signifi cantly. 
We investigated a possible relation between Rsys and Ra, because Rsys and Ra 
signifi cantly changed whereas Rvr did not change with intravascular fl uid administration. 
The results of individual data are indicated in fi gure 8.3. The relation between Ra 
and Rsys (Ra = 0.52(95%CI 0.44-0.62) • Rsys–0.55 (95%CI -2.11 +1.02), Pearson 
correlation 0.945) appeared highly signifi cant.
Discussion 
This study shows that both Pmsf and Pcc can be determined at the bedside in intensive 
care patients with intact dynamic circulation. The pressure gap of 26.8 ± 10.7 mmHg 
between Pcc and Pmsf indicates that a waterfall phenomenon is likely to be present. 
These data are consistent with the fi ndings of several animal studies14,15 as well as 
those reported in humans.6-8 However, the human studies were performed in patients 
during ventricular fi brillation and total circulatory arrest. The duration of circulatory 
arrest in humans ranged from 7.5 seconds7 to 30 seconds.8 Schipke et al.6 reported a 
mean Pcc of 24.2 ± 5.3 mmHg during cardiac arrest after 13 ± 2 seconds. Kottenberg-
Assenmacher et al.8 found values of Pcc of 26.6 and 23.9 mmHg after 15 and 30 
seconds of cardiac arrest. However, using a predictive model on heart beating data, i.e. 
on the aortic pressure decay, these authors found a signifi cant higher value (53 ± 15.6 
mmHg). The Pcc value of 45.5 ± 11.1 mmHg in our study is in the range Kottenberg-
Assenmacher et al.8 found on heart beating data, but is substantially higher than values 
found during cardiac arrest. The discrepancy between heart beating and cardiac arrest 
values can be explained by a leak in the waterfall. As long as the volume supply exceeds 
the volume loss, the height of the waterfall will be intact. This is the case in the intact 
circulation, which was preserved in our study. However, when supply becomes less 
than the volume loss, as is the case during a cardiac arrest, the drain of arterial blood 
through those vascular waterfalls with lower local Pcc values will result in a reduction 
of measured Pcc.
Despite the difference of absolute values of Pcc for the intact circulation versus 
circulatory arrest, the observed pressure gap of 26.8 mmHg between Pcc and Pmsf 
in our patients is remarkably similar to the values Jellinek, Schipke and Kottenberg-
Assenmacher et al. report.6-8 In animal stop-fl ow studies, the pressure gap between 
arterial and venous pressure was already well known and the reason for using a pump 
or large arteriovenous fi stula to move blood from the arterial compartment to the 
venous compartment to achieve equilibrium pressure during the stop-fl ow period.2 
The implications of a Pcc signifi cantly greater than Pmsf are that our interpretation of 
vasomotor tone and vascular resistance must change. 
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Figure 8.3 Relationship between arterial vascular resistance (Ra) and total systemic vascular 
resistance (Rsys)
Ra is calculated as (mean arterial pressure - critical closing pressure)/cardiac output. Rsys is calculated 
as (mean arterial pressure – central venous pressure)/cardiac output. The fi lled squares represent 
measurements at baseline, the open squares represent measurements after volume loading.
Vascular resistance. Classically, Rsys is calculated as the ratio of the pressure difference 
between mean Pa and mean Pcv, and CO. Kottenberg-Assenmacher et al.8 already 
pointed out that Rsys has to be partitioned into an Ra and an Rvr, or rather the resistance 
before and after the waterfall. Our study extends their fi ndings. We were able to calculate 
arterial resistance as Ra = [Pa-Pcc]/CO and venous resistance as Rvr = [Pmsf-Pcv]/CO. 
Based on our fi ndings, we conclude that Rsys is an entity that does not exist in vascular 
physiology and calculated Rsys overestimates the sum of Ra and Rvr. In fi gure 8.4, 
a dotted line is plotted directly after the waterfall, because it is not known whether 
the waterfall ends directly in vascular lacunae (where Pmsf is located). Furthermore, 
we have no information about the presence of parallel blood streams to the waterfall. 
However, if the clinician at the bedside wants to understand if arterial tone is increased, 
decreased, or normal, and how it changes in response to time and treatment, then he or 
she needs to measure CO, Pa and Pcc. Ra can be calculated directly from CO, Pa, and 
Pcc (fi gure 8.3). Measurement of Pcc and Pmsf and calculation of Ra and Rvr allows 
us to understand physiology and the point of action of vasoactive medication and in 
future could guide the clinician in the hemodynamic treatment of critically ill patients.
Infl uence of volume expansion. The response to volume loading is an increase in Pmsf, 
while a stable value of Pcc is expected. With the analogy of a lake fi lled by a waterfall, 






















adding volume will increase the fi lling pressure below the waterfall, but the pressure 
at the edge of the waterfall would not be changed. Surprisingly, Pcc did increase after 
volume expansion, although less than Pmsf did. We do not have an explanation for 
this fi nding. Importantly, there was an increase in both Pmsf and the pressure gradient 
for venous return with intravascular volume expan sion, resulting in an increase in 
CO. Resistance to venous return did not change with fl uid expansion in our study. 
Although we do not have a solid explanation for the decrease in Ra with intravascular 
volume administration, vascular stress-relaxation associated with increased fl ow and 
baroreceptors-induced decreased sympathetic tone are potential mechanisms for this 
phenomenon. We saw only a minor decrease in heart rate after intravascular volume 
administration, whereas pulse pressure (systolic blood pressure - diastolic blood 
pressure) increased less (24%) than stroke volume increased (30%). These fi nding are 
also consistent with baroreceptors-induced arterial vasodilation.
Figure 8.4 Schematic graph of the pressure trend from arterial blood pressure (Pa) to critical 
closing pressure (Pcc), mean systemic fi lling pressure (Pmsf) to venous pressure (Pv)
The pressure drop between Pcc and Pmsf (the vascular waterfall) shows that total systemic vascular 
resistance (Rsys) does not exist. Instead vascular resistance can be divided in a resistance upstream 
of the waterfall (arterial resistance Ra) and downstream (venous resistance Rvr). The dotted line 
between the waterfall and Pmsf indicates that it is unknown how close to the waterfall Pmsf is located.
Methodological issues. For the inspiratory hold method to defi ne vascular state, several 
assumptions are made. First, a steady state in which venous return equals CO must be 
created. Figure 8.1 demonstrates that during an inspiratory hold, a plateau in Pcv, Pa, and 
CO is reached during the last seconds of the inspiratory pause. Second, measurements 
must be done before autonomic refl exes occur. We did not observe any change in heart 
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the use of propofol and sufentanil, which can depress baroreceptor refl exes.16-18 Third, 
a linear relationship between CO and Pcv and between CO and Pa is needed to be 
able to extrapolate to the point of zero fl ow. The presence of such linear relations was, 
indeed, shown by Guyton1, in several animal studies19-22 and in our study in humans.3
Before concluding that there is a waterfall phenomenon, other possible explanations 
for the pressure gap between Pcc and Pmsf need to be addressed. An underestimation 
of Pmsf by our method is unlikely. On the contrary, the positive intrathoracic pressure 
in theory can increase effective circulatory volume by squeezing blood from the liver 
and the pulmonary vessels.23 An overestimation or underestimation of Pcc could be 
possible, because of the extrapolation of the CO-Pa curve beyond the data range (fi gure 
8.2). However, during the inspiratory holds of 35 cmH2O in some patients cardiac 
output reached very low values during a few seconds, almost abolishing the need for 
extrapolation. However, none of these potential arguments explain the large pressure 
gap between Pcc and Pmsf of 26.8 mmHg.
Waterfalls, where are they located and what is their function? The exact location of 
the vascular waterfall is not known, but generally an arteriolar or precapillary locus 
is assumed.10,24 In all animal studies, critical closing pressures higher than venous 
pressures were found.25,26 From stop-fl ow experiments in animals, such local Pcc 
to venous pressure gaps were reported for brain27,28, kidneys29, and coronaries.8 
Importantly, the organ-specifi c Pcc values are often different, refl ecting organ specifi c 
vascular fl ow control.
Why are there vascular waterfalls,and what is their purpose? First, because different 
organs may have different Pcc values, with the heart and the brain probably having lower 
Pcc values than muscle, kidney, and gut, they allow for vital organ perfusion at lower Pa 
values. Furthermore, vital organ perfusion is maintained transiently during stop-fl ow 
conditions. After cardiac arrest, arterial blood pressure will be reduced to Pcc. Because 
Pcv slowly increases to the level of Pmsf, a pressure gradient (between Pcc and Pmsf) 
will be preserved for some time. Thus, at least temporarily some fl ow and perfusion 
pressure is maintained to the brain and heart. Indeed, during ventricular fi brillation in 
pigs, fl ow in the left carotid artery was preserved at a low level for minutes.30 Second, 
and perhaps more importantly, short-lasting changes in Pcv induced by intrathoracic 
pressure changes (by inspiration, coughing, or Valsalva maneuvers) will only affect the 
downstream portion of the waterfall, thereby maintaining the stability of circulatory 
fl ow from the arteries into the organs. Only after some time, will an increase in Pcv 
decrease venous return and thus CO.24
Limitations. Although the size of the study group was small, the gap between Pmsf and 
Pcc was large in every patient during baseline conditions and following intravascular 
volume expansion. Because only cardiac surgery patients with relative intact ventricular 
function were included, these conclusions may not carry the same magnitude of inter-
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relation in patients with impaired ventricular function. The small size of the study 
population did not allow conclusion on subgroups as responders and nonresponders to 
the intravascular fl uid administration as all our subjects increased CO in response to 
intravascular volume administration.
Conclusions
With our bedside measurement of Pcc and Pmsf, we showed that there is a systemic 
vascular waterfall in cardiac surgery patients, and the practitioner is now able to estimate 
Ra and Rvr separately. The vascular waterfall is not affected by intravascular fl uid 
administration. Furthermore, because of this vascular waterfall, in excess of 25 mmHg, 
estimations of vasomotor tone using calculations of systemic vascular resistance will 
both overestimate actual vasomotor tone and may not accurately represent changes in 
vasomotor tone. 
Determination of vascular waterfall
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Abstract
We present a new physiological model that discriminated between changes in the 
systemic arterial and venous circulation. To test our model, we studied the effects 
of dobutamine and hypovolemia in intact pentobarbital-anesthetized piglets. Aorta 
pressure (Pao), central venous pressure (Pcv), mean systemic fi lling pressure (Pmsf) and 
cardiac output (CO), were measured in 10 piglets, before, during and after dobutamine 
infusion (6 μg·kg-1·min-1), as well as during hypovolemia (-10 ml·kg-1), and after fl uid 
resuscitation to normovolemia. Venous (Rvr) and total systemic (Rsys) resistance 
were determined from Pao, Pcv, Pmsf and CO. The quotient of Rvr/Rsys was used 
to determine the predominant location of vascular changes (i.e. vasoconstriction or 
dilatation on either venous or arterial side). Administration of dobutamine increased 
heart rate and CO, whereas it decreased Pmsf, Rsys, Rvr and Rvr/Rsys. The decrease 
in Rvr was signifi cantly greater than Rsys. Pao and Pcv did not change. Hypovolemia 
decreased CO, Pcv, Pmsf, Rvr and Rvr/Rsys, but kept Rsys constant and increased 
heart rate. In conclusion, hypovolemia and dobutamine differentially alter Pmsf, Rsys, 
Rvr and Rvr/Rsys ratio. The increase in CO during dobutamine infusion was attributed 
to the combined increased cardiac function and decreased Rvr. The decrease in CO 
with hypovolemia was due to a decrease Pmsf but was partly compensated for by a 




The hemodynamic effects of therapeutic interventions have been extensively studied 
on isolated arterial, venous or heart models either in vitro or in vivo. Although, intact 
circulation models have been used before, they are often limited to only one study 
characteristic; i.e. heart function, venous capacitance, (un)stressed volume, vascular 
compliance, mean systemic fi lling pressure or venous resistance.1 None of these models 
is applicable in ICU patients and none was used to determine the coherent characteristics 
of the venous and arterial vasculature and heart function. Since arteries, veins and heart 
operate in concert, we developed an integrated in vivo model, applicable in patients, 
based on Guytonian Physiology. 
We modelled the systemic circulation with one resistor upstream (Ra) and one resistor 
downstream (Rvr) of mean systemic fi lling pressure (Pmsf) (fi gure 9.1). At the site 
where the pressure is equal to Pmsf the large blood volume is indicated by a capacitor.2-4 
This site contains about 70% of total blood volume and has been reported to correspond 
with the location of the capillaries and post-capillary venules.5 Resistance over the total 
systemic circulation (Rsys) and over the venous system (Rvr) can be calculated from 
aortic pressure (Pao), central venous pressure (Pcv) and cardiac output (CO) values as 
(Pao-Pcv)/CO and Rvr by (Pmsf-Pcv)/CO, respectively (fi gure 9.1). Rsys refl ects both 
arterial and venous resistance: Rsys = Ra + Rvr. So, Ra = Rsys - Rvr.
Figure 9.1 Circulation model
The circulation model to compute the resistances up-streams (Ra) and down-streams (Rvr) of 
mean systemic fi lling pressure (Pmsf). The sum of Ra and Rvr is equal to total systemic resistance 
(Rsys). Aortic pressure (Pao) and central venous pressure (Pcv) are measured. Q’ao is the fl ow in the 
aorta (cardiac output); Q’v is the venous return. Mean systemic fi lling pressure is determined with 
inspiratory hold maneuvers. 
In this study we used a hemodynamic condition of hypovolemia as well as dobutamine 
as a known cardiovascular stimulant to test our model in an intact anesthetized piglet 
model. In the vasculature, Ruffolo and colleagues6 presumed that with dobutamine, 
the β2 mediated effects are counterbalanced by the α1 activity leading to a decreased 
total peripheral vascular resistance by a reduction of sympathetic tone and arterial 
vasodilatation. However, since local vascular effects may differ owing to local 
differences in receptor expression which varies in arteries and veins, one may see 
Pao PmsfRa PcvRvr
Q’ao Q’v
Partitioning the resistances along the vascular tree: effects of dobutamine and hypovolemia
126
either local vasodilatation or vasoconstriction. Presently, no intact-circulation model 
exists to study differences in systemic arterial and venous resistance. Since we recently 
validated a bedside technique to estimate mean systemic fi lling pressure (Pmsf)7, we 
are now able to determine the venous resistance in patients. Thus, examining both total 
blood fl ow and the ratio of the systemic to venous resistance one can quantify the effect 
of different hemodynamic conditions and vasoactive agents on total systemic vascular 
resistance and venous resistance.
The aim of our study was to determine the reproducibility of Pmsf, Rsys and Rvr in our 
intact in vivo piglet model and, secondly, we tested our model during dobutamine and 
hypovolemia. We hypothesized that dobutamine would increase CO by the combined 
actions of increasing inotropy, arterial vasodilation, with less evident venodilation. 
Furthermore, we expected both hypovolemia and dobutamine to decrease Pmsf and 
hypovolemia to not change in the site of Pmsf, i.e. the ratio Rvr/Rsys to be constant. 
Methods and materials
All experiments were performed according to the ‘‘Guide for Care and Use of Laboratory 
Animals’’ published by the US National Institutes of Health and were approved by the 
local Animal Care Committee. 
Surgery 
Ten Yorkshire piglets were anesthetized with 30 mg·kg-1 sodium pentobarbital intra-
peritoneally, followed by a continuous infusion of 9.0 mg·kg-1·h-1. After tracheostomy, 
the animals were ventilated at a rate of 10 breaths per min at an I:E-ratio of 2.4:3.6 and 
with a tidal volume adjusted to maintain arterial pCO2 of approximately 40 mmHg, while 
a positive end-expiratory pressure of 2 cmH2O was applied. PCO2, airway pressure and 
airfl ow were measured in the tracheal cannula. The animals were placed in a supine 
position on a thermo-controlled operating table (38° C). A catheter was inserted through 
the right common carotid artery into the aortic arch to measure Pao and to sample 
arterial blood. Two other catheters were inserted through the right external jugular 
vein. A pulmonary artery catheter was inserted to measure pulmonary artery pressure, 
to measure thermodilution cardiac output (COtd) and to sample mixed venous blood. A 
quadruple-lumen catheter was inserted into the superior vena cava to measure Pcv and 
to infuse sodium pentobarbital and pancuronium bromide (Organon N.V., Boxtel, the 
Netherlands). The catheters for vascular pressure measurements were kept patent by 
an infusion of saline with 2.5 IE Heparin ml-1 at 3 ml·h-1. The bladder was cannulated 
trans-abdominally to check urine loss in order to maintain water balance. After an 
intercostal thoracotomy in the second left intercostal space, an electromagnetic fl ow 
probe (type transfl ow 601, model 400, Skalar, Delft, The Netherlands) was placed 
within the pericardium around the ascendant part of the aortic arch to measure aortic 
blood fl ow. Two suction catheters, one dorsal and one ventral, were inserted into the 
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left pleural space. The thorax was closed airtight and both air and fl uids were evacuated 
for 1-2 minutes with -10 cmH2O suction while applying a PEEP of 10 cmH2O. After 
surgery and while on continuous pentobarbital infusion, the animals were paralyzed 
with an intravenous infusion of pancuronium bromide (0.3 mg·kg-1·h-1), after a loading 
dose of 0.1 mg·kg-1 in 3 min. 
Measurements 
The electrocardiogram (ECG), Pao, pulmonary artery pressure (Ppa), Pcv, fl ow probe 
signal and ventilatory pressure (Pvent) fl ow were simultaneously recorded. Zero level 
of blood pressures was chosen at the level of the tricuspid valves, indicated by the 
pulmonary artery catheter during lateral-to-lateral radiography. The airway pressure 
transducer was balanced at zero level against ambient air. During the observation periods, 
ECG, blood fl ow and pressure signals were sampled in real time for 30-s periods at 250 
Hz. The mean of four thermodilution cardiac output measurements equally distributed 
of the ventilatory cycle was used to obtain the value of COtd.8,9 Areas under the aortic 
blood fl ow curves were analyzed online and calibrated by COtd to estimate beat-to-
beat cardiac output (COem). After the surgical procedure the animals were ventilated 
at a rate of 10 min-1 with an infl ation time of 2.4 s and an expiration time of 3.6 s. 
Tidal volume was readjusted to an end-expiratory pCO2 of approximately 5.33 kPa (40 
mmHg), usually corresponding with a slightly higher arterial pCO2. The ventilatory 
settings were kept constant during the observation periods. 
We determined Pmsf using inspiratory pause procedures as previously described.5,10,11 
Briefl y, during infl ation of the lungs venous capacitance is loaded due to an increase in 
Pcv, which leads to a transient reduction in venous return, in right ventricular output 
and consequently in left ventricular output (fi gure 9.2). To avoid transient effects on 
the relationship between venous return and Pcv, we measured Pcv and (CO) during 
short periods of end-inspiratory steady state following these initial non-steady state 
conditions. CO and Pcv are determined over the fi nal 5 seconds for a set of seven 
12-second inspiratory hold procedures at seven randomly applied tidal volumes between 
25 and 300 ml. The inspiratory hold maneuvers are separated by 5-min intervals to re-
establish the initial hemodynamic steady state. From the steady-state values of Pcv and 
CO measured by an electromagnetic fl ow probe (COem) during the seven inspiratory 
pause periods a venous return curve was constructed by fi tting a linear regression line 
according to the method of least square means through these data points (fi gure 9.3). 
Pmsf is defi ned as the extrapolation of this linear regression to zero fl ow.5,10,11
Protocol 
To eliminate the effects of surgery, opening of the pericardium, and applying mechanical 
ventilation on the hemodynamic measurements, the piglets were allowed to stabilize 
for 60 to 120 minutes after surgery. Data collection started once heart rate (HR), 
mean Pao and Pcv were stable for at least 15 minutes. After stabilization, baseline-1 
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measurements were performed. Next, continuous dobutamine infusion was started with 
6 μg·kg-1·min-1 and hemodynamic measurements were performed after 30 minutes. The 
dobutamine infusion was stopped and after 30 minutes baseline-2 measurements were 
obtained. The observations were continued 15 minutes after bleeding the animals with 
10 ml·kg-1. The observations ended with baseline-3 measurements 15 minutes after 
giving back the withdrawn 10 ml·kg-1 blood.
Figure 9.2 Example of an inspiratory hold maneuver
Effects of an inspiratory hold maneuver on aortic pressure (Pao), central venous pressure (Pcv), 
airway pressure (Pt) and beat-to-beat cardiac output (COem). Preceding the hold maneuver the effects 
of a normal ventilatory cycle are plotted. 
Data analysis and statistics 
We fi tted the set of seven data points of Pcv and COem by linear regression for each 
condition to defi ne the venous return curve. We defi ned Pmsf as the extrapolation of 
this linear regression to zero fl ow (fi gure 9.3), assuming that airway pressure does 
not affect Pmsf. We have previously validated this extrapolation in piglets.5,10,11 Total 
systemic vascular resistance (Rsys) was calculated as the ratio of the pressure difference 
between mean Pa and mean Pcv and COtd (Rsys = (Pa - Pcv)/COtd). The resistance 
downstream of Pmsf was taken to refl ect the resistance to venous return (Rvr) and was 
calculated as the ratio of the pressure difference between Pcv and Pmsf and COtd (Rvr 
= (Pmsf-Pcv)/COtd). Systemic arterial resistance (Ra) was taken to be the difference 
between systemic and venous resistance. The ratio of Rvr and Rsys describes the location 
within the circulation where Pmsf exists. A higher ratio implies a more upstream Pmsf 
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location. After confi rming a normal distribution of data with the Kolmogorov-Smirnov 
test, differences in parameters during baseline and interventions were analyzed using 
paired t-tests. Repeatability was calculated from the three baseline conditions using 
Bland-Altman analysis. Hereto, for each animal the mean and difference of the values 
of baseline-1 and 2 and of baseline-2 and 3 was determined. The upper and lower limits 
of agreement were calculated as bias ± 2SD. The coeffi cient of variation (COV) was 
calculated as 100% x (SD/mean). Effects of time on our data set were calculated by 
comparing baseline values. Changes induced by the interventions with dobutamine and 
hypovolemia were compared to the mean of the baseline values before and after the 
interventions to eliminate time effect. All values are given as mean ± SD. A p-value < 
0.05 was considered statistically signifi cant.
Figure 9.3 Venous return curve for an individual animal
The relationship between venous return (COem) and central venous pressure (Pcv) is plotted. Mean 
system fi lling pressure (Pmsf) is indicated by extrapolating the curve to COem = zero.
Results
Ten 8–10 week old piglets (al l females) bodyweight of 10.3 ± 0.7 kg were studied. 
Pooled data are shown in table 9.1. A Kolmogorov-Smirnov test indicated normal 
distribution of all data. In 10 animals baseline-1, dobutamine, and baseline-2 data were 
obtained, in only 8 animals we were able to study the effects of bleeding by 10 ml·kg-1.
Repeatability 
Bland-Altman analyses for repeated measurements of the main derived variables 
Pmsf, Pvr, Rsys, Rvr and Rvr/Rsys are given in table 9.2. A remarkable low percentage 
coeffi cient of v ariation of 3.8% was found for Pmsf. The percentage coeffi cient of 
variation increases with the number of variables incorporated in the calculation and 
was highest for Rvr/Rsys.
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Table 9.1 Pooled results for 10 piglets at start (Baseline-1), 30 minutes after the start of 6 μg•kg-1•
min-1 IV dobutamine infusion (Dobutamine), 30 minutes after stopping the dobutamine 
infusion (Baseline-2), 15 minutes after bleeding 10 ml/kg (Hypovolemia) and 15 minutes after 
reestablishing normovolemia (Baseline-3)
Baseline-1 Dobutamine Baseline-2 Hypovolemia Baseline-3
Pao (mmHg)   88.10 ± 17.24 87.51 ± 9.37  82.56  ± 17.02    83.05 ± 14.46   86.83 ± 18.30
Ppa (mmHg) 15.52 ± 3.51 19.77 ± 6.99 19.74 ± 7.39  17.10 ± 6.51 18.96 ± 5.97
Pcv (mmHg)   4.09 ± 1.33   4.10 ± 1.03   4.62 ± 1.38      3.75 ± 1.71 †   4.69 ± 1.47
HR (min-1) 146 ± 42   215 ± 33 ‡ 152 ± 42    175 ± 47 ‡ 150 ± 45
COtd (ml•s-1) 24.15 ± 3.70   33.64 ± 3.94 ‡ 24.53 ± 5.38    22.69 ± 3.87 † 24.57 ± 4.64 
Pmsf (mmHg) 13.59 ± 1.04   12.02 ± 1.27 † 14.10 ± 1.37    10.94 ± 1.81 ‡   4.85 ± 1.28
Pvr (mmHg) 10.71 ± 1.21      7.88 ± 1.12 *   9.50 ± 1.72      7.19 ± 1.66 ‡   0.15 ± 1.75
Rvr (mmHg•s•ml-1)   0.401 ± 0.095     0.237 ± 0.037 ‡   0.406 ± 0.126      0.327 ± 0.104 †   0.465 ± 0.085
Rsys (mmHg•s•ml-1)  3.474 ± 0.424     2.507 ± 0.271 ‡   3.379 ± 0.322    3.496 ± 0.352   3.359 ± 0.455
Rvr/Rsys   0.117 ± 0.031     0.096 ± 0.019 †   0.127 ± 0.037      0.095 ± 0.035 †   0.129 ± 0.039
Hb (g•dl-1)   9.56 ± 1.02   10.34 ± 1.22 †   9.73 ± 0.99    9.67 ± 0.89   9.71 ± 1.05
Aorta pressure (Pao), pulmonary artery pressure (Ppa), central venous pressure (Pcv), heart rate (HR), 
cardiac output with thermodilution (COtd), mean systemic fi lling pressure (Pmsf), pressure gradient for 
venous return (Pvr), venous fl ow resistance (Rvr),systemic fl ow resistance (Rsys), location of Pmsf
(Rvr/Rsys), and hemoglobin (Hb). 
* p < 0.05, † p < 0.01 and ‡ p < 0.001 to the average of the baseline value before and after the intervention.
 
Interventions 
The infusion of 6 μg·kg-1·min-1 dobutamine increased HR and COtd and decreased Pmsf, 
Pvr, Rvr, Rsys and Rvr/Rsys ratio. Whereas Pao, Ppa and Pcv did not change during the 
study. The decrease of Rvr during dobutamine was larger than the decrease in Rsys, 52% 
and 28% respectively. Recovery baseline condition after dobutamine (baseline-2) did 
not show any signifi cant changes from the initial baseline values (baseline-1), except 
for HR which decreased after dobutamine infusion was stopped but still was elevated 
compared to baseline-1. Bleeding the animals with 10 ml·kg-1 showed a decrease in 
Pcv, Pmsf, Pvr, Rvr and Rvr/Rsys. Recovery to baseline condition after bleeding 
(baseline-3) did not show any signifi cant changes from baseline values before bleeding 
(baseline-2). Surprisingly, hemoglobin (Hb) increased during continuous dobutamine 
infusion and returned to baseline-1 values 30 minutes after the infusion was stopped. 
Hemoglobin did not change by bleeding.
Discussion 
Our data support the feasibility to estimate Pmsf, Rsys and Rvr. The discrimination 
between arterial and venous resistance is possible because we can estimate Pmsf 
accurately. Our data on vascular resistance clearly show that although both arterial and 
venous components of vascular resistance decrease, the primary peripheral vascular 
effects of dobutamine in the healthy animal model was to induce more venodilation 
than arterial dilation. Bleeding the animals showed  Pmsf, Pcv, COtd and surprisingly 
Rvr to decrease and Pao and Rsys to be constant. Evidently, there is some compensation 
for the loss of venous return by adaptation of Rvr.
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Table 9.2 Bland-Altman results for repeated measurements of mean systemic fi lling 
pressure (Pmsf), gradient for venous return (Pvr), systemic vascular resistance (Rsys), 
the resistance for venous return (Rvr) from Pmsf to central venous pressure and the 
quotient Rvr/Rsys as a location of Pmsf in the circulation. Data of baseline-1, baseline-2 
and baseline-3 are used (n = 18)
Mean Bias SD COV (%)        Limits of agreement
       Lower Upper
Pmsf (mmHg) 14.17 -0.55 0.54 3.8 -1.63 0.53
Pvr (mmHg) 9.64 -0.18 0.78 8.1 -1.74 1.38
Rsys (mmHg•s•ml-1) 3.422 0.078 0.348 10.0 -0.618 0.774
Rvr (mmHg•s•ml-1) 0.415 -0.023 0.059 14.2 -0.141 0.095
Rvr/Rsys 0.12 0.01 0.02 16.7 -0.03 0.05
HR, heart rate; Pcv, central venous pressure; CO, cardiac output; MAP, mean arterial pressure; Temp, 
body temperature; CABG, coronary artery bypass grafting; AVR, aortic valve replacement; Dobu, 
dobutamine; NPN, nitroprusside sodium; Nor, norepinephrine; Enox, enoximone.
Repeatability
Comparison of baseline-1, -2 and -3 showed no differences, except for the observation of 
heart rate HR during baseline-2. Therefore, we conclude for stable observation periods 
in our animals. We determined the precision of the main derived variables, i.e. Pmsf, 
Pvr, Rsys and Rvr, by Bland-Altman analysis of repeated measurements (table 9.2). 
Although, Pmsf is determined by extrapolation of the venous return curve to COem 
is equal to zero (fi gure 9.3), the coeffi cient of variation appeared to be surprisingly 
low (3.8%). With the low coeffi cient of variation for Pmsf, Rvr and Rsys changes by 
the intervention with dobutamine and hypovolemia can be monitored with precision. 
Therefore, we consider the data as presented in table 9.1 as reliable.
Our estimated Pmsf values (11-15 mmHg) are in agreement with those described in 
highly instrumented animals, which are in dogs 7-12.5 mmHg12-17, rats 7-9 mmHg18,19, 
pigs 10-12 mmHg5,10,11, and as high as 20-30 mmHg in conscious calves implanted 
with an artifi cial heart.20 Furthermore, we report a baseline Pmsf value of 19 mmHg in 
cardiovascular surgical patients.7 
How can our data be explained? In a non-controlled circulation a decrease in effective 
blood volume (i.e. a change from stressed to unstressed volume) will be refl ected by a 
decrease in Pmsf.21 If dobutamine caused arterial vasodilation such that the number of 
perfused capillaries increased, then unstressed volume should also increase, decreasing 
Pmsf for a constant blood volume. The greater number of draining venous conduits 
would also decrease the resistance to venous return. We found that dobutamine 
decreased Pmsf without altering Pcv, decreasing the pressure gradient for venous 
return. Despite this decrease in pressure gradient, cardiac output was increased. Thus, 
the decrease in Rvr was more than inversely proportional to the increase in cardiac 
output or cardiac output would have remained constant. A decrease in Rvr may be 
caused by four mechanisms; (1) a decrease of the length of the vascular bed between 
the sites were the pressure is equal to Pmsf and right atrium, (2) an increase in cross 
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section of the vascular bed, (3) a decrease in blood viscosity or (4) a combination of 
the three mechanisms. As we measure an increase in Hb during dobutamine infusion a 
decrease in viscosity is very unlikely. Thus, the observed decrease in Pmsf combined 
with the increased COtd requires that Rvr decrease due to an increase in the venous 
fl ow cross-sectional area, presumably due to dobutamine-induced increased parallel 
vascular blood fl ow.
The changes in Pao, Pcv, COtd, Rsys and Rvr are illustrated schematically in fi gure 9.4, 
in which fl ow resistance is projected on the x-axis. We have used this graphical model 
to analyze two different stationary conditions in circulation, i.e. baseline condition and 
during infusion of dobutamine. The numeric data for this model are taken from table 
9.1, columns baseline-1 and dobutamine. The lines between Pao and Pcv represent the 
pressure gradient (Psys) over Rsys and between Pmsf and Pcv; the pressure gradient 
(Pvr) for venous return over Rvr. The slope of the lines represent blood fl ow, i.e. COtd 
= Psys/Rsys = Pv/Rvr. During dobutamine infusion the Pao-Pcv difference was equal 
to baseline. However, COtd increased and both Rsys and Rvr decreased signifi cantly. 
The fall in Rvr due to dobutamine was larger than the fall in Rsys, 52% and 28% 
respectively. From this difference in response to dobutamine we conclude that the 
primary peripheral vascular effect of dobutamine is on the venous side of the circulation 
as shown in fi gure 9.4. The larger decrease on the venous side can be explained mainly 
by the decrease in Pmsf due to dobutamine. If we had observed no change in Pao, 
Pcv or Pmsf despite an increase in COtd, then Rvr must have changed proportional to 
Rsys, which is described by the intersection of dashed Pao-Pcv dobutamine line and 
solid Pmsf line. Importantly, our method to determine Pmsf has recently also been 
validated in mechanically ventilated patients7, thus this approach can now to applied to 
humans as well. In addition, we confi rmed the well-known positive inotropic effect of 
dobutamine as manifest by the increase in HR and stroke volume despite an unchanged 
Pcv and Pao. It is unclear from our data which factor plays a greater role in increasing 
COtd, increasing inotropy or decreasing Rvr.
In our animals hypovolemia caused Pmsf, Pcv, COtd and surprisingly Rvr to decrease 
and Pao and Rsys to be constant. The gradient for venous return, Pvr = Pmsf - Pcv, 
decreased with 27%, so with a constant resistance for venous return, Rvr, we expected 
a decrease in CO of the same order (CO = Pvr/Rvr). However, Rvr decreased by 16% 
leading to a decrease in COtd with only 9%. Thus, there appears to be compensation for 
the loss of venous return by adaptation of Rvr, manifested by the signifi cant increase 
in heart rate. Potentially, this occurred by shifting blood away from the splanchnic 
circulation with its higher Rvr to other systemic vascular circuits, as we have previously 
shown22, but our study does not allow us to confi rm this speculation. However, since 
we observed that the location at which Pmsf exists (Rvr/Rsys) shifted more into the 
direction of the venous site of the circulation, suggests that such a redistribution of 
blood fl ow did occur. 
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Figure 9.4 Conceptual model of the systemic circulation.
Horizontally, the linear projection of vascular fl ow resistance (Rsys) between aortic valves (at the 
right) and right atrium (at the left) is plotted. In this linear projection the aorta takes about 2%, the 
arterioles about 55%, the remaining arterial system about 15% and the rest is distributed between 
capillaries and the venous system. The resistance (Rvr) down-streams mean systemic fi lling pressure 
(Psf) and central venous pressure (Pcv) is indicated. Vertically, aortic pressure (Pao), central venous 
pressure (Pcv) and mean systemic fi lling pressure for baseline condition and during infusion of 
dobutamine are plotted. The values of table 9.2 are used to construct the model. Further explanation 
is given in the text. 
Limitations 
Some limitations apply to our model. The technical set-up with a fl ow probe around 
the aorta is not general applicable in humans. A reliable less invasive beat-to-beat 
determination of cardiac output by trans-oesophageal ultrasound or arterial pulse 
contour allow similar studies to be done in humans.7 
We measured only Pao and Pcv and calculated Pmsf. Pmsf is a lumped variable of all 
the vascular beds. Thus, it is not clear, which specifi c or general vascular beds were 
affected by dobutamine infusion or hypovolemia. The difference in local adrenergic 
receptor (subtype) expression and overall expression of the receptors vary between 
different vascular beds and between species. Although the circulation of the pig bares 
macroscopic resemblance to the human physiology, a direct extrapolation of the results 
is precarious. This, however, also applies for previous studies.1,6 Clearly, future human 
studies using less invasive means will need to be done to validate these fi ndings in 
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Conclusions
The use of our in vivo animal model to assess the hemodynamic effects on Pmsf, Rsys, 
Rvr and Rvr/Rsys of a cardiovascular drug and of hypovolemia was successfully tested. 
The discrimination between arterial and venous resistance is possible because we can 
estimate Pmsf accurately. The higher cardiac output seen during dobutamine infusion 
was attributed to the combined increased cardiac function and decreased venous fl ow 
resistance despite a decrease in Pmsf. Hypovolemia decreases as expected Pmsf but 
this decrease was partly compensated for by a decrease in Rvr to preserve venous 
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Abstract
Norepinephrine can either increase or decrease cardiac output, but the determinants 
have not been studied in ICU patients. The aim of the study was to explain these 
effects with the use of Guytonian venous return and cardiac function curves. In sixteen 
mechanically ventilated postoperative cardiac surgery patients inspiratory holds were 
performed at baseline-1, during increased norepinephrine infusion and baseline-2 
conditions. We determined mean arterial pressure, central venous pressure, cardiac 
output, stroke volume variation and mean systemic fi lling pressure, resistance for 
venous return and systemic vascular resistance. Increasing norepinephrine by 0.04 ± 
0.02 μg·kg-1·min-1 increased mean arterial pressure 20 mmHg in all patients. Cardi ac 
output decreased in 10 and increased in 6 patients. In all patients mean systemic fi lling 
pressure, systemic vascular resistance and resistance for venous return increased and 
stroke volume variation decreased. Resistance to venous return and systemic vascular 
resistance increased more (p = 0.019 and p = 0.002) in the patients with a cardiac 
output decrease. Heart rate decreased in the patients with a decline in cardiac output 
and was unchanged in the patients with a cardiac output increase. Baseline stroke 
volume variation was higher in those in whom cardiac output increased (14.4 ± 4.2 
versus 9.1 ± 2.4%, p = 0.012). Stroke volume variation > 8.7% predicted the increase 
in cardiac output to norepinephrine (ROC AUC 0.900). In conclusion, the change 
in cardiac output induced by norepinephrine is determined by the balance between 
volume recruitment (as determined by mean systemic fi lling pressure) and change in 
resistance for venous return and baseline heart function. Furthermore, the response of 





Norepinephrine (NE) is the vasopressor of choice in septic shock1 because of its ability 
to maintain vasomotor tone, but it is also recommended as treatment for resistant 
cardiogenic shock.2,3 However, the effect of NE on cardiac output (CO) is highly 
variable. Both increases and decreases in CO can be seen in response to NE in patients 
with both septic shock4-10 and without.11,12 Cardiovascular mechanisms used to explai n 
these effects include increases in cardiac contractility, cardiac preload, coronary 
perfusion and afterload5,13,14 as  recently described in humans with septic shock.10
Central to these arguments is that changes in effective circulating blood and venous 
return occur independent of changes in contractility. Potentially, the fi nal CO change 
in response to NE must be determined by the balance between the increased preload 
effects of increasing peripheral vasomotor tone versus the increased afterload effect 
of increasing mean arterial pressure (Pa). Furthermore, the resistance to venous return 
(Rvr) may also be increased by NE owing to venoconstriction. But until now no studies 
have been done in humans that describe the effects of NE based on effective circulating 
blood volume (by measurements of mean systemic fi lling pressure (Pmsf)), Rvr, total 
systemic resistance (Rsys), and the intersection of venous return and cardiac function 
curves. Recently, we showed that it is possible to measure Pmsf and Rvr at the bedside 
in intensive care patients.15 Furthermore, using the same measurement techniques, we 
described the hemodynamic effects of dobutamine in piglets.16 
The aim of the study was to determine the effects of NE on the determinants of the 
CO change and to explain these effects with the use of Guytonian venous return and 
cardiac function curves. We hypothesized that NE could increase CO by increasing 
effective circulating volume by recruitment from venous capacitance vessels (increase 
in Pmsf) or decrease CO by either an increase in venous resistance decreasing venous 
return or an increase in left ventricular afterload (increase in Rsys). 
Materials and methods
Patients. The study was approved by the hospital ethics committee of Leiden University 
Medical Center and was carried out in Leiden. The Institutional Review Board of 
University of Pittsburgh approved review and analysis of the data. We included 16 
patients planned for elective coronary artery bypass surgery or mitral valvuloplasty. 
All patients signed informed consent on the day before surgery. Patients with previous 
myocardial infarction, left ventricular ejection fraction < 45%, aortic insuffi ciency, 
aortic aneurysm or extensive peripheral arterial occlusive disease were not considered 
for the study. The protocol was started during the fi rst postoperative hour after admission 
to the ICU. Sedation was maintained with propofol (3.2 mg·kg-1·h-1) and sufentanil 
(0.17 μg·kg-1·h-1). The patients were mechanically ventilated in airway pressure 
release ventilation mode (Evita 4, Dräger AG, Lübeck, Germany) adjusted to achieve 
normocapnia (arterial pCO2 between 40 and 45 mmHg) with tidal volumes of 7.3 ± 1.3 
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ml·kg-1, a respiratory rate of 12·min-1 and 5 cmH2O positive end-expiratory pressure. 
All patients were in sinus rhythm. Hemodynamic stability was achieved using fl uids 
(60 ml·hour-1) and catecholamines. During the study interval, no changes were made 
in vasoactive drug therapy, except for the protocolized increase in NE dosage, and all 
patients were hemodynamically stable. Every patient experienced full recovery from 
anesthesia within 8 hours after surgery and was discharged from intensive care unit on 
the fi rst postoperative day.
Physiological monitoring. Pa was measured with a radial artery catheter and central 
venous pressure (Pcv) was measured with a venous catheter inserted in the right 
internal jugular vein. Both catheters were connected to a pressure transducer (PX600F, 
Edwards Lifesciences, Irvine, Califormia, USA). Zero levels of blood pressures were 
referenced to the intersection of the anterior axillary line and the fi fth intercostal space. 
Airway pressure was measured at the proximal end of the endotracheal tube with an 
air-fi lled catheter connected to a transducer, balanced at zero level against ambient air. 
Beat-to-beat CO, stroke volume and stroke volume variation (SVV) were obtained by 
Modelfl ow pulse contour analysis (Modelfl ow, FMS, Amsterdam, The Netherlands) 
as previously described and validated by us.17-20 Modelfl ow was calibrated with the 
averaged result of three measurements with the bolus lithium indicator dilution method 
(LiDCO Ltd, Cambridge, UK) at the beginning of the protocol. For the lithium dilution 
method an injection of lithium chloride (0.3 mmol) is given in the central venous 
catheter, and the resulting arterial lithium-time curve is recorded by withdrawing blood 
past a lithium sensor attached to the patient’s radial artery line. Pressures were recorded 
online using a data acquisition program on a personal computer.
Determination of Pmsf. Previously we described the bedside determination of Pmsf 
in detail.15 Summarizing, we measured steady-state Pa, Pcv and CO over the fi nal 3 
seconds for a set of four inspiratory holds of 12 seconds at airway plateau pressures of 
5, 15, 25 and 35 cm H2O. The inspiratory hold maneuvers were separated by 1-minute 
intervals to reestablish the initial hemodynamic steady state. During these inspiratory 
holds, when airway pressure increased, Pcv increased concomitantly, whereas CO and 
Pa decreased with a delay of three to four beats resulting in a plateau between 7 and 
12 seconds after start of the infl ation. Next, a venous return curve was constructed by 
plotting the values of the four pairs of Pcv and CO against each other. Pmsf was defi ned 
as the Pcv after fi tting a linear line through these data points and extrapolating CO to 
zero (fi gure 10.1).
Protocol. After stabilization of the patient in the intensive care unit, series of baseline-1 
measurements were done of Pa, Pcv, CO and Pmsf. Next, continuous NE infusion 
rate was increased to induce a 20 mmHg increase in Pa and after 15 minutes the 
series of measurements were repeated. The observation period ended with baseline-2 
Chapter 10
141
measurements 15 minutes after returning to a NE infusion rate equal to baseline-1 
condition.
Figure 10.1 Example of a venous return curve
Venous return curve plotted for 1 patient after 4 inspiratory hold maneuvers. At increasing values of 
airway pressure, central venous pressure (Pcv) increases and cardiac output (CO) decreases. Mean 
systemic fi lling pressure (Pmsf) is the value of Pcv, when cardiac output is extrapolated to zero 
(marked with an arrow). Measurements were performed during baseline conditions (closed diamonds, 
straight line, Pmsf indicated by a) and after norepinephrine dosage increase (open circles, dotted line, 
Pmsf indicated by b).
Data analysis and statistics. The venous return data (Pcv versus CO) were fi tted 
using a least-squares method. The extrapolation of the regression line to zero CO 
determines Pmsf. Total vascular systemic resistance was calculated as the ratio of the 
pressure difference between Pa and Pcv and CO (Rsys = (Pa-Pcv)/CO). The resistance 
downstream of Pmsf was taken to refl ect resistance for venous return and calculated 
as the ratio of the pressure difference between Pmsf and Pcv and CO (Rvr = (Pmsf-
Pcv)/CO). The pressure gradient for venous return (Pvr) was defi ned as the pressure 
difference between Pmsf and Pcv. After confi rming a normal distribution of data with 
the Kolmogorov-Smirnov test, differences in parameters during baseline condition 
(mean of baseline-1 and baseline-2) and the condition with increased NE infusion 
rate were analyzed using paired t-tests. SVV as predictor of the NE-induced change 
in CO was analyzed using a receiver operating characteristic curve. The precision of 
the receiver operating characteristic analysis for the area under the curve, sensitivity, 
specifi city and cut-off values are reported as 95% confi dence intervals. All values are 
given as mean ± SD. A p-value < 0.05 was considered statistically signifi cant.
Results
Sixteen patients were included in the study with a mean age of 64 ± 11 years, mean 
weight 90 ± 17 kg, and mean length 176 ± 8 cm. All patients underwent coronary 
artery bypass surgery, except one patient who had a mitral valvuloplasty. All patients 
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which was given to one patient in low dosage (1 μg·kg-1·min-1), no other vasoactive 
medication was given. 
Table 10.1 shows the pooled results of baseline measurements before (baseline-1), 
during increased NE infusion rate and after return to original NE dose (baseline-2). 
There were no signifi cant differences in hemodynamic values between baseline-1 and 
baseline-2. An average increase in NE dosage of 0.04 ± 0.02 μg·kg-1·min-1 induced 
an increase of Pa with 19.7 ± 8.7 mmHg. Increasing NE resulted in a decrease in CO 
in 10 patients and an increase in CO in 6 patients (table 10.1). In the patients with 
a CO decrease, NE was increased from 0.04 ± 0.04 to 0.09 ± 0.06 μg·kg-1 ·min-1; in 
the patients with a CO increase, NE was increased from 0.04 ± 0.04 to 0.08 ± 0.02 
μg·kg-1 ·min-1). The dose of NE during baseline conditions as well as the dose during 
NE increase did not differ between both groups. The 10 patients that decreased CO on 
NE had a signifi cantly higher rise in Pcv, Rsys and Rvr during NE (p-values 0.042, 
0.002 and 0.019 respectively) compared to the 6 patients that increased CO on NE. 
Furthermore, these 10 patients had a decline in HR (p = 0.002) and a stable stroke 
volume, while the group of 6 patients with an increase in CO had a stable HR and an 
increase in stroke volume (p = 0.001). The patients with a CO decrease during NE had 
at baseline a signifi cant lower SVV (p = 0.012) as well as a lower SVV during NE (p = 
0.001) compared to the patients with a CO increase during NE.  
When predicting CO response to NE based on SVV, a receiver operating characteristic 
curve with an area under the curve of 0.900 (95% CI 0.647-0.987, p = 0.0001) was 
found and a cut-off SVV value of 8.7% with a sensitivity and specifi city of 100% and 
70%, respectively.
Discussion
Our study shows that NE-induced increases in arterial pressure can be associated with 
either an increase or a decrease in CO in stable postoperative cardiac surgery patients 
depending on baseline ventricular responsiveness. Those patients with a greater baseline 
SVV increased their CO in response to a NE-induced increase in arterial pressure.  
The physiologic explanation for these divergent CO responses in a group of otherwise 
similar patients rests in the differential effects NE had on venous return and ventricular 
function between these two subgroups of patients. To illustrate this point, we plotted 
venous return curves (based on the inspiratory hold maneuvers) and an estimation of 
a cardiac function curve for both CO-increasing and CO-decreasing patients (fi gure 
10.2A and B). We used SVV as a measure of the steepness of the cardiac function 
curve.21 Because the heart can only pump into the arteries that which it receives and the 
heart has minimal reservoir capacity venous return matches CO very closely over a few 
heart beats.22 Thus, the intersection of the cardiac function and venous return curves 
at the time of study refl ects steady-state CO and its change if either of these relations 
varies. These points are expanded upon below.
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Table 10.1 Pooled results for 16 patients at start (Baseline-1), after increasing norepinephrine 
dosage (NE) and 15 minutes after decreasing the norepinephrine infusion to original dosage 
(Baseline-2).
All Patients (n = 16)
      Baseline-1             NE       Baseline-2             p
Pa (mmHg)   81.60 ± 10.16   101.85 ± 9.81    82.80 ± 13.60       < 0.001
HR (min-1)     74.4 ± 14.0       70.1 ± 13.8      75.7 ± 14.1          0.003
CO (l•min-1)     4.30 ± 0.78       4.09 ± 0.67      4.44 ± 0.80          0.043
SV (ml)     59.4 ± 13.3       60.4 ± 15.2      60.7 ± 15.6          0.825
Pcv (mmHg)     7.61 ± 2.07       8.55 ± 2.35      7.58 ± 2.13       < 0.001
Pmsf (mmHg)   21.44 ± 6.12     27.57 ± 7.39    21.98 ± 5.34       < 0.001
Pvr (mmHg)   13.60 ± 5.66     19.02 ± 6.20    14.26 ± 5.16          0.001
Rvr (mmHg•min•l-1)     3.14 ± 0.94       4.72 ± 1.64      3.22 ± 0.99       < 0.001
Rsys (mmHg•min•l-1)   17.42 ± 3.88     23.31 ± 4.09    17.35 ± 4.27       < 0.001
Rvr/Rsys     19.0 ± 7.9       20.4 ± 6.6      19.2 ± 6.9          0.305
SVV (%)     11.1 ± 4.0         7.9 ± 4.3      11.0 ± 4.7       < 0.001
Patients with CO increase after NE Group A (n = 6)
      Baseline-1             NE       Baseline-2             p
Pa (mmHg)   81.65 ± 13.67     98.41 ± 10.68     85.14 ± 19.27          0.010
HR (min-1)     73.2 ± 17.0       72.7 ± 16.1 h.       73.0 ± 16.1          0.419
CO (l•min-1)     4.06 ± 0.93       4.31 ± 0.86 d.       4.16 ± 0.80          0.004
SV (ml)     57.5 ± 16.9       61.4 ± 16.8       59.2 ± 17.1          0.001
Pcv (mmHg)     7.57 ± 2.30       8.03 ± 2.68 e.       7.37 ± 2.25          0.064
Pmsf (mmHg)   19.80 ± 5.27     23.57 ± 4.62     19.22 ± 4.40          0.014
Pvr (mmHg)   12.23 ± 4.36     15.55 ± 4.34     11.85 ± 4.02          0.024
Rvr (mmHg•min•l-1)    2.97  ± 0.57       3.58 ± 0.64 c., f.       2.82 ± 0.73          0.026
Rsys (mmHg•min•l-1)   18.83 ± 5.01     21.54 ± 4.36 g.     18.97 ± 5.07          0.022
Rvr/Rsys     16.7 ± 6.0       17.1 ± 4.3       15.2 ± 3.4          0.355
SVV (%)     14.4 ± 4.2 a.       11.9 ± 2.7  b.       14.9 ± 3.7          0.009
Patients with CO decrease after NE Group B (n = 10)
      Baseline-1             NE       Baseline-2             p
Pa (mmHg)   82.52 ± 8.10   103.91 ± 9.19     82.22 ± 9.21       < 0.001
HR (min-1)     75.1 ± 12.8       68.6 ± 12.9 h.       77.3 ± 13.4          0.002
CO (l•min-1)     4.46 ± 0.64       3.96 ± 0.52 d.       4.61 ± 0.74          0.002
SV (ml)     60.5 ± 11.6       59.8 ± 15.1       61.6 ± 15.5          0.558
Pcv (mmHg)     7.57 ± 1.93       8.86 ± 2.22 e.       7.65 ± 2.06       < 0.001
Pmsf (mmHg)   22.40 ± 6.11     29.97 ± 7.88     23.51 ± 4.94          0.005
Pvr (mmHg)   14.77 ± 5.52     21.10 ± 6.38     15.86 ± 4.54          0.010
Rvr (mmHg•min•l-1)     3.29 ± 1.00       5.41 ± 1.68 c., f.       3.48 ± 0.93          0.001
Rsys (mmHg•min•l-1)   16.67 ± 2.34     24.37 ± 3.74 g.     16.49 ± 2.96       < 0.001
Rvr/Rsys     20.3 ± 7.8       22.3 ± 7.2       21.5 ± 6.4          0.478
SVV (%)       9.1 ± 2.4 a.         5.3 ± 2.9 b.         8.7 ± 3.6       < 0.001
NE, norepinephrine; Pa, mean arterial blood pressure; HR, heart rate; CO, cardiac output; SV, stroke 
volume; Pcv, central venous, pressure; Pmsf mean systemic fi lling pressure; Pvr, pressure gradient for 
venous return; Rvr, resistance to venous return; Rsys, systemic vascular resistance; Rvr/Rsys, location of 
Pmsf; SVV, stroke volume variation. 
Comparing mean baseline value between Group A and B: a. p = 0.012. Comparing norepinephrine values
between Group A and B:b. p = 0.001; c. p = 0.009. Comparing change in value induced by norepinephrine
between Group A and B: d. p < 0.001; e. p = 0.042; f. p = 0.019; g. p = 0.002; h. p = 0.003
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Cardiac output increase by norepinephrine. In 6 patients CO increased during NE. 
We schematically constructed an averaged venous return curve and a cardiac function 
curve for these patients (fi gure 10.2A) based on the average values of Pcv, Pmsf and CO 
(table 10.1). Two mechanisms determine the change in the venous return curve during 
NE: an increase in effective circulating blood volume as manifest by an increased Pmsf 
and an increase in Rvr. How can Pmsf increase during NE?  This can occur due to a 
decrease in systemic vascular compliance or a decrease in systemic vascular unstressed 
volume. Changes in systemic vascular compliance in response to low dose NE are 
minimal; however, decreases in unstressed volume are more likely owing to blood fl ow 
redistribution away from high unstressed volume vascular beds.23 Unstressed volume 
is the blood volume that is required to fi ll the circulatory system without causing 
intravascular pressure and stressed volume (the volume that stretches the vascular 
system to create the intravascular pressure, Pmsf).23 Thus, as Pmsf increased during 
NE without a change in total blood volume, the increase in Pmsf is the result of a 
volume shift from the unstressed to the stressed compartment (fi gure 10.2A shift from 
point a to b). This recruitment of volume from unstressed to stressed volume can be the 
result of an increased arteriolar resistance to those parts of the circulation with a high 
proportions of unstressed volume (e.g. splanchnic circulation)24 or a selective increase 
in venous smooth muscle tone.
An increase in venous smooth muscle tone will not only decrease unstressed volume, 
but also diminish the cross-sectional area of the venous vessels and increase Rvr, which 
will be manifest by the lower slope of the venous return curve during increased NE 
compared to baseline condition (fi gure 10.2A, point c). The increase in Pmsf with 
NE while Pcv was constant results in an increased Pvr. Although both Pvr and Rvr 
increased, the ratio (which defi nes venous return) increased during NE. Because venous 
return and cardiac output must be equal over time, the intersection of the venous return 
curve and the heart function curve determines cardiac output (fi gure 10.2A, points a 
and c). The heart function curve has to fi t through these data points if there is no change 
in heart function. 
The decrease in SVV from baseline to NE (14.4% to 11.9%) indicated that the patients 
shifted to a less steep part of their cardiac function curve. This change in ventricular 
responsiveness could have been due to either the increased fi lling or the impaired output 
owing to the associated increased afterload. Since CO increased in these patients, the 
most likely primary mechanism for the decrease in SVV is an increase in preload (an 
increase in venous return), resembling volume expansion, which, in this case, is achieved 
by recruitment of volume from the unstressed to the stressed compartment. Thus, in our 
patients who increased CO on NE, the likely working mechanism of NE is recruitment 
of intravascular volume resulting in an increase in Pmsf, which has a stronger effect 
than the associated increase in Rvr and left ventricular afterload (increased Pa).
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Figure 10.2 Effects of norepinephrine explained with venous return and cardiac output curves
Venous return (VR) curve and cardiac output (CO) curve constructed from average values of central 
venous pressure (Pcv), mean systemic fi lling pressure (Pmsf) and CO for patients who increased CO 
(A) and decreased CO (B) after norepinephrine (NE) dose increase. The dots are the mean values 
derived from table 2 for the CO-increasing and the CO-decreasing group. 
Panel A: a. indicates working point of the circulation during baseline condition; b. indicates volume 
effect of generalized venoconstriction on CO by NE; c. indicates additional effect of venoconstriction 
on resistance to venous return (Rvr).
Panel B: d. indicates working point of the circulation during baseline condition; e. indicates volume 
effect of generalized venoconstriction on CO by NE; f. indicates additional effect of venoconstriction 
on Rvr; g. indicates effect of decreased heart function.
Such vasopressor-induced recruitment of blood volume from the unstressed compartment 
was previously described in dogs given α-adrenoceptor agonists (methoxamine 
hydrochloride and UK 14304-18).25 Similarly, in pigs with normal cardiac function, 
NE indeed shifted the venous return curve to the right (and increased Pmsf), without 
affecting Rvr, which increased venous return and thus CO.13 Recently, an increase in 
cardiac preload (defi ned as left ventricular end-diastolic area) was found in septic shock 
patients when NE infusion was started or infusion rate increased.5,10 It is not clear from 
those studies if the increased end-diastolic volume was due to increased venous return, 
cardiac dilation due to increased afterload or both. Potentially, in sepsis, the unstressed 
volume could act as a reservoir, from which blood volume can be recruited. Considering 
the marked vasodilation and excess blood fl ow often seen in resuscitated patients in 
septic shock, this assumption seems reasonable. Monnet et al.10 also suggested that in 
states where vasoconstriction is predominant, such as cardiogenic and hypovolemic 
shock, NE would not alter preload signifi cantly and thus could have different effects 
on CO. Indeed, NE infusion was associated with an unchanged CO in other studies in 
cardiogenic shock11,26, in head trauma and in septic patients.12 The latter two studies 
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in these patient groups or that their study group also consisted of both CO-increasing 
and CO-decreasing patients.
Cardiac output decrease by norepinephrine. In the remaining 10 patients in our study 
NE caused CO to decrease. In fi gure 10.2B we indicate at least three mechanisms 
determining the change in venous return or cardiac output with NE. These include 
the same two as for the other group, namely an increase in Pmsf (shift from point d to 
e) and Rvr (shift to point f), plus specifi cally for this group a decrement in the heart 
function curve (shift to point g). As in the increased CO with NE group, the increase in 
Pmsf is probably caused by same mechanisms, namely an increase in effective blood 
volume by recruitment of blood from unstressed to stressed volume concomitant with 
an increased Rvr. Importantly, the slope of the venous return curve (Rvr) changes 
signifi cantly more with NE in the CO decrease group as compared to the CO increase 
group. Despite the increase in Pmsf in the CO decrease group (point e), venous return 
decreased because of larger rise in Rvr (i.e. the fl attening of the slope of the venous 
return curve, point f) resulted in a decrement in the ratio of Pvr to Rvr and since venous 
return = Pvr/Rvr, these changes explain the resultant CO decrease.
Plotting the cardiac function curve and the intersection with the venous return curve 
revealed the third mechanism for the effects of NE on CO. Because Pmsf and Pcv both 
increased with NE, a shift of the working point downward to the steeper part on the 
same cardiac function curve cannot be the explanation for the decrease in CO in these 
patients. Also, the decrease in SVV is inconsistent with this explanation. The fall in 
CO can only be explained by a decrement in the cardiac function curve, as manifest 
by a less steep slope and reaching a lower plateau than it had at baseline (fi gure 10.2B, 
dashed heart function curve, point g). Thus, in patients that decrease CO on NE, the 
negative impact of increased left ventricular afterload becomes the dominant process. 
That initial baseline SVV, a measure of ventricular responsiveness, also identifi ed 
these patients from those whose CO increased, not only supports this mechanism 
but also suggests that simple bedside measures can be used to predict the response to 
NE-induced increased vasomotor tone on CO. Others have reported similar fi ndings. 
Desjars et al.7 observed a fall in CO in septic patients in response to a NE-induced 
increased Pa. Similarly CO decreased in hypotensive septic shock patients given nitric 
oxide synthase inhibition to raise Pa27 and in patients with cardiogenic shock where the 
decrease was attributed to mitral valve insuffi ciency.11 
Importantly, in our patients who decreased CO with NE, they also displayed HR 
reduction. This fi nding resulted in a stroke volume unchanged. HR changes in response 
to NE have been reported before but the changes are variable. No decrease in HR 
was reported in septic shock patients treated with NE.5,8,10,28,29 In fact, HR increased 
during NE infusion in both septic shock patients29 and septic pigs.13 Still other studies 
demonstrated a NE-induced reduction in HR in healthy humans30-32, normal and 
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hypertensive subjects33 and in several animal studies.14,34-36 The HR reduction in all 
these studies was attributed to a baroreceptor-mediated central sympathetic withdrawal 
triggered by the NE-induced increased blood pressure.34,36 However, such baroreceptor-
induced change in HR is accompanied by vasodilation of veins and arterioles.37 Thus 
a decrease in vascular resistance might also be expected. Presumably, the NE-induced 
increased vascular smooth muscle tone overrides the decrement in sympathetic tone 
because Pa increased. Still, it is diffi cult to explain why our subjects who decreased 
their CO in response to NE also manifest this HR reduction because the increase in 
Pa was similar to that of the other sub-group whose CO increased similarly. Another 
possible explanation is a chemoreceptor-mediated response, but this mechanism is 
more effective in hypotensive than in hypertensive states.37 Direct stretch of the right 
atrium by an increase in stressed volume (the Bainbridge refl ex) cannot explain the HR 
reduction, because it induces the opposite effect.37 Finally, if anything, any direct effect 
of NE should be an increase in HR due to direct beta adrenergic receptor stimulation. 
The differential effects of NE on CO in our study, together with an increase in Pa, are 
remarkably similar to those reported earlier for the hemodynamic response to aortic 
cross clamping prior to aortic aneurysm repair. The immediate effect of abdominal 
aortic cross clamping is to increase Pa. However, in those subjects with preserved 
ventricular pump function the decreased vascular bed perfusion reduces unstressed 
volume increasing both Pmsf and CO, whereas in those with impaired ventricular pump 
function, although Pmsf also increases the increased afterload results in a decrement 
in CO.38
Clinical implications of our study. In a hypotensive patient, maintenance of organ 
perfusion pressure while still sustaining an adequate CO is critical. Thus, the clinician 
has the choice between fl uid loading and vasoactive medication. Our study allows an 
insight in the mechanisms by which NE may alter CO. In some patients administration 
of NE mimics the effect of fl uid loading on CO and in others the CO declines because 
a disproportional increase in Rvr reduces venous return and because of decreased 
contractile reserve. Our data further suggests that in postoperative cardiac surgery 
patients a SVV > 8.7% is associated with an increased CO in response to NE. In the 
hypotensive critically ill patient the clinician can therefore choose either fl uid loading, 
administration of NE, or both to attempt to restore cardiovascular suffi ciency, depending 
on the fl uid responsiveness of the patient. Importantly, not only does a SVV < 8.7% in our 
study predict that NE will decrease CO but also that this is associated with a decrease in 
HR and cardiac function. In these patients, if one must simultaneously increase Pa and 
CO, the addition of an inotropic agent, like dobutamine, could be indicated. In pigs we 
showed that dobutamine decreases Pcv by an increase in cardiac function, leading to 
an increase in the pressure gradient for venous return. Together with a decrease in Rvr 
this results in an increase in CO.16 Although further study in patients with more diverse 
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clinical conditions, like trauma and sepsis, needs to be done before such a simplifi ed 
approach can be assumed to universally inform clinical decision-making, the approach 
we describe above can be used in studying those populations as well.
From a clinical perspective, increasing CO is not always the goal of resuscitation. In the 
hyperdynamic hypotensive patient, restoration of Pa, in order to improve vital organ 
perfusion pressure, despite a reduction in CO, is often an acceptable strategy. Finally, 
avoidance of peripheral edema is another potential goal of balanced resuscitation. In 
that regard, both NE and fl uid loading increase Pmsf, and thus the hydrostatic pressure 
in the capillaries and venules, increasing the potential for peripheral edema formation. 
Accordingly, using NE to avoid peripheral edema is not supported by the results of 
these studies. Theoretically, NE may have possible salutary effect on capillary fi ltration 
coeffi cient, if arterial vasoconstriction decreases capillary pressure. Furthermore, NE-
induced vasoconstriction might lead to reduced blood fl ow through some capillary 
beds all together, reducing global capillary fi ltration pressure. However, these effects 
of NE on peripheral edema formation are beyond the scope of this study.
Limitations and assumptions.  We only studied 16 patients, though their responses were 
very specifi c and the data reached statistical signifi cance. Thus, we doubt that increasing 
the number of study patients would reduce the differences found. Still some of the 
differences in calculated parameters may have reached statistical signifi cance with a 
larger patient cohort, although the directional changes would unlikely reverse. In this 
study population, a change in NE dose was not clinically indicated, as the patients had 
adequate CO and blood pressure. Restoring blood pressure in a previously hypotensive 
patient may result in different responses than those observed in our normotensive 
patients. However, no human study has been previously reported of the effects of NE 
on Pmsf and resistance to venous return. For this explorative study, we therefore chose 
a stable group of highly instrumented patients to describe the effects of NE. Future 
studies will need to examine the effect of NE on CO during hypotension due to sepsis, 
hypovolemia and impaired ventricular function and after volume resuscitation.  
Pmsf measured with the inspiratory hold technique has not been validated by comparing 
it with Pmsf by total circulatory stop-fl ow.39 However, Pinsky40 in intact canine showed 
Pmsf by ventilatory maneuvers to be equal to Pmsf by total circulatory stop-fl ow. We41 
recently showed in pigs that fl ow measured with a fl ow probe around the pulmonary 
artery, with a fl ow probe around the aorta and with Modelfl ow pulse contour were 
interchangeable. Furthermore, we found that estimations of Pmsf with the inspiratory 
hold technique using a fl ow probe around the aorta and pulse contour Modelfl ow method 
were interchangeable. We did not recalibrate the Modelfl ow after increasing NE dose 
because in a previous multicenter study18 in cardiac surgery patients, we showed that a 
single calibration of Modelfl ow was adequate and that vasoactive drugs did not affect 
the ability to track changes in CO thus induced.
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We assumed venous compliance to be constant during baseline and NE conditions. 
There are no human studies examining the effect of NE on venous compliance, but NE 
infusion in cats did not alter venous compliance.42 
Our patients were mechanically ventilated without spontaneous breathing efforts and 
they had regular heart rates, all prerequisites for a reliable estimation of the venous 
return curves, Pmsf, CO and SVV. These prerequisite conditions make our analysis not 
directly applicable to other patient groups. 
Conclusions
NE-induced increased Pa can either increase or decrease CO. The effect of NE on CO 
is a balance between increasing effective circulatory blood volume,  venoconstriction 
and increased left ventricular afterload in stable postoperative cardiac surgery patients. 
Larger SVV correlates with increasing CO in response to NE.
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Final considerations and clinical implications
The critical care physician has several therapeutic options in hemodynamically unstable 
patients. Fluid resuscitation can restore effective circulating volume and thereby 
increase venous return (VR), cardiac output (CO) and consequently oxygen delivery 
to vital organs. However, too vigorous fl uid administration can induce general and 
pulmonary edema which can lead to prolonged hospitalization1,2 and even increased 
mortality.3 Several vasoactive drugs are available: vasopressors, positive inotropic 
agents, vasodilators et cetera. The clinician has to decide frequently which strategy 
to use. Several tools are available to help the clinician in this decision-making, e.g. 
blood pressure, cardiac output, ventilator-induced variation in stroke volume or pulse 
pressure and echocardiography. 
Vo lume status and fl uid responsiveness
In order to decide either to give fl uid loading or medication, ideally one would like to 
know the exact volume status of a patient. In this respect, it is important to recognize 
that volume status and fl uid responsiveness are not the same.4 In the following examples 
this principle is illustrated. In fi gure 11.1 a normovolemic (panel A) and a hypovolemic 
patient (panel B) are depicted. The areas of unstressed volume (Vu) and stressed volume 
(Vs) are smaller in the hypovolemic patient and mean systemic fi lling pressure (Pmsf) 
is lower. Obviously with volume resuscitation, the normovolemic condition (panel A) 
can be restored in the hypovolemic patient. When treated with a vasoconstrictive agent, 
Pmsf is restored, volume is shifted from the unstressed to the stressed compartment and 
VR is augmented, but the patient still remains hypovolemic (panel C). 
Figure 11.1 Schematic representation of intravascular volumes during normovolemia and 
hypovolemia
Panel A: normovolemia, with total blood volume divided into unstressed volume (Vu) and stressed 
volume (Vs). Mean systemic fi lling pressure (Pmsf) is the pressure in the compartment of Vs
Panel B: hypovolemia, with a reduced area of Vu and Vs, and a decline in Pmsf
Panel C: hypovolemia with administration of venoconstrictive medication. Note that the sum of the 
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Figure 11.2 shows a normovolemic (panel A) and a septic patient (B). In the septic patient 
volume has shifted from the stressed to the unstressed compartment due to vasodilation 
and Pmsf is substantially lower. Subsequently, the pressure gradient for venous return 
will be lower, which compromises VR. The septic patient is actually normovolemic, 
because the sum of areas A and B are equal to panel A. However, the septic patient 
is fl uid responsive, just like the hypovolemic patient, and volume resuscitation will 
restore Pmsf. Consequently VR is corrected (panel C). Though, volume resuscitation 
will increase total blood volume substantially (seen as the larger sum of areas in panel 
C). During recovery this extra volume again has to be excreted. Another approach could 
be to restore venous tone with a vasoconstrictive agent. This will also restore Pmsf 
and VR (to panel A), without the cost of volume loading. In conclusion, both patients 
are fl uid responsive, but the patient in fi gure 11.1 is hypovolemic and the patient in 
fi gure 11.2 is normovolemic. Therefore a measure of volume status complementing 
fl uid responsiveness parameters is clinically valuable.
Figure 11.2 Schematic representation of intravascular volumes during sepsis
Panel A: normovolemia, with total blood volume divided into unstressed volume (Vu) and stressed 
volume (Vs). Mean systemic fi lling pressure (Pmsf) is the pressure in the compartment of Vs
Panel B: distributive shock, volume has shifted from Vs to Vu due to vasodilation and Pmsf is reduced.
Panel C: distributive shock after volume resuscitation, restoring Pmsf. Note that the sum of the areas 
Vu and Vs is enlarged.
The intravascular volume contains Vs and Vu. Vs is the most informative of these two 
volumes, because it represents the effective circulating blood volume. Vs generates 
Pmsf and consequently contributes to the pressure gradient for venous return. Vu can 
be seen as the reservoir from which volume can be recruited, but Vu does not take 
active part in the circulation. Magder and De Varennes5 succeeded in measuring Vs in 
the operating room during hypothermic circulatory arrest for major vascular surgery 
by stopping the cardiac bypass pump and passively draining blood in a reservoir and 
found a stressed volume of 1290 ± 296 ml. Obviously this technique does not lend 












Mean systemic fi lling pressure
Pmsf, which is the pressure that exists in the stressed volume compartment, could be 
a measure of Vs if we assume a constant systemic compliance (Csys). Indeed Vs = 
Pmsf • Csys. In this thesis we showed that it is feasible to determine Pmsf in ventilated 
ICU patients with the use of inspiratory holds.6 However, the technique of measuring 
Pmsf and Vs with the inspiratory hold method is too time-consuming for a practical 
application in the ICU.
Pmsf should theoretically be measured anywhere in the circulation, therefore the arm 
occlusion technique (Parm) could offer a solution. This interesting technique of creating 
a stop-fl ow in the arm was already proposed by Anderson.7 Parm can be measured 
relatively simple with only an upper arm cuff and a radial artery pressure measurement. 
We explored if Parm could be used as a measure for Pmsf. Although representing only a 
part of the body and thus being only a contributing factor to Pmsf, we found acceptable 
bias and limits of agreement (Chapter 5). Therefore, we concluded that Parm could 
serve as a substitute for Pmsf. With measurements of Parm after volume loading steps 
we showed that the possibility to estimate Vs (Chapter 7). With multiple volume steps 
of 50 ml a volume-pressure curve could be made, from which Vs could be calculated 
(fi gure 11.3). We showed that compliance did not change during the volume loading 
steps. In addition, we found that patients who had an increase in CO after fl uid loading 
had a signifi cantly smaller Vs than patients who did not increase CO. Thus patients on 
the steep part of the cardiac function curve had a smaller Vs than patients on the fl at part 
of the cardiac function curve. We need to emphasize that we included only postoperative 
cardiac surgery patients and excluded patients with impaired heart function. Therefore, 
further research has to be done to investigate this technique in other clinical conditions 
such as cardiac failure and septic shock. In septic shock, vasodilation reduces Pmsf and 
Parm with unchanged total blood volume (fi gure 11.2). In fi gure 11.3 is schematically 
depicted how Vs is reduced in sepsis, implying an increase in Vu.
Could Pmsf serve as a predictor of fl uid responsiveness as well? Pmsf assessed with the 
inspiratory hold method can only be determined in mechanically ventilated patients, 
which is the same limitation other predictors of volume responsiveness (stroke volume 
variation (SVV), pulse pressure variation (PPV)) have. We showed that Parm performs 
as good as SVV as predictor of CO response to fl uid loading (Chapter 6). Importantly, 
Parm can be determined in all patients, including spontaneously breathing patients and 
even in patients with irregular heart rate.  
Venous return
Besides being a measure of stressed volume, Pmsf is the driving force for venous 
return. Assessment of Pmsf allows the physician to construct venous return curves, to 
assess resistance to venous return and estimate vascular compliance (Chapter 7). As 
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Guyton8 showed, the venous return curve can be combined with a cardiac function 
curve. The intersection of both curves represents the working point of the circulation. 
The knowledge of the specifi c effects of vasoactive medication based on venous return 
curves and cardiac function curves in groups of patients, may guide the clinician in 
therapeutic actions in an individual patient. 
Figure 11.3 Determination of stressed volume 
Relationship between change in blood volume and mean systemic fi lling pressure (Pmsf) for a non-
septic patient at normovolemia (a) and after volume loading with 500 ml (b). In the fi gure stressed 
volume (Vs,n) is indicated. Removal of 1300 ml blood in this patient will lead to a Pmsf of 0, what 
rests in the circulation is unstressed volume. Thus Vs,n is 1300 ml. Sepsis is characterized by lower 
Pmsf at baseline (c) and after volume loading (d). Assuming a constant compliance, extrapolation 
leads to a stressed volume (Vs,s) of 800 ml, which is lower than Vs,n. As total blood volume is 
unchanged, unstressed volume increases in the septic patient.
The ability to assess resistance to venous return (Rvr) separately from total systemic 
vascular resistance (Rsys) allows specifying the hemodynamic effects of vasoactive 
medication. The question whether vasoactive medication affects the venous or the 
arterial side of the vascular system or both in ICU patients, can now be answered. In 
this thesis we showed that a positive inotropic agent as dobutamine predominantly 
decreases Rvr and to a lesser extent Rsys in pigs (Chapter 9). Besides increasing 
cardiac contractility, which is well known, dobutamine increases venous return due to 
the increase in the pressure gradient for venous return and the decrement in Rvr. 
There may be differences in effects between different species. Thus the question if 
























inspiratory hold method in future studies. 
Even within one species, humans, vasoactive medication can have opposite effects. In 
postoperative cardiac surgery patients, norepinephrine increased CO in some patients, 
while in other patients CO decreased (Chapter 10). We unraveled the different working 
mechanisms using venous return curves and cardiac function curves. The patients who 
increased CO increased venous return by recruitment of volume from the unstressed 
compartment. The patients with a CO decrease showed a signifi cant larger increase 
in Rvr and Rsys during administration of norepinephrine. Furthermore we showed 
that the response to norepinephrine could be predicted with SVV measurement. In 
addition, a reduction in heart rate seemed to indicate a decline in CO in response to 
norepinephrine. By increasing Pmsf, norepinephrine potentially can induce edema 
similar to fl uid loading. We concluded that our model with venous return and cardiac 
function curves makes it possible to investigate the effects of other vasoactive agents in 
different ICU patients with different pathophysiologic and pharmacologic conditions 
and possibly even predict these effects. 
Rvr is an intriguing parameter, which is important for control of venous return and 
which can be manipulated with medication. The combination of norepinephrine and 
dobutamine is frequently used in the ICU. Our studies with norepinephrine (increasing 
stressed volume, but also increasing Rvr and with a variable effect on CO) and 
dobutamine (increasing contractility as well as decreasing Rvr) provide a rationale 
for this combination. Future studies addressing the hemodynamic effects of other 
vasoactive medication (in terms of venous return and cardiac function curves), could 
provide further insight in choosing the appropriate agent, e.g. targeting Rvr, and could 
present other combinations e.g. vasopressin and nitroglycerin.  
Critical closing pressure and vascular waterfall
With the measurement of critical closing pressure (extrapolating arterial pressure at zero 
fl ow, Pcc), which exceeded Pmsf, we confi rmed the presence of a vascular waterfall 
(Chapter 8). The presence of this vascular waterfall allows a temporary preservation 
of fl ow to vital organs in case of cardiac arrest.9 When cardiac arrest continues, blood 
volume will leak from the arterial side of the vascular system to the venous side, because 
of the pressure gradient from Pcc tot Pmsf. Ultimately intravascular pressure will 
equilibrate to one pressure and fl ow will cease. The existence of a vascular waterfall 
has implications for calculation of vascular resistances. Arterial resistance should be 
calculated separately from Rvr. This further extends the model to characterize effects 
of medication.
Limitations
Because the application of inspiratory holds is necessary for the determination of Pmsf, 
Pcc and venous return, this technique is limited to mechanically ventilated patients. The 
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technique, we used in our studies, is as yet not available and suitable for routine clinical 
use, because it is time-consuming to execute the measurements. It takes approximately 
4 minutes to apply the inspiratory holds, and the subsequent analysis again takes several 
minutes. However, it could be possible to incorporate measurement and analysis into a 
computer program, providing the clinician with an extra set of hemodynamic variables, 
as Pmsf, Pcc, Rvr and Ra. 
For the assessment of Vs we assumed compliance to remain constant. We observed a 
constant compliance in the range of the measurements. We have no information about 
compliance beyond this range. Though, the values we observed were concordant with 
the values Magder and De Varennes5 measured during cardiac arrest. Also for the study 
on norepinephrine, we assumed an unchanged compliance, which was confi rmed in an 
animal study.10 Further studies regarding compliance will be of value.  
In conclusion, study of the venous side of the circulation broadens the clinician’s horizon 
beyond fl uid responsiveness and cardiac function. Measurement of Pmsf and Pcc adds 
to the understanding of the physiology and pathophysiology of hemodynamics and 
the effects of medication. Future studies to the effects of vasoactive medication with 
the inspiratory hold technique, will advance our knowledge and help the clinician in 
choosing the appropriate interventions (medication or fl uid strategy) in the treatment 
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The circulation is a circuit, in which blood fl ows to the heart (venous return), to be 
pumped by the heart (via the lungs) to the aorta (cardiac output). Starling placed the 
heart centrally in the circulation with the cardiac function curve. Consequently, analysis 
regarding cardiac output (CO) mostly concerns with preload, heart rate, contractility 
and afterload. The heart can be the limiting factor in the circulation, for example after 
myocardial infarction. However, when cardiac function is intact, CO is determined by 
venous return (VR). After all, the heart can only pump out, that which it receives and 
has very limited storing possibilities. Only for short periods of time CO can differ from 
VR after an intervention, but eventually CO and VR must reach a new equilibrium. 
Mean systemic fi lling pressure (Pmsf) is the pressure in the vascular system during 
cardiac arrest and is determined by intravascular stressed volume and venous vasomotor 
tone. Guyton was the fi rst to construct a VR curve by controlling right atrial pressure 
and measuring CO. When right atrial pressure was increased, VR and CO declined until 
zero fl ow was reached. At the point of zero fl ow right atrial pressure was equal to Pmsf. 
The pressure gradient between Pmsf and right atrial pressure or central venous pressure 
(Pcv) is the driving force for VR. The other determinant for VR is the resistance to 
venous return (Rvr). 
In this thesis measurement of Pmsf and Guytonian analysis of venous return curve is 
taken from the animal laboratory to the intensive care unit (ICU). 
Chapter 1 
This chapter focuses on the importance of the VR curve for the circulation and its 
historic background. Pmsf is determined by intravascular stressed volume and venous 
vasomotor tone and is thus a measure of volume status. The intravascular volume can 
be divided in stressed volume and unstressed volume. Volume can be shifted between 
the stressed compartment and the unstressed compartment by changes in venous 
vasomotor tone. In the VR curve, Pmsf is the zero intercept on the x-axis. The slope 
of the VR curve is determined by Rvr, which in turn is infl uenced by venodilation or 
venoconstriction, but mostly changed by redistribution of blood in the vascular system. 
Several clinical conditions in the ICU patient are analyzed using the combined VR 
curve and cardiac function curve. Compensation mechanisms and possible therapeutic 
actions are derived from these curves. Until recently Pmsf could only be measured 
during circulatory arrest. We describe a method to asses Pmsf by constructing a VR 
curve with the inspiratory hold method, which was used in several studies in the 
following chapters. 
Chapter 2 
This chapter focuses on VR physiology and the construction of VR curves with the 
inspiratory hold method in mechanically ventilated patients. With an inspiratory hold 
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maneuver a steady state with an increased Pcv and a reduced CO is induced. Applying 
several inspiratory holds at different airway pressure levels, the corresponding Pcv 
and CO values can be plotted into a VR curve. From these VR curves the clinician can 
obtain at the bedside not only Pmsf, but also the derived parameters: Rvr (slope of VR 
curve), systemic compliance (changes in Pmsf after volume expansion) and stressed 
volume (from a Pmsf-volume curve). This technique opens the door for future studies of 
the determinants of VR and the control of CO in different patient populations, different 
pathophysiologic conditions and under different pharmacologic conditions. In the 
future cardiovascular therapy can be based on assumptions derived by venous return 
physiology and can be directed by measuring Pmsf, Rvr, stressed volume and systemic 
compliance in a fashion like the way we now measure CO and arterial pressure.
Chapter 3 
In this study we investigated if Pmsf could be measured at the bedside using the 
inspiratory hold method in 12 postoperative cardiac surgery patients. We measured Pcv 
and CO (pulse contour analysis) during 4 inspiratory holds at different airway pressures. 
We constructed VR curves and determined Pmsf. Measurements were performed 
during 3 volume states: normovolemia (baseline), relative hypovolemia by placing the 
patients in 30˚ head-up position and relative hypervolemia by volume loading with 500 
ml colloid. The VR curve was linear for all measurements and the slope was unaltered 
by volume status. As expected, Pmsf increased with volume loading and decreased 
when a relative hypovolemic state was created. Mean baseline compliance was 0.98 
ml·mmHg-1·kg-1 en mean stressed volume was 1677 ml. We conclude that Pmsf can 
be determined in ICU patients with an intact circulation, making serial measures of 
circulatory compliance and stressed volume feasible.
Chapter 4 
The aim of this study was to validate the assumptions made in our study in Chapter 
3. These assumptions were: a. Pmsf can be determined with CO measurements using 
the pulse contour method and b. 4 inspiratory holds at different pressure levels are 
suffi cient to determine Pmsf. CO was measured in 10 piglets with a fl ow probe around 
the pulmonary artery (COr), with a fl ow probe around the aorta (COl) and with pulse 
contour method from aortic pressure (COpc). Seven inspiratory holds were applied with 
different airway pressures. We showed that COr equaled COl equaled COpc at the end 
of the inspiratory holds. Pmsf obtained with COl and with COpc were interchangeable 
and the small coeffi cient of variation confi rmed a good repeatability. Pmsf can thus be 
determined with use of pulse contour method. Furthermore we showed that Pmsf can 
be correctly estimated with 4, 3 and even 2 inspiratory holds. Consequently this study 





In this study we compared the level of agreement of three methods to measure Pmsf: 1. 
Pmsf determined with inspiratory hold maneuvers, 2. stop-fl ow pressure estimated in a 
model analogue of the circulation (Pmsa) and 3. arm equilibrium pressure during a 30 
second stop-fl ow in the arm (Parm). In eleven postoperative cardiac surgery patients 
measurements were performed in supine position, rotating the bed to 30 head-up tilt 
(HUT) and after fl uid loading (500 ml colloid). Mean Pmsf, Parm and Pmsa across 
all three states were 20.9 ± 5.6 mmHg, 19.8 ± 5.7 mmHg and 15.9 ± 4.9 mmHg, 
respectively. Bland-Altman analysis for the difference between Parm and Pmsf showed 
a non-signifi cant bias of -1.0 ± 3.08 mmHg and limits of agreement of -7.3 and 5.2 
mmHg. For the difference between Pmsf and Pmsa we found a bias of -6.0 ± 3.1 mmHg 
(p < 0.001) and limits of agreement of -12.4 and 0.3 mmHg. Changes in Pmsf and Parm 
and in Pmsf and Pmsa were fully concordant in response to HUT and volume loading. 
We conclude that Parm and Pmsf are interchangeable. Changes in effective circulatory 
volume are tracked well by changes in Parm and Pmsa.
Chapter 6 
Pmsf is the equilibrium pressure anywhere in the circulation under circulatory arrest 
and it could theoretically be measured at any site in the circulation. Furthermore, Pmsf 
is a measure of effective circulating volume. In this study we explored if the pressure 
in the arm under stop-fl ow conditions, which can be seen as the equilibrium pressure 
of the arm, can be used as a predictor of fl uid responsiveness. Arm occlusion pressure 
(Parm) was defi ned as the radial artery pressure after applying an upper-arm stop-
fl ow for 35 seconds with a cuff at a pressure 50 mmHg above patients’ systolic blood 
pressure. Measurements were performed before and after fl uid loading (500 ml colloid). 
In 24 patients after cardiac surgery, Parm was compared to SVV and PPV as a predictor 
of fl uid responsiveness. Patients whose CO increased by at least 10% were defi ned as 
the responders. The study population was divided into responders (n = 17) and non-
responders (n = 7). The area under the curve to predict fl uid loading responsiveness 
for Parm was 0.786 (95% CI: 0.567-1.000). For Parm < 21.9 mmHg sensitivity was 
71% and specifi city was 88% to predict fl uid loading responsiveness. Prediction of 
responders with Parm was not different from that of SVV and PVV. We conclude that 
Parm is a good predictor of fl uid loading responsiveness in cardiac surgery patients 
with normal ventricular function.
Chapter 7 
In this study we explored the value of Pmsf measured in the arm (Pmsfarm) for 
determination of vascular compliance and stressed volume. Hereto in 15 postoperative 
cardiac surgery patients 10 sequential infusions of 50 ml colloid were administered. 
After each fl uid loading step Pmsfarm, Pcv and CO were obtained. The Pmsfarm-volume 
curve was linear, indicating a stable vascular compliance. Stressed volume could be 
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determined by extrapolating the Pmsfarm-volume curve to zero pressure intercept. 
Stressed volume was estimated to be 1265 ± 541 ml (28.5 ± 15% predicted total blood 
volume). Cardiac function curves were plotted with the Pcv and CO values after each 
volume loading step. Patients who increased CO with > 12% after 500 ml fl uid loading 
were described as fl uid responsive. Fluid responding patients were on the steep part 
of the cardiac function curve and non-responding patients were on the fl at part of the 
curve. From these results we conclude that systemic vascular compliance, stressed 
volume and cardiac function curves can be determined at the bedside and may be used 
to characterize patients hemodynamically. 
Chapter 8 
During cardiac arrest a pressure gap persisted between venous pressure (i.e. Pmsf) and 
arterial pressure (Pa). The plateau to which Pa declines is called arterial critical closing 
pressure (Pcc). In this study we explored the feasibility of determining Pcc with the 
inspiratory hold method. In 10 postoperative cardiac surgery patients CO, Pcv and Pa 
were obtained with inspiratory holds at 4 increasing airway pressures. The pairs of 
CO and Pa can be plotted in a ventricular output curve. Pcc was the value of Pa when 
fl ow was extrapolated to zero. Arterial resistance (Ra) was calculated as the ratio of 
Pa-Pcc and CO, while Rvr was the ratio of Pmsf-Pcv and CO. Pcc exceeded Pmsf in all 
cases, with an average pressure gap of 26.8 mmHg. We conclude that vascular pressure 
gradients in cardiac surgery patients suggest the presence of a vascular waterfall 
phenomenon. Furthermore, vascular resistance can now be divided into arterial (Ra) 
and venous resistance (Rvr). Ra is closely related to total systemic vascular resistance 
(Rsys).
Chapter 9 
In this study we explored the hemodynamic effects of dobutamine and hypovolemia 
with a physiological model, which incorporated the VR curve, Pmsf, Rvr and Rsys. In 
10 piglets measurements were performed before, during and after dobutamine infusion 
and during hypovolemia and after fl uid resuscitation. Dobutamine increased CO and 
heart rate, but decreased Pmsf, Rsys and Rvr. The decrease in Rvr was signifi cantly 
greater than the decrease in Rsys. Hypovolemia decreased CO, Pcv, Pmsf and Rvr, while 
heart rate increased. We conclude that the increase in CO during dobutamine infusion 
is due to the combined increased cardiac function and decreased Rvr. The decrease in 
CO with hypovolemia is attributed to a decreased Pmsf, but is partly compensated for 
by a decrease in Rvr tending to preserve VR and thus CO.
Chapter 10 
In this study we explored the effects of norepinephrine on CO with use of VR curves 
and cardiac function curves. In 16 postoperative cardiac surgery patients, on low dose 
of norepinephrine, we measured Pmsf, Pcv, heart rate, stroke volume variation (SVV) 
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and CO before, during and after increased norepinephrine infusion. In 10 patients CO 
decreased and in 6 patients CO increased. In all patients Pmsf, Rsys and Rvr increased 
and SVV decreased. In the patients with a decline in CO, Rvr and Rsys increased 
more than in the patients who increased CO. Heart rate decreased in the patients with 
a decrease in CO and was unchanged in the patients with a CO increase. Baseline SVV 
was higher in the patients who increased CO and a SVV value > 8.7% predicted the 
increase in CO to norepinephrine (area under the curve of 0.900). We conclude that 
norepinephrine can increase CO by recruiting volume from the unstressed compartment, 
while the decrease in CO is attributed to a decrease in VR due to an increase in Rvr and 
possibly a decrease of heart function. The change in CO induced by norepinephrine is 
determined by the balance between volume recruitment (as determined by Pmsf) and 
the change in Rvr and heart function. Furthermore the response of CO to norepinephrine 
can be predicted by baseline SVV.
Chapter 11 
This chapter focuses on the difference between volume status and fl uid responsiveness. 
The clinical implications of VR curves, Pmsf and Pcc are explored. Finally limitations 
and suggestions for further research are discussed.
Nederlandse samenvatting
De bloedsomloop is een gesloten system, waarin bloed naar het hart stroomt (veneuze 
terugvloed), waarna het door het hart (via de longen) naar de aorta wordt gepompt 
(hartminuutvolume). Starling plaatste het hart centraal in de bloedsomloop met de 
hartfunctiecurve. Daarom staan in het onderzoek naar hartminuutvolume (cardiac 
output, CO) voorbelasting, hartfrequentie, contractiliteit en nabelasting van het hart op 
de voorgrond. Het hart kan de beperkende factor in de bloedsomloop zijn, bijvoorbeeld 
na een myocardinfarct. Als de hartfunctie echter intact is, wordt de CO bepaald door de 
veneuze terugvloed. Het hart kan immers alleen datgene uitpompen, dat het ontvangt en 
heeft weinig opslagruimte voor bloed. De CO kan na een interventie alleen kortdurend 
afwijken van de veneuze terugvloed, maar uiteindelijk zal er een nieuw evenwicht 
ontstaan tussen CO en veneuze terugvloed. De statische vullingsdruk (Pmsf) is de druk 
die ontstaat in het vasculaire systeem bij een hartstilstand en wordt bepaald door het 
circulerend bloedvolume en de veneuze vaattonus. Guyton liet als eerste zien hoe een 
veneuze terugvloedcurve kon worden geconstrueerd door de rechter atrium druk te 
veranderen en de CO te meten. Bij verhoging van de rechter atrium druk namen de 
veneuze terugvloed en de CO af, totdat uiteindelijk een CO van nul werd bereikt. Bij 
een CO en veneuze terugvloed van nul werd de rechter atriumdruk gelijk aan de Pmsf. 
Het drukverschil tussen Pmsf en de rechter atrium druk of de centraal veneuze druk 
(Pcv) is de drijvende kracht voor veneuze terugvloed. De andere determinant voor de 
veneuze terugvloed is de weerstand voor veneuze terugvloed (Rvr). 
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In dit proefschrift wordt het meten van de statische vullingsdru k (Pmsf) en de analyse 
van de curve van de veneuze terugvloed naar het hart beschreven. We maken hierin de 
stap van het dierexperimentele laboratorium naar de intensive care.
 
Hoofdstuk 1 
Dit hoofdstuk beschrijft het belang van de veneuze terugvloed voor de circulatie. 
De geschiedenis van het bepalen van de veneuze terugvloed en de Pmsf wordt kort 
beschreven. Pmsf wordt bepaald door het actief circulerend bloedvolume en de veneuze 
vaattonus en is dus een maat voor de volumetoestand. Het intravasculaire bloedvolume 
bestaat uit twee compartimenten: een compartiment met een bloedvolume, dat druk 
veroorzaakt in de bloedvaten (stressed volume, Vs) en een compartiment met een 
bloedvolume, dat de bloedvaten vult zonder druk op te bouwen (unstressed volume, 
Vu). Bloed kan verplaatst worden van het ene naar het andere compartiment door de 
veneuze vaattonus te veranderen. In de veneuze terugvloedcurve is Pmsf het snijpunt 
met de x-as, bij een CO van nul. De hellingshoek van de curve wordt bepaald door de 
weerstand voor veneuze terugvloed, die op zijn beurt wordt beïnvloed door veneuze 
dilatatie of constrictie, maar vooral door redistributie van bloed in het vasculaire 
systeem. Met behulp van de veneuze terugvloedcurve en de hartfunctiecurve worden 
relevante klinische ziektebeelden op de intensive care met compensatiemechanismen 
en behandelingsmogelijkheden beschreven. Tot voor kort kon de Pmsf alleen gemeten 
worden tijdens een circulatiestilstand. Wij beschrijven een methode om Pmsf te bepalen 
door een veneuze terugvloedcurve te maken met behulp van metingen van Pcv en CO 
tijdens inademingspauzes. Deze methode wordt in verschillende onderzoeken in de 
volgende hoofdstukken gebruikt.
Hoofdstuk 2 
In dit hoofdstuk beschrijven we de fysiologie van de veneuze terugvloed en het maken 
van een veneuze terugvloedcurve met behulp van inademingspauzes bij beademde 
patiënten. Tijdens een inademingspauze wordt een stationaire toestand bereikt met een 
verhoging van de Pcv en een verlaging van de CO. Nadat meerdere inademingspauzes 
met verschillende luchtwegdrukken zijn gegeven, wordt met de gemeten waarden van 
Pcv en CO een veneuze terugvloedcurve gemaakt. Uit deze veneuze terugvloedcurve 
kan de clinicus aan het bed niet alleen de Pmsf bepalen, maar ook afgeleide parameters: 
weerstand voor veneuze terugvloed (Rvr, helling van de curve), compliantie van de 
bloedsomloop (verandering in Pmsf na vloeistoftoediening) en actief circulerend 
volume (Vs, uit een Pmsf-volume curve). Deze techniek maakt het mogelijk onderzoek 
te doen naar de determinanten van de veneuze terugvloed en naar de beïnvloeding van 
de CO bij verschillende patiëntengroepen, verschillende pathofysiologische toestanden 
en bij verschillende farmacologische condities. In de toekomst zal de cardiovasculaire 
behandeling gebaseerd zijn op aannames, gestoeld op de fysiologie van de veneuze 
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terugvloed, en gestuurd worden door het meten van Pmsf, Rvr, actief circulerend 
volume en compliantie, zoals wij nu de CO en arteriële bloeddruk meten.
Hoofdstuk 3 
In dit hoofdstuk onderzoeken we bij 12 mechanisch beademde, postoperatieve, 
cardiochirurgische patiënten of Pmsf op de intensive care kan worden bepaald met 
gebruik van de methode met inademingspauzes. Tijdens 4 inademingspauzes met 
verschillende luchtwegdrukken werd de bij-behorende Pcv en CO (drukgolfmethode) 
gemeten. Hiermee werd een veneuze terugvloedcurve gemaakt, waaruit de Pmsf 
werd berekend. Deze metingen werden gedaan tijdens 3 vullingstoestanden: normale 
vulling (basistoestand), relatieve ondervulling (door de patiënten in 30˚ hoofd-omhoog 
positie te plaatsen) en relatieve overvulling (500 ml colloid toediening). Er was een 
linaire relatie tussen Pcv en CO en de hellingshoek hiervan werd niet beïnvloed door 
de vullingstoestand. Zoals verwacht steeg de Pmsf na volumetoediening en daalde de 
Pmsf in de toestand van relatieve ondervulling. De gemiddelde compliantie van de 
bloedsomloop in basistoestand was 0.98 ml·mmHg-1·kg-1 en het gemiddeld effectief 
circulerend volume was 1677 ml. Wij concluderen dat Pmsf gemeten kan worden bij IC-
patiënten met een intacte bloedsomloop door gebruik te maken van inademingspauzes 
met het beademingsapparaat. Deze procedure maakt het mogelijk de compliantie van 
de bloedsomloop en het effectief circulerend volume te volgen bij beademde patiënten.
Hoofdstuk 4 
Het doel van dit onderzoek was om de aannames te valideren, die gemaakt werden in het 
onderzoek uit Hoofdstuk 3. Deze aannames waren a. dat de Pmsf kon worden bepaald 
met behulp van CO metingen met de drukgolfmethode en b. dat 4 inademingspauzes 
met verschillende luchtwegdrukken voldoende waren voor de bepaling van de Pmsf. 
Bij 10 biggen werd de CO bepaald door de stroomsnelheid te meten in de arteria 
pulmonalis (COr) en in de aorta (COl) en met een drukgolfmethode van de druk in de 
aorta (COpc). Er werden 7 inademingspauzes met verschillende drukken gegeven. We 
toonden aan dat aan het eind van een inademingspauze de COr gelijk was aan de COl, 
die weer gelijk was aan de COpc. De Pmsf verkregen met COl en met COpc waren 
uitwisselbaar en de lage variatiecoëffi ciënt wees op een goede herhaalbaarheid. De Pmsf 
kan dus bepaald worden met behulp van de drukgolfmethode. Vervolgens lieten we 
zien dat de Pmsf correct kon worden bepaald met 4, 3 of zelfs 2 inademingspauzes. Dit 
onderzoek vormt daarmee een ondersteuning voor de aannames, die in het onderzoek 
in Hoofdstuk 3 gedaan werden.
Hoofdstuk 5
In dit onderzoek werden 3 manieren om de Pmsf te meten vergeleken: 1. Pmsf met de 
methode met inademingspauzes , 2. de druk berekend met een model van de circulatie 
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(Pmsa) en 3. equilibratiedruk tijdens een lokale circulatiestilstand van 30 seconden in 
de arm (Parm). Deze metingen werden bij 11 postoperatieve hartchirurgie patiënten 
gedaan in rugligging, in een 30˚ hoofd-omhoog positie en na 500 ml colloid toediening. 
De gemiddelde waarden van Pmsf, Pmsa en Parm over de 3 toestanden waren 20.9 ± 5.6 
mmHg, 19.8 ± 5.7 mmHg en 15.9 ± 4.9 mmHg. Een Bland-Altman analyse voor Parm 
en Pmsf liet een niet signifi cant systematisch verschil zien van -1.0 ± 3.08 mmHg en 
grenzen van overeenkomst van of -7.3 en 5.2 mmHg. Voor Pmsf en Pmsa vonden we een 
systematisch verschil -6.0 ± 3.1 mmHg (p < 0.001) en grenzen van overeenkomst van 
-12.4 en 0.3 mmHg. De interventies (hoofd-omhoog en colloid toediening) induceerden 
veranderingen in Pmsf en Parm, en in Pmsf en Pmsa, die volledig concordant waren. 
We concluderen dat Parm en Pmsf inwisselbaar zijn en dat veranderingen in effectief 
circulerend volume goed worden gevolgd door veranderingen in Parm en Pmsa.
Hoofdstuk 6 
Pmsf is de druk die ontstaat in de bloedvaten tijdens een hartstilstand na het vormen van 
een nieuw evenwicht en kan dus theoretisch gezien op elke plaats in de bloedsomloop 
worden gemeten. Pmsf is tevens een maat voor het effectief circulerend volume. We 
onderzochten of de druk in de arm (Parm), gemeten tijdens een lokale circulatiestilstand, 
een maat is voor Pmsf en of Parm gebruikt kan worden als een voorspeller voor 
vloeistofresponsiviteit. Met een manchet om de bovenarm, opgeblazen tot 50 mmHg 
boven de systolische bloeddruk van de patiënt gedurende 35 seconden, werd een lokale 
circulatiestilstand verkregen. Parm werd gedefi nieerd als de druk in de arteria radialis 
30 seconden na het induceren van een circulatiestilstand in de arm. De metingen werden 
verricht voor en na de toediening van volume (500 ml colloid). De Parm werd bij 24 
patiënten na cardiochirurgie als voorspeller van vloeistofresponsiviteit vergeleken met 
slagvolumevariatie (SVV) en polsdrukvariatie (PPV). Patiënten met een stijging in CO 
van 10% of meer werden geclassifi ceerd als responders. 
De onderzoekspopulatie werd verdeeld in patiënten met vloeistofresponsiviteit (n 
= 17) en patiënten zonder vloeistofresponsiviteit (n = 7). De oppervlakte onder de 
voorspellingscurve voor Parm was 0.786 (95% betrouwbaarheidsinterval 0.567-1.000). 
Een Parm < 21.9 mmHg had een sensitiviteit van 71% en een specifi citeit van 88% om 
vloeistofresponsiviteit te voorspellen. Hiermee lijkt Parm een goede voospeller van 
vloeistofresponsiviteit bij cardiochirurgische patiënten met een goede ventrikelfunctie.
Hoofdstuk 7 
In dit hoofdstuk onderzochten wij de waarde van Pmsf gemeten in de arm (Pmsfarm) voor 
de bepaling van de compliantie van de bloedsomloop en het effectief circulerend volume. 
Daarvoor kregen 15 postoperatieve cardiochirurgische patiënten 10 opeenvolgende 
hoeveelheden van 50 ml colloid toegediend. Na elke vullingsstap werden Pmsfarm, 
Pcv en CO bepaald. Er was een linaire relatie tussen Pmsfarm en volume, wijzend 
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op een constante compliantie. Het effectief circulerend volume kon worden bepaald 
door extrapolatie van de Pmsfarm-volume curve naar een druk van 0. Het effectief 
circulerend volume werd geschat op 1265 ± 541 ml (28.5 ± 15% van voorspeld totaal 
bloed volume). Met behulp van de waarden van Pcv en CO na elke vullingsstap werd 
tevens een hartfunctiecurve gemaakt. Patiënten, bij wie de CO > 12 % steeg op 500 ml 
vulling, werden vloeistof-responders genoemd. Vloeistof-responders bevonden zich op 
een steil deel van de hartfunctiecurve, terwijl de patiënten, die niet vloeistofresponsief 
waren, zich op een vlak deel van de hartfunctiecurve bevonden. Uit dit onderzoek 
concluderen we dat de compliantie van de bloedsomloop, het actief circulerend volume 
en hartfunctiecurves bij intensive care patiënten kunnen worden bepaald en gebruikt 
om patiënten hemodynamisch in kaart te brengen.
Hoofdstuk 8 
Tijdens een circulatiestilstand blijft er een drukverschil bestaan tussen de veneuze 
bloeddruk (Pmsf) en de arteriële bloeddruk (Pa). Pa daalt tot een niveau, dat arteriële 
sluitingsdruk (Pcc) wordt genoemd. In dit onderzoek onderzochten wij de mogelijkheid 
om Pcc te bepalen met de methode van de inademingspauzes. Bij 10 postoperatieve 
cardiochirurgische patiënten werden tijdens inademings-pauzes met 4 toenemende 
luchtwegdrukken de CO, Pcv en Pa gemeten. Met de gepaarde waardes van CO en Pa 
kan een curve worden gemaakt, die we de ventrikel outputcurve noemden. De Pcc werd 
gedefi nieerd als de waarde van Pa bij een extrapolatie van de CO naar nul. De arteriële 
weerstand (Ra) werd berekend als de deelsom van Pa-Pcc en CO, terwijl Rvr gelijk was 
aan de deelsom van Pmsf-Pcv en CO. De Pcc was in alle patiënten hoger dan Pmsf, met 
een gemiddeld drukverschil van 26.8 mmHg. We concluderen dat de drukgradiënten bij 
cardiochirurgische patiënten wijzen op de aanwezigheid van een vasculaire waterval. 
Daarnaast tonen we dat de vasculaire weerstand nu gespecifi ceerd kan worden in een 
arteriële (Ra) en een veneuze weerstand (Rvr). Ra is nauw gerelateerd aan de totale 
systemische vasculaire weerstand (Rsys). 
Hoofdstuk 9 
Met een fysiologisch model, waarin de veneuze terugvloedcurve, Pmsf, Rvr en Rsys 
zijn opgenomen, onderzochten we de hemodynamische effecten van dobutamine en 
hypovolemie. Bij 10 biggen werden metingen gedaan voor, tijdens en na dobutamine 
toediening, en gedurende hypovolemie en na vloeistofresuscitatie. Dobutamine gaf 
een stijging van CO en hartfrequentie, maar een daling van Pmsf, Rsys en Rvr. De 
daling in Rvr was groter dan de daling in Rsys. Hypovolemie gaf een afname in CO, 
Pcv, Pmsf en Rvr en een toename in hartfrequentie. We concluderen dat de stijging 
in CO tijdens dobutamine toediening veroorzaakt wordt door de combinatie van een 
verbeterde hartfunctie en een afgenomen Rvr. De daling in CO tijdens hypovolemie 
wordt toegeschreven aan een daling van Pmsf, maar wordt gedeeltelijk gecompenseerd 
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door een daling van Rvr, waardoor de veneuze terugvloed en dus de CO gedeeltelijk 
behouden blijven.
Hoofdstuk 10 
In dit onderzoek werden de effecten van noradrenaline op de cardiac output (CO) 
geanalyseerd met behulp van veneuze terugvloedcurves en hartfunctiecurves. Bij 16 
postoperatieve cardiochirurgische patiënten, behandeld met een lage dosis noradrenaline, 
werden de Pmsf, Pcv, hartfrequentie, slagvolume variatie en CO gemeten voor, tijdens 
en na het verhogen van de noradrenaline dosering. Tien patiënten reageerden met 
een daling van de CO op noradrenaline en bij zes patiënten nam de CO toe. Bij alle 
patiënten werd een stijging gezien van Pmsf, Rsys en Rvr, terwijl de SVV afnam. Bij 
de patiënten met een afname in CO stegen Rvr en Rsys meer dan bij de patiënten met 
een CO stijging. De hartfrequentie nam af bij de patiënten met een afname in CO en 
bleef onveranderd bij de patiënten met een stijging van CO. De basismeting van SVV 
was hoger in de patiënten met een CO stijging en een basismeting van SVV > 8.7% 
voorspelde een CO stijging op noradrenaline (oppervlak onder de curve 0.900). We 
concluderen dat noradrenaline de CO kan verhogen door volume te rekruteren uit het 
unstressed volume. Een daling in CO op noradrenaline kan worden verklaard door een 
daling in veneuze terugvloed ten gevolge van een verhoogde Rvr en een mogelijke 
vermindering van hartfunctie. De verandering in CO in respons op noradrenaline wordt 
bepaald door de balans tussen rekrutering van volume (stijging Pmsf) en de verandering 
in Rvr en hartfunctie. De verandering in CO op noradrenaline kan worden voorspeld 
door de basismeting van SVV. 
Hoofdstuk 11
Dit hoofdstuk beschrijft het verschil tussen volumetoestand en vloeistof-responsiviteit. 
Daarnaast worden de klinische implicaties van veneuze terugvloedcurves, statische 
vullingsdruk en arteriële sluitingsdruk beschreven.
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List of abbreviations
AUC  Area under the curve
AVR  Aortic valve replacement
CABG  Coronary artery bypass graft
CO   Cardiac output
COV  Coeffi cient of variation
Csys  Total systemic vascular compliance
HR   Heart rate
HUT  Head-up tilt
ICU   Intensive care unit
LOA  Limits of agreement
LV   Left ventricle
NE   Norepinephrine
Pa   Arterial blood pressure
PAC   Pulmonary artery catheter
Pao   Aortic pressure
Parm  Arm equilibrium pressure
Pcc   Critical closing pressure
Pcv   Central venous pressure
PEEP  Positive end-expiratory pressure 
Pmsa  Model analogue pressure
Pmsf  Mean systemic fi lling pressure
Ppa   Pulmonary artery pressure
PPV   Pulse pressure variation 
Pra   Right atrial pressure
Pv   Venous pressure
Pvent  Ventilatory plateau pressure
Pvr   Pressure gradient for venous return
Ra   Arterial vascular resistance
ROC  Receiver operating characteristic
Rsys  Total systemic vascular resistance
RV   Right ventricle
Rvr   Resistance to venous return
SD   Standard deviation
SV   Stroke volume 
SVV  Stroke volume variation
Temp  Temperature
VR   Venous return
Vs   Stressed volume
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